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 II 
ABSTRACT 
 
 
There has been an increase in number of human infections by mycobacteria and 
opportunistic pathogens of the closely related nocardioform bacteria.  Frequent 
multiple drug resistance in these organisms makes it desirable to identify novel 
targets for antimicrobial agents.  Bacteriophages offer one way to do this as analysis 
of their DNA reveals great diversity in their genetic makeup, suggesting variety in the 
way they interfere with host cells.  Four novel nocardiophages were therefore isolated 
from soil and characterized.  Libraries of their nucleic acid were constructed and 
screened for clones inhibitory to a nocardioform of the genus Rhodococcus.  Nine 
clones were characterized, and minimum necessary DNA for inhibitory activity 
sequenced.  Of 18 ORFs predicted on these DNAs, 13 could not be assigned a 
function.  Genes similar to ones in databases apparently interfered with DNA 
metabolism, protein synthesis, or integrity of plasma membrane.  This genetic 
approach may be an efficient and effective way to discover novel targets for 
antibiotics. 
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 1 
1. INTRODUCTION 
 
 
 
 
1.1 Nocardioforms 
 
Nocardioforms are a group of Gram-positive bacteria which form a mycelium that 
breaks up into rods or coccoid elements.  They are a member of the aerobic 
actinomycetes and possess GC-rich DNA.  Their cell walls contain mycolic acids and 
have a type IV composition, recognized by the presence of meso-diaminopimelic 
acid, arabinose, and galactose.  In the ninth edition of Bergey’s Manual of 
Determinative Bacteriology, the genera Nocardia, Gordonia, Rhodococcus, and 
Tsukamurella are included in the nocardioforms (Holt et al., 1994).  Currently, 
taxonomy within these genera is changing rapidly, as modern molecular biological 
techniques contribute to the recognition of new species and reassignment of old ones 
(Brown-Elliot et al., 2006).  Closely related organisms include Mycobacterium and 
Corynebacterium.  The nocardioforms are usually saprophytic and abundant in the 
soil worldwide. 
 
 
1.1.1 Nocardioform infections 
 
Many nocardioform species cause infection in animals and humans, both 
immunocompetent and immunocompromised.  Typically, they cause a granulomatous 
inflammatory reaction, which may progress to abscess formation (McNeil and 
Brown, 1994).  However, symptoms may vary at each of potential infection sites 
including lungs, brain, bones, pericardium, skin, among others (Salinas-Carmona, 
2000).  Nocardioform species which cause human infections are listed in Table 1.1. 
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Table 1.1 Nocardioform species associated with human infections. 
Genus Species 
N. asteroides 
N. brasiliensis 
N. farcinica 
N. nova 
N. otitidiscaviarum 
Nocardia 
N. pseudobrasiliensis 
Rhodococcus R. equi 
G. terrae 
G. bronchialis Gordonia 
G. rubropertincta 
Tsukamurella T. paurometabola 
 
 
Although infrequently encountered in clinical practice, nocardioform infections are 
challenging to clinicians for several reasons.  They are difficult to diagnose because 
of nonspecific clinical presentations.  This problem is made worse by the difficulty in 
species identification, caused by their slow growth rate and incomplete classification.  
Recent advances in serological, biochemical, and molecular biological methods have 
not completely solved this problem.  Obtaining biological samples is another 
problem, as it requires invasive procedures in the infected organs (Corti and Fioti, 
2003).  In addition, a rapid test for routine use for most nocardioform species does 
not exist (Lederman and Crum, 2004). 
 
Knowledge of molecular basis of nocardioform virulence is slight, and host immune 
responses affecting disease progression are not well understood.  Main route of 
acquisition is believed to be through direct inhalation into the lungs or inoculation 
through the skin.   
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Incidence of human infections by nocardioforms has increased significantly over the 
last two decades, probably due to increase in population of the immunocompromised, 
mostly attributed to HIV/AIDS.  For example, autopsies have revealed that as many 
as 4% of AIDS patients die with evidence of Nocardia infection (Lederman and 
Crum, 2004).  There is a significant risk of mortality associated with many 
nocardioform infections.  For example, with R. equi, the overall rate of mortality is 
~25%: 50 – 55% in HIV-infected patients; 20 – 25% in non-HIV 
immunocompromised patients; and ~11% in immunocompetent hosts (Kedlaya, et 
al., 2001).  With Nocardia infections, the rate of mortality in immunocompetent hosts 
is estimated to be 10 – 50% (Lederman and Crum, 2004). 
 
In addition to their own importance in clinical settings, nocardioforms are 
phylogenetically close to major human pathogens Mycobacterium tuberculosis, 
causing human tuberculosis, and Mycobacterium leprae, causing leprosy.  
Tuberculosis claims ~2 million lives per year, more than can be attributed to any 
other bacterial infection (Corbett et al., 2003).  They are also pathogenically related, 
as both nocardioforms and mycobacteria may produce similar symptoms.  As a result, 
many Rhodococcus and Nocardia infections have been mistaken for tuberculosis 
(Takasugi and Godwin, 1991). 
 
There is no standard treatment for nocardioform infections, due to diverse clinical 
manifestations, variable levels of host immunocompetence, and variation in 
susceptibility to drugs.  Although surgery has been beneficial depending on the site 
and symptom of infection, combination antibiotic therapy is most widely in use 
(McNeil and Brown, 1994).  However, multiple resistance to all major classes of 
drugs by some of these organisms has been reported (Corti and Fioti, 2003; Hsueh et 
al., 1998; McNeil and Brown, 1994; Nordmann et al., 1992; Yazawa et al., 1993), 
making it desirable to identify additional targets and develop novel antimicrobial 
agents. 
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1.2 Targets for antibiotics 
 
Antibiotics are low molecular weight compounds that kill or inhibit susceptible 
bacteria and are either produced by microorganisms or artificially synthesized.  
Currently, there are five major targets for the action of antibiotics: biosynthesis of cell 
wall, protein, DNA, RNA, and folate coenzyme.  Major classes of antibiotics 
inhibiting these targets are briefly described below.   
 
 
1.2.1 Antibiotics which target cell wall biosynthesis 
 
The Gram-positive cell wall consists of a single 20 – 80 nm thick peptidoglycan layer 
outside the plasma membrane, while the Gram-negative counterpart consists of a 2 – 
7 nm thick peptidoglycan layer surrounded by a 7 – 8 nm thick outer membrane.  
Major classes of antibiotics which inhibit cell wall biosynthesis are β-lactams and 
glycopeptides. 
 
β-lactams act by making themselves available for catalytic action of transpeptidases, 
which are responsible for covalent cross-linking of peptide strands of peptidoglycan.  
The transpeptidases mistake the β-lactams for substrates, causing the enzyme to be 
stranded in mid-catalytic cycle (Knox et al., 1996). 
 
Glycopeptides prevent the cross-linking of the peptidoglycan units by binding to 
pentapeptidyl tails terminating in D-Ala4-D-Ala5.  This process occurs in both 
polymerized (but yet to be cross-linked) peptidoglycan units and lipid II molecules at 
the periplasmic face of plasma membrane (Walsh et al., 1996). 
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1.2.2 Antibiotics which target protein biosynthesis 
 
Prokaryotic protein biosynthesis is a complex process that takes place at 50S and 30S 
ribosomal subunits.  The 50S subunit consists of 23S rRNA, 5S rRNA, and ~34 
proteins, while the 30S subunit consists of 16S rRNA and ~21 proteins.  Major 
classes of antibiotics which target protein biosynthesis are macrolides, tetracyclines, 
aminoglycosides, and oxazolidinones. 
 
Macrolides bind to the 23S rRNA in the region of nucleotides 2058 – 2062, blocking 
the peptide exit tunnel and resulting in premature release of peptidyl-tRNA 
(Schlunzen et al., 2001). 
 
Tetracyclines block the binding of incoming aminoacyl-tRNAs to A-site on the 16S 
rRNA in the 30S ribosomal subunit.  This causes premature release of aminoacyl-
tRNA, which terminates the translation process without peptide bond formation 
(Chopra and Roberts, 2001). 
 
Aminoglycosides bind to a 16S rRNA pocket in the 30S ribosomal subunit, blocking 
the A-site for aminoacyl-tRNA binding (Carter et al., 2000). 
 
Oxazolidinones are the only structurally novel antibiotic to be developed in the last 
three decades.  The exact mechanism of action is unknown but has been proposed 
that they block the first step in peptide bond formation by binding to P-site in 
peptidyltransferase centre of the 23S rRNA in the 50S ribosomal subunit (Patel et al., 
2001). 
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1.2.3 Antibiotics which target DNA replication and repair 
 
Although not as complex as protein biosynthesis, DNA replication involves ~20 
proteins, especially by DNA polymerase III.  Fluoroquinolones target DNA 
replication, causing accumulation of cleaved DNA molecules by preventing their re-
ligation by α subunit of DNA gyrase and halt replication by preventing progression of 
DNA replication forks (Maxwell, 1997). 
 
 
1.2.4 Antibiotics which target folic acid metabolism 
 
Folic acid is essential for the synthesis of pyrimidines and purines, the precursors of 
DNA and RNA.  Sulfamethoxazole and trimethoprim block essential steps in the folic 
acid pathway, the former by inhibiting dihydropteroate synthase in a reaction which 
converts dihydropterin pyrophosphate and para-aminobenzoate to dihydropteroate, 
and the latter by inhibiting dihydrofolate reductase in a reaction which converts 
dihydrofolate into tetrahydrofolate (Walsh, 2003). 
 
 
1.2.5 Antibiotics which target DNA transcription 
 
The only antibiotics in clinical use which target transcription are rifamycins such as 
rifampicin.  They inhibit RNA polymerase by binding in the DNA/RNA tunnel of the 
β subunit, thereby preventing the RNA chain from elongating (Campbell et al., 2001).  
 
 
1.2.6 Summary of major targets for antibiotics 
 
Major classes of antibiotics and their targets are summarized in Table 1.2. 
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Table 1.2 Major classes of antibiotics and their targets. 
Antibiotic Target 
Cell wall synthesis  
     β-Lactams transpeptidases  
     Glycopeptides D-Ala-D-Ala termini of peptidoglycan and of lipid II 
Protein synthesis  
     Macrolides 23S rRNA 
     Tetracyclines A-site on 16S rRNA 
     Aminoglycosides A-site on 16S rRNA 
     Oxazolidinones P-site on 23S rRNA  
DNA replication / repair  
     Fluoroquinolones α subunit, DNA gyrase 
Folate coenzyme synthesis  
     Sulfamethoxazole dihydropteroate synthase 
     Trimethoprim dihydrofolate reductase 
RNA synthesis  
     Rifamycins β subunit, RNA polymerase 
 
 
1.3 Bacterial resistance to antibiotics 
 
Soon after any antibacterial agent is introduced for clinical use, resistance arises.  
Selection of resistance is inevitable, as it is a Darwinian consequence of antibiotic 
usage.  Bacteria resist antibiotics using four general mechanisms: drug inactivation, 
target alteration, prevention of drug influx, and drug efflux (Putman et al., 2000).   
 
The pharmaceutical industry has responded with modifications to already existing 
drugs or with new classes of drugs.  For example, penicillinase-stable penicillins, and 
second generation aminoglycosides were produced to counteract resistant organisms.  
However, resistance has emerged to the new agents in all cases, thereby repeating the 
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cycle (Bush, 2004).  Usage of a combination of existing drugs is not a complete 
solution, as evidenced by the emergence of multidrug-resistant pathogens 
(Livermore, 2004).  In order to keep ahead of resistance, development of new 
antimicrobial agents is vital. 
 
 
1.4 Antibacterial drug discovery 
 
Despite the emergence of multidrug-resistant bacteria, there has been a serious 
decline in development of novel antibacterials in the past several decades.  In 2000, 
the oxazolidinones were the first structurally novel antibiotic to be introduced in over 
thirty years.  Most antibiotics introduced since 1968 have been modifications of 
already existing ones (Powers, 2004).  One reason for this decline is difficulty in 
target identification (Projan and Shlaes, 2004). 
 
Traditionally, antibiotics were developed by screening natural sources for molecules 
with antimicrobial effects.  Most recently, searches for antibacterials have utilized 
bioinformatics to identify essential and conserved ORFs in bacterial genomes which 
may be potential targets (Thomson et al., 2004).  Currently, complete genome 
sequences of ~ 300 bacterial species are publicly available (http://www.tigr.org/tigr-
scripts/CMR2/CMRGenomes.spl), including those of many clinically important 
pathogens.  However, after more than 15 years since the beginning of the genomics 
era, not a single antimicrobial agent has been developed by this approach (Thomson 
et al., 2004).  Other novel methods currently employed for the discovery of new 
targets are transcriptional profiling and proteomic analysis (Bandow et al., 2003). 
 
Besides searching the bacterial genomes, various potential antimicrobial agents are 
currently under investigation.  These include antimicrobial peptides, bacteriophages, 
and probiotic bacteria (Gillor et al., 2005). 
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1.5 Antimicrobial peptides 
 
1.5.1 Eukaryotic antimicrobial peptides 
 
Gene-encoded, ribosomally synthesized antimicrobial peptides (AMPs) are widely 
distributed in nature and produced by both eukaryotes and prokaryotes.  AMPs are 
produced in phagocytes and mucosal epithelial cells of mammals, haemolymph of 
insects, and skin of amphibians, where they provide an early defence against invading 
microorganisms (Boman, 1995).  Some of well-characterized animal AMPs are 
defensins of humans, cecropins of insects, and magainins of frogs.  Animal AMPs 
display a broad spectrum of activity against both Gram-positive and -negative 
bacteria.  Although various AMP structures exit, those for which the mode of action 
has been elucidated act by membrane permeabilization (Papagianni, 2003).  
Examples of eukaryotic AMPs are shown in Table 1.3. 
 
 
Table 1.3 Examples of eukaryotic AMPs grouped according to structure. 
Structure Peptide Source 
Abaecin Insects 
Bac-5 Sheep  
High content of certain amino 
acid 
Prophenin Pigs 
α-Defensins Humans 
Insect defensins Insects Intramolecular disulfide bridges 
Plant defensins Plants 
Magainins Frogs 
Bombinins Frogs Amphiphilic α-helical structure 
Cecropin Insects 
(Modified from Papagianni, 2003) 
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1.5.2 Prokaryotic antimicrobial peptides 
 
Prokaryotic AMPs, known as bacteriocins, are a large and diverse group of toxins 
found in both bacteria and archaea.  They are narrow spectrum antimicrobials and use 
a variety of killing mechanisms.  Lactic acid bacteria produce the best-known Gram-
positive bacteriocins, the lantibiotics, which include nisin, a commercially used food 
preservative.  Bacteriocins produced by Gram-positive bacteria act by membrane 
depolarization, membrane leakage, and cell wall synthesis inhibition (Pag and Sahl, 
2002).  Well known bacteriocins from Gram-negative bacteria include colicins, 
microcins, both of which are produced by E. coli, and pyocins produced by 
Pseudomonas spp.  Modes of action by colicins include depolarization of cell 
membrane, degradation of DNA and RNA, and inhibition of cell wall and protein 
synthesis (Braun et al., 1994).  Microcins target cell membranes and biosynthesis of 
DNA, RNA, and proteins (Pons et al., 2002; Destoumieux-Garzón et al., 2002).  
Pyocins act by forming pores on cell membranes and degrading DNA and RNA 
(Duport et al., 1995; Parret and De Mot, 2000; Gillor et al., 2005).  Different groups 
of bacteriocins and their targets are summarized in Table 1.4.   
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Table 1.4 Bacteriocin types and their targets. 
Bacteriocin Class/type Target 
IA, II cell membrane 
IB cell wall synthesis: lipid II 
Lactic acid 
bacteria 
bacteriocins III unknown 
A, B, E1, Ia, Ib, K, 
N 
cell membrane 
E2, E7, E8, E9 DNA 
E3, E4, E6 protein synthesis: 16S rRNA 
E5, D protein synthesis: tRNA  
Colicins 
M cell wall synthesis: lipid carrier 
DNA replication: β subunit, DNA gyrase 
(gyrB) 
Transcription: β' subunit, RNA polymerase 
Modified 
Protein synthesis 
Microcins 
Non-modified cell membrane 
R, F cell membrane 
DNA 
cell membrane 
Pyocins 
S 
protein synthesis: tRNA 
 
 
1.6 Bacteriophage-mediated antimicrobials 
 
Bacteriophages hold potential for the development of novel antimicrobials.  This may 
be possibly done in three different ways: 1) phage therapy, 2) phage lytic enzymes, 
and 3) target identification. 
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1.6.1 Phage therapy 
 
The idea of using bacteriophages, the most abundant organisms on the planet, as 
antimicrobials is not new.  After d’Hérelle coined the term “bacteriophage” in 1916, 
he successfully treated a patient with severe dysentery using a phage preparation 
taken orally and set up phage therapy trials across the globe (Stone, 2002).  Phage 
therapy was extensively tested, succeeding against diseases such as dysentery, 
typhoid, paratyphoid, cholera, pyogenic and urinary-tract infections (Thacker, 2003).  
However, overall results were variable; due to ineffective trials and the advent of 
antibiotics, the use of bacteriophages as antimicrobials was abandoned.  In hindsight, 
the ineffective trials were caused by prescription of wrong phages or phages which 
were no longer viable (Pirisi, 2000). 
 
Although abandoned in the west, phages continued to be used as antibacterial agents 
in the former Soviet Union and Eastern Europe.  For example, during a civil war in 
the early 1990’s, Georgian soldiers carried spray cans with a phage suspension 
effective against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, 
Streptococcus pyogenes, and Proteus vulgaris (Stone, 2002).  In some Russian 
villages, civilians relied exclusively on phages as the cheaper option compared to 
antibiotics (Pirisi, 2000).  Although some data have been published, most do not exist 
in English. 
 
Phage therapy may offer several advantages over antibiotics.  Phages are able to 
mutate in step with evolving bacteria, thereby maintaining their virulence against 
pathogens which may build resistance.  Also, while antibiotics are metabolized by the 
host, phages multiply as long as host cells are present.  In addition, phages are 
specific in their bacterial targets, thus sparing patients from side effects which cause 
the destruction of beneficial bacteria and other cells.  Normal microbial balance in the 
body is therefore maintained, reducing risk of secondary infection, often by 
antibiotic-resistant pathogens (Merril et al., 1996).  Moreover, owing to the 
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abundance and diversity of phages in nature, it may be possible to constantly isolate a 
new variant that maintains its virulence. 
 
Due to the emergence of multidrug-resistant pathogenic bacteria, there has been a 
recent revival in interest in phage therapy.  One advance in phage therapy is against 
vancomycin-resistant enterococci, for which clinical trials are currently underway 
(Bradbury, 2004). 
 
 
1.6.2 Phage lytic enzymes 
 
Instead of phage therapy, there has been a recent interest in purification and 
characterization of phage lytic enzymes, which can be used to combat target bacteria.  
Phage enzymes directed against Gram-positive pathogens, including Streptococcus 
pneumoniae and Bacillus anthracis, have been isolated and shown to successfully 
destroy these pathogens both in vitro and in vivo (Loeffler et al., 2001; Schuch et al., 
2002).  For example, lytic enzyme Pal from S. pneumoniae phage Dp-1 has been 
shown to kill fifteen common serotypes of the bacterium, including highly penicillin-
resistant strains (Loeffler et al., 2001).  Lysin PlyG from B. anthracis phage γ is host 
specific, binding to cell wall antigens not recognized by current antibiotics (Schuch et 
al., 2002). 
 
 
1.6.3 Phage-mediated target identification 
 
Another approach to phage-mediated antimicrobial development is target 
identification.  This has been exemplified by a study by Liu et al. (2004), who 
screened the genomes of S. aureus phages for ORFs which were inhibitory to the host 
bacterium.  Targets of these antibacterial ORFs were then biochemically identified, 
followed by a high-throughput screen to discover small molecules which could 
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inhibit the host cell by the same mechanism as the phage protein.  Using this 
approach, 31 novel polypeptide families were identified from 26 S. aureus phages, 
several of which were inhibitory to DNA replication and transcription (Liu et al., 
2004).  This approach may be a powerful method to identify effective targets in the 
host, as phages are believed to have evolved multiple strategies to disable host cells. 
 
Although there is potential in the traditional phage therapy or in the use of their lytic 
enzymes, the development of novel antibiotics by recruiting phages in the 
identification of new targets may be the best phage-mediated antimicrobial.  Small 
antimicrobial molecules that are commonly used have been selected to have a 
sufficient degree of distribution in human tissues and appropriate levels of other 
pharmacokinetic properties.  Therefore, novel antibiotics are expected to better meet 
these criteria of an effective medicine compared to a phage particle or even a lytic 
protein, whose complexity is much higher and size much larger (Projan, 2004).  
 
 
1.7 Phage diversity 
 
A major factor contributing to the potential of phage-mediated target identification is 
the abundance of these viruses in nature.  For instance, > 50 different phages capable 
of infecting E. coli have been included in the Universal Virus Database 
(http://ncbi.nlm.nih.gov/ICTVdb/Ictv/index.htm).  In addition, it has been calculated 
that there are ~10 million bacterial species (Curtis et al., 2002).  If each of these is a 
host for ≥ 10 different phages, then the number of phage species may be at least 100 
million. 
 
Despite the predicted abundance of phages, the use of phage ORFs in identifying 
novel targets will be effective only if phages employ diverse mechanisms in 
inhibiting their hosts.  If all phages possess similar genes and use identical 
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mechanisms to act against their hosts, there are limited prospects of discovering new 
bactericidal mechanisms. 
 
Recent comparative genomic analyses of phages infecting Mycobacterium smegmatis 
(Hatfull et al., 2006; Pedulla et al., 2003), Pseudomonas aeruginosa (Kwan et al., 
2006), and S. aureus (Kwan et al., 2005) imply enormous diversity in their genetic 
makeup.  Only 15% of protein families from 30 sequenced mycobacteriophage 
genomes have sequence similarity to previously reported proteins (Hatfull et al., 
2006).  This percentage for 18 sequenced P. aeruginosa phages and 27 S. aureus 
phages are 35% and 45%, respectively (Kwan et al., 2006; Kwan et al., 2005).  
Moreover, all of these phage genomes display little relationship to each other (Hatfull 
et al., 2006; Kwan et al., 2006; Kwan et al., 2005), suggesting that each individual 
phage possesses unique genes.  Further support for these findings comes from a 
shotgun sequencing of uncultured viral communities in sea water, which have shown 
that ~75% of phage sequences are novel (Breitbart et al., 2002). 
 
Average number of ORFs from the sequenced M. smegmatis phages, P. aeruginosa 
phages, and S. aureus phages, are 112, 105, and 80, respectively (Hatfull et al., 2006; 
Kwan et al., 2006; Kwan et al., 2005).  If a conservative assumption is made that all 
100 million phage species in the world possess 50 ORFs, of which 50% are unknown, 
then there are 2.5 billion phage ORFs to be discovered (Rohwer, 2003).  Obviously, 
only a fraction of these ORFs would participate in killing the host; however, phages 
present an enormous pool of genes from which a large number of novel bactericidal 
mechanisms may be identified. 
 
 
1.8 Phage lethal genes 
 
Expression of phage genes may be early, middle, or late, depending on the time at 
which their transcription begins after initiation of infection.  Many lethal genes are 
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expressed early, as they take part in shutoff of host macromolecular biosynthesis.  
Knowledge of mechanism by which a phage functions in a host is limited.  Similarly, 
an overwhelming majority of genes believed to be lethal are uncharacterized.  Studies 
also suggest that a single phage may possess several numerous such genes.  A small 
number of them have been studied; when tested individually, a majority of these 
bactericidal genes have been proven to be dispensable during infection, indicating 
that a single phage has multiple strategies for killing a host.  Therefore, with respect 
to novel antimicrobial target identification, not only does the potential of phages 
attribute to the number of species and their genetic heterogeneity, but also to the 
variety of targets attacked by individual phage species.  It should also be noted that 
killing of hosts may not be the only function of many lethal genes; they may have 
other benefits for phage replication, while being deleterious to the host.  Some of the 
studied lethal phage genes are summarized below. 
 
 
1.8.1 Phage T4 
 
Studies on E. coli phage T4 began in the 1940s, but of its ~300 ORFs, 127 still have 
no assigned function (Miller et al., 2003).  Many of these unknown genes are 
unclonable, reinforcing the notion that they are lethal to the E. coli host, and a high 
level of their expression occurs early in the infection cycle (Miller et al., 2003).   
 
One example of a T4 lethal gene is alc, which uniquely recognizes the rapidly 
elongating form of RNA polymerase complex, leading to termination of transcription 
(Kutter et al., 1994).  Another example is Alt protein, which is packaged in the capsid 
and transported with DNA into the cell upon infection.  Alt functions by ADP-
ribosylating the α subunit of the host RNA polymerase (Igarashi et al., 1991). 
 
T4 possesses at least two other ADP-ribosyltransferase genes, modA and modB, 
which are known to be lethal to the host.  ModA ADP-ribosylates both α subunits of 
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the host RNA polymerase (Tiemann et al., 1999), whereas ModB acts on the 
translation machinery of the ribosome by ADP-ribosylating the S1 protein, elongation 
factor EF-Tu, and the chaperone “trigger factor” (Tiemann et al., 1999).  
 
Other T4 gene products inhibiting translation are Lit and Gol proteins.  Lit cleaves 
the host EF-Tu at a region which is central to the Mg-GTP-binding domain (Yu and 
Snyder, 1994).  This process is aided by Gol, which stabilizes the EF-Tu-GDP open 
complex, making it accessible for cleavage (Bingham et al., 2000).  Gol is also a part 
of a T4 head capsid protein, suggesting its dual function (Bingham et al., 2000). 
 
Intron- or intein-encoded DNases with highly specific recognition sequences are 
called homing endonucleases, which help to disseminate the intron/intein into 
specific regions of the genome.  T4 possesses > 15 such genes (Chevalier and 
Stoddard, 2001).  Although purpose served by the introns/inteins is not clear, these 
endonucleases have been shown to be bactericidal (Sharma et al., 1992). 
 
 
1.8.2 Phage T7 
 
T7 is an E. coli phage which has a number of genes implicated in host transcription 
shutoff.  Gp2 binds to promoters of host DNA, thereby abolishing promoter 
recognition by the host RNA polymerase (Nechaev and Severinov, 1999).  Gp0.7 is a 
serine/threonine protein kinase, which phosphorylates various biosynthetic 
components: among the transcription machinery includes the β' subunit of RNA 
polymerase (Zilling et al., 1975); RNase III, which is responsible for mRNA 
processing (Mayer and Schweiger, 1983); RNase E, which is involved in mRNA 
decay (Marchand et al., 2001); among the translation machinery includes IF1, IF2, 
IF3, elongation factor G, and ribosomal proteins S1 and S6 (Robertson et al., 1994).  
Phosphorylation of the β' subunit of RNA polymerase is lethal (Severinova and 
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Severinov, 2006).  Whether host viability is affected by the phosphorylation of other 
targets is yet to be discovered. 
 
 
1.8.3 Phage lambda 
 
Lambda is an extensively studied E. coli phage, although most works have focused 
on non-lethal genes.  One of few identified bactericidal gene products is peptidyl-
tRNA hydrolase, which cleaves peptidyl-tRNA and aminoacyl-tRNA (Garcia-
Villegas et al., 1991).  In addition, lambda p gene causes host death by inhibiting the 
binding of template DNA and ATP to the DnaA protein (initiator protein), thereby 
preventing DNA replication to begin (Datta et al., 2005).  CII gene product is another 
inhibitor of host DNA replication.  Although the exact mechanism is unknown, it 
seems to interfere with the association of DNA helicase with origin of replication 
(Kędzierska et al., 2003).  Another lethal gene product, Kil protein, inhibits cell 
division by interacting with components of the cell envelope (Sergueev et al., 2001). 
 
 
1.8.4 Phage SPO1 
 
Phage SPO1 of Bacillus subtilis possesses a cluster of early genes in a region named 
“host-takeover module”, including ~24 of mostly unknown function but believed to 
be involved in inhibition of host biosynthesis (Stewart et al., 1998).  An example of 
such gene is e3, whose expression leads to inhibition of DNA, RNA, and protein 
synthesis in both B. subtilis and E. coli (Wei and Stewart, 1993).  Products of genes 
44, 50, and 51 cause inhibition of host transcription, possibly by binding to RNA 
polymerase (Sampath and Stewart, 2004). 
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1.8.5 Phages with ssDNA or ssRNA genomes 
 
Where phages with dsDNA genomes encode two to five proteins to carry out host 
lysis, phages with small, single-stranded nucleic acids usually have only a single gene 
required for rupturing host cells (Bernhardt et al., 2001).  Instead of attacking pre-
existing peptidoglycan, these phages interfere with cell wall synthesis, thereby 
causing weakness in the wall, which collapses from osmotic pressure from within.  
For example, ssDNA phage фX174 encodes a single lytic enzyme, E, which blocks 
MraY, a bacterial membrane protein responsible for transfer of murein precursors to 
lipid carriers that transport it through the cell membrane (Bernhardt et al., 2000).  In 
the ssRNA genome of phage Qβ is a2 gene, encoding a protein inhibiting MurA, 
another essential enzyme for cell wall synthesis (Bernhardt et al., 2001).  Protein A2 
has multiple functions including adsorption to host sex pilus and protection against 
ribonucleases (Bernhardt et al., 2001). 
 
 
1.9 Phage isolation 
 
For phage-mediated antimicrobial identification, an additional advantage is that they 
are generally readily isolated from a variety of environments, such as soil, seawater, 
and sewage.  Félix d’Hérelle Reference Center for Bacterial Viruses constantly keeps 
a global record of new phage descriptions, including many unpublished data.  It is 
evident from their record (Ackermann, 2001) that a majority of isolated phages since 
1959 have hosts belonging to the genera Pseudomonas, Rhizobium, Escherichia, 
Salmonella, Vibrio, Lactococcus, Staphylococcus, Streptococcus, Bacillus, 
Clostridium, Lactobacillus, Listeria, and Streptomyces.  Nocardiophages, or phages 
that infect nocardioforms, are very scarce in their record (Anderson and Bradley, 
1961; Brownell et al., 1967; Riverin et al., 1970; Hiddema et al., 1985; Dabbs, 1987; 
Dabbs, 1998).  
 
 20 
In my previous study (Shibayama, 2004), a few nocardiophages were isolated using 
Rhodococcus erythropolis as a host and characterized.  Electron micrographs of two 
of these phages, FA2 and FA3, are shown in Figure 1.1.  In the current study, phage 
FA3 has been renamed Fairland1. 
 
 
  
                                               FA2                                            FA3 
 
Figure 1.1 Electron micrographs of phages FA2 and FA3 (Fairland1). 
             Bar = 100nm 
             (Taken from Shibayama, 2004) 
 
 
1.10 Aim of the project 
 
The aim of this work is to identify genes in novel nocardiophages whose products are 
inhibitory towards susceptible microorganisms.  To achieve this, novel 
nocardiophages will be isolated from soil and characterized.  Phage genomic libraries 
will be constructed using an E. coli-Rhodococcus shuttle vector and screened for 
genes inhibitory to the host by transformations.  For individual clones, minimum 
necessary DNA will be determined, sequenced, and compared to those in the 
databases.  Where possible, the functions of these genes will be identified by 
sequence similarity searches. 
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2. MATERIALS AND METHODS 
 
 
 
 
For all solutions and reagents used in this work refer to Appendix A. 
 
 
2.1 Bacterial and bacteriophage strains  
 
Bacterial strains used in this work, excluding those used for phage host range study, 
are listed in Table 2.1.  Bacterial strains used for phage host range study are listed in 
Table 2.2.  Phage strains are listed in Table 2.3. 
 
Table 2.1 Bacterial strains used in this work. 
Strain Relevant characteristics Source / reference 
E. coli   
MM294-4 hsdR17 endA1 gyrA Quan et al., 1997 
MM294-4 [λ] MM294-4 lysogenized with λcI857S7 Quan et al., 1997 
GM2929 dcm-6 dam13::Tn9 recF143, hsdR2 Bachman, B. 
   
R. erythropolis   
SQ1 Highly transformable derivative of 
ATCC4277 
Quan and Dabbs, 
1993 
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Table 2.2 Bacterial strains used for phage host range study. 
Strain Source 
Rhodococcus  
R. erythropolis ATCC 4277  Ferreira, N. 
R. erythropolis DSM 1069  DSM 
R. rhodochrous Ri8  Dabbs, E. 
R. opacus HL PM-1  Heiss, G. 
R. equi ATCC 14487  Ferreira, N. 
  
Gordonia  
G. australis A554 Ferreira, N. 
G. rubropertincta ATCC 25593  Ferreira, N. 
G. desulfuricans NB4  van Hamme, J. 
  
Nocardia  
N. mexicana IFO 3927  IFO 
  
Mycobacterium  
M. smegmatis mc
2
 155  Durbach, S. 
M. parafortuitum 490  Dabbs, E. 
ATCC, American Type Culture Collection; DSM, Deutsche Sammlung von 
        Mikroorganismen; IFO, Institute of Fermentation, Osaka. 
 
 
Table 2.3 Phages used in this work. 
Phage Host organism used for isolation Source / reference 
Fairland1 R. erythropolis Shibayama, 2004 
Wits1 R. erythropolis This work 
Kanazawa1 R. equi This work 
Perouges1 R. erythropolis This work 
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2.1.1 Media and growth conditions 
 
Liquid cultures of all bacterial strains were grown in LB medium on a shaker or 
wheel.  Plate cultures were grown on the same medium solidified with 1.5% agar. 
 
E. coli MM294-4 and GM2929 were grown overnight at 37°C, and MM294-4 [λ] was 
grown at 30°C.  Growth medium for MM294-4 and MM294-4 [λ] was supplemented 
with 50 µg/ml nalidixic acid. 
 
Rhodococcus, Gordonia, Nocardia, and Mycobacterium strains were grown for 2 – 4 
days at 30°C.  Growth medium for R. erythropolis SQ1 was supplemented with 50 
µg/ml rifampicin. 
 
For short-term storage, all strains were kept on agar plates at 4°C.  For long-term 
storage, cells suspended in 33% glycerol were stored at -70°C. 
 
All phages were propagated using R. erythropolis SQ1.  Optimal MOIs for phage 
propagation are shown in Table 3.6.  All phage suspensions were stored at 4°C. 
 
 
2.2 Plasmids 
 
Plasmids used in this work are listed in Table 2.4. 
 
Table 2.4 Plasmids used in this work. 
Plasmid Relevant characteristics Source / reference 
pDA71 E. coli – Rhodococcus shuttle vector Dabbs et al., 1995 
pUC18/19 E. coli cloning vector with lacZ', Amp-R Fermentas 
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Plasmid pDA71 was selected in transformations by 200 µg/ml ampicillin for E. coli 
and 40 µg/ml chloramphenicol for R. erythropolis.  Plasmid pUC18/19 was selected 
by 200 µg/ml ampicillin for E. coli.  Plasmids were stored in 6.09 M CsCl or 4 mM 
Tris-HCl at -20°C. 
 
 
2.3 Isolation of nocardiophages 
 
2.3.1 Soil assay 
 
One gram of soil was agitated in 10 ml of LB supplemented with 10 mM CaCl2 and 
MgCl2 in a 100 ml flask on a rotary shaker at ~80 rpm for 8 – 16 hr at 30°C.  The soil 
suspension was centrifuged in a Beckman JA-20 rotor at 15000 rpm for 10 min, after 
which the supernatant was decanted.  2 ml of this supernatant was added to 50 µl of a 
stationary phase culture of R. erythropolis SQ1, vortexed for 1 sec, and left at 30°C 
for 30 min.  Then 2 ml of sloppy agar was added, mixed by rolling between the 
palms, and poured on an LA plate supplemented with 100 µg/ml rifampicin, 100 
µg/ml kanamycin, 50 µg/ml nystatin, 10 mM CaCl2 and MgCl2.  The plate was 
incubated for ~2 days and checked for plaques. 
 
 
2.3.2 Production of phage suspensions 
 
Plaques were picked with by stabbing a toothpick through the soft agar and dipping 
this into 100 µl LB.  The suspension was vortexed for 1 sec, left for 5 min, and 
microfuged for 1 min, after which the phage was in the supernatant.   
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2.3.3 Single plaque purification 
 
Phage suspension was serially diluted with LB.  Order of the dilution depended on 
the suspected titre of the phage suspension, as it needed to be sufficient for single 
plaques to appear.  For the last dilution, 10 µl of the phage suspension was added to 2 
ml of LB and 50 µl of stationary phase R. erythropolis SQ1 culture, vortexed for 1 
sec, and left at 30°C for 30 min.  2 ml of sloppy agar was added and poured onto an 
agar plate containing 10 mM CaCl2 and MgCl2.  The plate was incubated at 30°C for 
2 days.  A plaque was picked, and the purification was repeated twice. 
 
 
2.4 Preliminary phage characterization 
 
2.4.1 Determination of divalent ion requirement 
 
Four LA plates were prepared: 1) LA, 2) LA + 10 mM CaCl2, 3) LA + 10 mM 
MgCl2, and 4) LA + 10 mM CaCl2 & MgCl2.  Each plate was overlaid with 50 µl of 
R. erythropolis SQ1 and dried with the lid open at 47°C for 15 min.  Onto each plate, 
10 µl of phage suspension was spotted.  The plates were incubated at 30°C for 2 days 
and checked for plaques. 
 
 
2.4.2 Determination of host range 
 
Phage host range was determined by spotting 10 µl of phage suspension onto an LA 
plate overlaid with a test strain of bacteria.  The plate was incubated at 30°C for 2 
days and checked for plaques. 
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2.4.3 Determination of efficiency of plaquing 
 
Titre of a phage suspension (pfu/ml) was determined on both R. erythropolis SQ1 and 
another strain.  Efficiency of plaquing (eop) was calculated by the following formula: 
 
eop = pfu/ml on another strain 
          pfu/ml on R. erythropolis SQ1 
  
 
2.4.3.1 Determination of plaque forming units (pfu) 
 
A phage suspension was serially diluted 10
-8
 using LB.  An LA plate was overlaid 
with R. erythropolis SQ1 and dried with the lid open at 47°C for 15 min.  On this 
plate 10 µl of each phage dilution was spotted.  The plate was incubated until plaques 
were visible.  Pfu/ml was calculated by the following formula: 
 
pfu/ml = number of plaques × dilution factor 
                             volume 
 
 
2.4.3.2 Determination of colony forming units (cfu) 
 
A bacterial culture was serially diluted 10
-7
 using LB.  On an LA plate, 10 µl of 10
-4
, 
10
-5
, 10
-6
, 10
-7
 dilutions were spread.  The plate was incubated until colonies were 
visible.  Cfu/ml was calculated by the following formula: 
 
cfu/ml = number of colonies × dilution factor 
                            volume 
 
 
 
 
 27 
2.4.4 Cross checking of phages using lysogens or resistant mutants 
 
On an LA plate overlaid with R. erythropolis SQ1, 10 µl of phage suspension was 
spotted.  The plate was incubated at 30°C until bacterial growth was visible inside the 
clearing region of lysis where the phage suspension had been spotted.  These colonies 
were picked and streaked to single colonies if necessary.  Cells from each colony 
were then grown in LB and tested for immunity to superinfection by the same phage. 
 
 
2.5 Lysate production 
 
2.5.1 Plate lysate production 
 
A phage suspension was serially diluted 10
-1
, 10
-2
, and 10
-3
.  10 µl of each dilution 
was added to 2 ml of LB and 50 µl of R. erythropolis SQ1 culture, vortexed for 1 sec, 
left at 30°C for 30 min, and overlaid onto an LA plate containing 10 mM CaCl2 and 
MgCl2.  The plate was incubated at 30°C for 2 days, or until a significant difference 
was observable between this plate and the cell-only control.   
 
Onto the plate lysate, 2 ml of LB was added.  The entire top agar layer, together with 
all the liquid, was collected with a spatula or pipette and transferred to a centrifuge 
tube.  The tube was vortexed for 1 sec, left for 5 min, and centrifuged in a JA-20 rotor 
at 15000 rpm for 10 min.  The supernatant was collected and titrated.   
 
When a titre of < 10
9 
pfu/ml was observed, plate lysate production was repeated with 
different conditions.  MOI was altered by changing the amount of added phages or 
cells until a higher titre was observed. 
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2.5.2 Small scale liquid lysate production 
 
To each of three 100 ml flasks, 10 ml of LB containing 10 mM CaCl2 and MgCl2 was 
added.  Into the first flask, 200 µl of phage lysate (from plate lysate) was added and 
mixed by gentle swirling.  From this flask, 100 µl of the content was transferred to 
the second flask and mixed.  The same was done from the second flask to the third.  
Into each flask, 250 µl of a stationary phase R. erythropolis SQ1 culture was added.  
The flasks were left at 30°C for 30 min.  They were then agitated on a rotary shaker 
at 80 rpm for 18 hr.  Following the agitation, they were centrifuged in a JA-20 rotor 
at 15000 rpm for 10 min.  The supernatant was collected and titrated.  If the titre was 
< 10
9
 pfu/ml, other MOIs were tested. 
 
 
2.5.3 Large scale liquid lysate production 
 
Condition optimal for the production of 10 ml lysate was applied to the production of 
500 ml lysate, (5×100ml LB in 1000 ml flasks). 
 
 
2.6 Phage purification 
 
To the large scale lysate NaCl was added to a final concentration of 1 M and 
dissolved by slow stirring on a magnetic stirrer.  Then polyethylene glycol (PEG 
6000) was added to a final concentration of 10% (w/v) and again dissolved in the 
same manner.  The lysate was cooled in ice-water slurry for at least 1 hr and 
centrifuged in a JA-10 rotor at 9000 rpm for 20 min at 4°C.  The supernatant was 
discarded, and the phage in the pellet was purified in either a step gradient or 
equilibrium gradient of CsCl. 
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2.6.1 Phage purification in a step gradient 
 
The phage pellet was dissolved in 3.5 ml of SC buffer containing 50% (w/v) CsCl 
and transferred to a Beckman Quick-Seal centrifuge tube using a Pasteur pipette.  A 
step gradient was produced by layering 800 µl of CsCl solutions of increasing density 
(1.45, 1.50, 1.70 g/ml) under one another at the bottom of the tube.  The tube was 
centrifuged in a Beckman VTi 65.2 rotor at 25000 rpm for 1 hr at 4°C.  The bluish 
band of phage was extracted using a needle and a syringe and titrated. 
 
 
2.6.2 Phage purification in an equilibrium gradient 
 
The precipitated phage was resuspended in 5 ml of SC buffer containing 81.7% (w/v) 
CsCl.  This was loaded into a Beckman Quick-Seal centrifuge tube and centrifuged at 
38000 rpm for 24 hr at 4°C.  The phage band was extracted and treated as in 2.6.1. 
 
 
2.7 Transmission electron microscopy 
 
2.7.1 Preparation of Formvar-carbon coated grids 
 
A microscope slide was vertically dipped into 0.35% Formvar solution until about 
half was immersed, removed, its bottom edge blotted on paper towel, and dried by 
standing vertically for 2-3 min.  Using a razor blade, the Formvar was scrapped off 
from the edges and corners of the slide.  The slide was slowly immersed into a tub of 
dH2O at a 45° angle, until the transparent film of Formvar peeled off the slide and 
floated onto the surface of the water.  Using fine forceps, hexagonal 200-mesh copper 
grids were individually placed onto the Formvar film, with the dull side of the grid 
facing downward.   The film of Formvar with the grids was lifted onto a filter paper 
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and air-dried.  The grids were then coated with a film of carbon by the Electron 
Microscope Unit at the University of the Witwatersrand. 
 
 
2.7.2 Negative staining of phages 
 
If a purified phage was to be negatively stained, it was diluted to a titre of ~10
10
 
pfu/ml with dH2O.  Phage from a lysate was not diluted.  5 µl of phage suspension 
was placed on the Formvar-carbon coated side of a copper grid.  This was left for 30 
min, after which excess fluid was drawn off by gently dabbing with a wedged filter 
paper.  A drop of dH2O was placed on the grid and immediately removed with a filter 
paper.  Then, 5 µl of 1% uranyl acetate stain was placed on the grid for 20 seconds.  
Excess stain was removed with a filter paper, and the grid was air-dried for 10 min. 
 
 
2.7.3 Observation of phage morphology 
 
Negatively stained phage was examined and photographed in a Joel JEM 100-S 
transmission electron microscope operating at 80 kV.  Micrographs were developed 
at the School of Animal, Plant, and Environmental Sciences at the University of the 
Witwatersrand by contact-printing the negatives. 
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2.8 DNA preparations 
 
2.8.1 Phage genomic DNA preparation 
 
2.8.1.1 Dialysis of purified phage in CsCl 
 
Dialysis tubing was prepared according to Sambrook et al., 1989.  Tubing of ~10 cm 
length was boiled for 10 min in 800 ml of 2% NaHCO3 and 1 mM EDTA (pH 8.0) 
and rinsed in dH2O.  The tubing was then boiled for 10 min in 800 ml of 1 mM 
EDTA (pH 8.0) and rinsed in dH2O. 
 
150-300 µl of purified phage suspension diluted to 1 ml with dH2O was pipetted into 
the dialysis tubing which was then dialyzed for 1 hr against 1000 volumes of a buffer 
containing 10 mM NaCl, 50 mM Tris-HCl (pH 8.0), and 10 mM CaCl2 while gently 
stirring with a magnetic stirrer.  The dialysis sac was then transferred to a fresh flask 
of buffer and dialyzed for another 1 hr. 
 
 
2.8.1.2 Phage genomic DNA extraction 
 
To obtain phage DNA from a plate lysate, DNaseI and RNase were added to a final 
concentration of 10 µg/ml and incubated at room temperature for 6 hr.  To obtain 
DNA from purified phage, dialyzed suspension was directly subjected to the 
following steps.   
 
To the phage suspension, EDTA (pH 8.0) was added to a final concentration of 20 
mM, proteinase K to a final concentration of 50 µg/ml, and SDS to a final 
concentration of 0.5% (w/v).  The mixture was incubated at 56°C for 1 hr, cooled to 
room temperature, subjected to three phenol extractions and one chloroform 
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extraction.  A salt-ethanol precipitation was performed on the phage DNA, which was 
then dissolved in dH2O. 
 
 
2.8.2 E. coli bulk plasmid preparation 
 
A single colony was inoculated into 100 ml of LB supplemented with 100 µg/ml 
ampicillin.  The culture was grown overnight on a shaker, after which cells were 
harvested by centrifugation in a JA-10 rotor at 6000 rpm for 10 min, resuspended in 5 
ml of solution I and transferred to a JA-20 tube.  Then, 10 ml of solution II was 
added, mixed by gentle inversion, and left for 15 min.  Thereafter, 7.5 ml of solution 
III was added, shaken vigorously, and left in ice-water slurry for 10 min.  Cellular 
debris was removed by centrifugation in a pre-cooled (4°C) JA-20 rotor at 15000 rpm 
for 10 min.  The supernatant was transferred to a fresh JA-20 tube, warmed to room 
temperature, and then 12 ml of isopropanol was added and left for 10 min.  The tube 
was centrifuged at 15000 rpm for 15 min.  The supernatant was decanted, after which 
the pellet was washed with 2 ml of 96% ethanol and vacuum dried for 20 min.  The 
DNA was resuspended in 4 ml of TE buffer for 2 hr at 30°C.  400 µl of 1% ethidium 
bromide (EtBr) and 4.1 g of CsCl were added, inverted to mix, and the refractive 
index was adjusted to between 1.387 and 1.389.  This was loaded into a Quick-Seal 
tube and centrifuged in a VTi 65.2 rotor at 45000 rpm for 16 hr.  The plasmid band 
was extracted under a UV light using a needle and syringe.   
 
EtBr was removed from the DNA solution by adding 1/10 volume of butanol, mixing 
by inversion, and microfuging for 10 sec.  Upper layer containing the EtBr was 
removed.  Butanol extraction was repeated ~3 times to remove all traces of EtBr.  
DNA in CsCl was stored at -20°C.  When required, CsCl was removed from the DNA 
by ethanol precipitation. 
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2.8.3 E. coli mini plasmid preparation 
 
A single colony was inoculated into 1 ml of LB supplemented with 100 µg/ml 
ampicillin.  After the culture was grown for > 6 hr at 37°C on a shaker, cells were 
harvested by microfuging for 1 min, the supernatant decanted, and the pellet 
resuspended in 80 µl of solution I.  160 µl of solution II was mixed in by gentle 
inversion, left for 15 min, 120 µl of solution III added, shaken vigorously, and left in 
ice-water slurry for 5 min.  Cellular debris was removed by microfuging for 5 min at 
4°C.  The supernatant was transferred to a fresh microfuge tube and warmed to room 
temperature.  220 µl of isopropanol was added and after 10 min at room temperature 
the tube was microfuged for 5 min, the supernatant decanted, then the pellet was 
washed with 150 µl of 96% ethanol and vacuum desiccated for 20 min.  The DNA 
was dissolved in 150 µl of dH2O containing freshly boiled RNase (10 µg/ml). 
 
 
2.8.4 E. coli / Rhodococcus miniprep of total DNA 
 
For E. coli, a single colony was inoculated into 1 ml of LB and grown at 37°C on a 
shaker overnight.  For R. erythropolis, a single colony was inoculated into 1 ml of 
LBG (2% glycine) and grown at 30°C on a shaker for 2-3 days.  Cells were harvested 
by microfuging for 1 min, followed by discarding the supernatant and resuspending 
the pellet in 500 µl of TE to which lysozyme had been freshly added.  The mixture 
was incubated at 37°C for 1 hr, with inversion every 10 min, after which 100 µl of 
10% TE-SDS was added and left for 10 min.  100 µl of 5 M KAc (pH 6.0) was 
added, shaken vigorously, left in ice-water slurry for 5 min, and microfuged for 5 min 
at 4°C.  The supernatant was subjected to phenol-chloroform extraction, followed by 
salt and ethanol precipitation.  The genomic DNA was resuspended in 150 µl of 
dH2O containing freshly boiled RNase (10 µg/ml).  
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2.9 DNA manipulations 
 
2.9.1 Phenol-chloroform DNA extraction 
 
For DNA volumes of < 300 µl, TE buffer was added to make it up to this volume.  
Then, 1/3 volume of TE-saturated phenol was added, mixed by inversion, and 
microfuged for 5 min at room temperature.  The aqueous phase was collected, to 
which 1/3 volume of chloroform was added, mixed by inversion, and microfuged for 
30 sec.  The aqueous phase was collected, and the DNA was subjected to salt and 
ethanol precipitation.   
 
 
2.9.2 DNA precipitations 
 
2.9.2.1 Salt and ethanol DNA precipitation 
 
DNA was precipitated by adding 1/10 volume of 1 M NaCl and 2 volumes of 96% 
ethanol.  The mixture was mixed by gentle inversion and microfuged for 20 min at 
4°C.  The supernatant was decanted and the tube was blotted on paper towel, 
followed by vacuum drying for 20 min.  The DNA was resuspended in an appropriate 
volume of dH2O or 4 mM Tris-HCl.  
 
 
2.9.2.2 Ethanol precipitation 
 
DNA was precipitated by adding 2 volumes of 96% ethanol.  The mixture was gently 
inverted and microfuged for 20 min at 4°C.  The supernatant was decanted and the 
tube was blotted on paper towel, followed by vacuum drying for 20 min.  The DNA 
was resuspended in an appropriate volume of dH2O or 4 mM Tris-HCl.  
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2.9.3 DNA digestions with restriction endonucleases 
 
Restriction endonucleases were obtained from Fermentas, Roche, and New England 
Biolabs and used according to their instructions.  An appropriate volume of 10× 
digestion buffer was added to the DNA, tapped to mix, and microfuged for 2 sec.  For 
double digestions, a common buffer in which both enzymes showed suitable activity 
was chosen.  Then, 0.5 µl of restriction endonuclease was added, tapped to mix, and 
microfuged for 2 sec.  The digestion was incubated at the correct temperature for > 3 
hr. 
 
If necessary, the endonuclease was inactivated by treatment with either heat or 
phenol.  If the enzyme could be heat-inactivated, the manufacturer’s instruction was 
followed for the correct temperature and incubation time.  Otherwise, phenol-
chloroform extraction was conducted. 
 
 
2.9.4 Alkaline phosphatase treatment 
 
Shrimp alkaline phosphatase (Roche) was used to prevent recircularization of vector.  
An appropriate volume of 10× dephosphorylation buffer and 1 µl of alkaline 
phosphatase were added and incubated at 37°C for > 1 hr.  The enzyme was then 
heat-inactivated at 65°C for 20 min. 
 
 
2.9.5 DNA ligation 
 
T4 DNA ligase (Fermentas) was used for ligation reactions.  Vector and insert DNA 
were added, and the volume was made up to 17 µl with dH2O.  2 µl of 10× ligation 
buffer was added, tapped to mix, and microfuged for 2 sec.  Thereafter, 1 µl of ligase 
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was added, tapped to mix, microfuged for 2 sec, and incubated at 22°C overnight.  
The ligase was then inactivated at 65°C for 10 min. 
 
 
2.9.6 Freeze-squeeze method of DNA extraction from agarose gels 
 
Piece of agarose containing the DNA of interest was placed in a microfuged tube, 
crushed with a spatula, and frozen at -70°C for 30 min.  The agarose was then 
completely thawed at room temperature, followed by microfuging for 6 min after 
which the supernatant was collected.  The pellet was crushed again, and the process 
was repeated.  The supernatants from the first and second rounds were pooled and 
subjected to salt and ethanol precipitation, the pellet washed once with ethanol, 
vacuum dried, and resuspended in 50 µl of dH2O. 
 
 
2.9.7 Determination of DNA concentration 
 
In order to measure the concentration of DNA solution, an aliquot was first run on a 
gel, which was then quantified using UVP LabWorks Image Acquisition and 
Analysis Software (Ver.4.5) by comparing band intensity between the DNA and the 
molecular weight marker, for which the concentration had been predetermined by the 
manufacturers.  
 
 
2.10 Gel electrophoresis 
 
2.10.1 Agarose gel electrophoresis 
 
Agarose stock solutions were prepared in 0.5× TBE buffer at concentrations of 0.4%, 
0.8%, and 1.0% depending on the size of the DNA fragment to be separated.  A gel 
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was prepared by pouring 20 ml of agarose solution containing 1 µg/ml EtBr into a gel 
tray inserted with a comb, which was then polymerized at 4°C for 30 min.  After 
removing the comb, the tray containing the gel was placed in an electrophoresis unit 
containing 0.5× TBE buffer with 1 µg/ml EtBr.  After DNA samples were mixed with 
bromophenol blue tracking dye and loaded into the wells, electrophoresis was 
conducted at 80-120 V at room temperature.  The gel was viewed and photographed 
using UVP BioDoc-It System.  Molecular weight markers used were Roche Lambda 
HindIII + EcoRI Marker III or Fermentas GeneRuler DNA Ladder Mix. 
 
 
2.10.2 Low gelling agarose gel electrophoresis 
 
Prior to usage, 20 ml of 1% low gelling agarose in 0.5× TBE buffer was autoclaved.  
EtBr was added to a final concentration of 1 µg/ml, and the agarose was poured into a 
tray inserted with a comb and polymerized at 4°C for 30 min.  The gel was placed in 
a pre-cooled electrophoresis unit containing 0.5× TBE with 1 µg/ml EtBr.  After 
DNA samples were mixed with bromophenol blue tracking dye and loaded into the 
wells, electrophoresis was conducted at 75 V at 4°C.  Using a scalpel under a UV 
light, a band of interest was excised from the gel, from which the DNA was extracted 
by either phenol-chloroform extraction or freeze-squeeze method.  In case of the 
phenol-chloroform extraction, the piece of agarose carrying the DNA was melted at 
60°C for 30 min, followed by three phenol extractions.  Between each extraction, 
1/15
 
volume of 1 M Tris-HCl was added.  One chloroform extraction was then 
conducted, followed by precipitation of the DNA. 
 
 
2.10.3 Pulsed field gel electrophoresis (PFGE) 
 
100 ml of 1% agarose in 0.5× TBE buffer was poured into a PFGE gel tray inserted 
with a comb and polymerized at 4°C for 30 min.  A plug of molecular weight marker 
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(New England Biolabs PFG Low Range Marker) embedded in agarose was cut with a 
scalpel to a length of 1 mm, placed inside a well, and the remaining space inside the 
well was filled with 1% agarose solution in 0.5× TBE buffer, which was then 
polymerized at room temperature for 5 min.  The electrophoresis unit used was 
BioRad CHEF-DR II Pulsed Field Electrophoresis System.  The gel was placed in the 
unit containing 2000 ml of 0.5× TBE, and DNA samples were mixed with 
bromophenol blue tracking dye and loaded into the wells.  Initial and final switch 
times were set at 1 and 12 sec, respectively.  Electrophoresis was conducted at 6 
V/cm at 4°C for 18.5 hr.  The buffer circulation pump was set at 750 ml/min and 
switched on 10 min after the start of the electrophoretic run.  Following 
electrophoresis, the gel was stained in 0.5 µg/ml EtBr solution for 20 min, destained 
in dH2O for 3 hr, and viewed. 
 
 
2.11 Transformations 
 
2.11.1 E. coli CaCl2 transformation 
 
20 ml of pre-warmed LB containing 0.5% glucose was inoculated with 200 µl of an 
overnight culture of E. coli and incubated at 37°C with vigorous shaking for 1.75 hr.  
The culture, while still being shaken, was cooled in ice-water slurry for 5 min and 
centrifuged in a pre-cooled JA-20 rotor at 10000 rpm for 5 min at 4°C.  The 
supernatant was decanted, and the pellet was resuspended in 10 ml of pre-cooled 
CaCl2 transformation buffer and placed on ice for 15 min, followed by centrifugation 
at 10000 rpm for 5 min at 4°C.  The supernatant was decanted, and the pellet was 
resuspended in 1.33 ml of pre-cooled transformation buffer.  The cells were left on 
ice for 2-24 hr. 
 
100 µl of competent cells and 5 µl of plasmid were added together, mixed by 
bubbling air with a pipette, and left on ice for 15 min.  They were heat-shocked at 
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42°C for 90 sec, after which 0.5 ml of pre-warmed LB was added and incubated at 
37°C for 1 hr.  The cells were spread on an LA plate containing 200 µg/ml ampicillin 
and incubated at 37°C overnight. 
 
 
2.11.2 Rhodococcus PEG-mediated transformation 
 
R. erythropolis SQ1 was grown in 5 ml of LBSG (2% glycine) at 30°C for 2 days.  
Cells from 1 ml of this culture were washed once in 1 ml of B buffer, resuspended in 
1 ml of B buffer containing freshly added lysozyme (5 mg/ml), and incubated at 37°C 
for 1.5 hr with inversion every 10 min.  During the incubation, 2 ml of P buffer was 
prepared.  P-PEG buffer was also prepared by UV-sterilizing 0.5 g of polyethylene 
glycol (PEG 6000) for 10 min and dissolving it in 1 ml of P-buffer by vigorous 
vortexing. 
 
The cells were microfuged for 10 sec, gently washed in 1 ml of B buffer, and 
resuspended in 500 µl of P buffer.  25 µl of the protoplast suspension and 5 µl of 
plasmid were added together, mixed by bubbling air with a pipette, and left for 10 
min.  An equal volume of P-PEG buffer was added, mixed by bubbling, and spotted 
onto a pre-cooled regeneration plate.  The plate was incubated at 28°C for 12 hr, 
underlaid with 250 µl of 4 mg/ml chloramphenicol, and further incubated at 28°C for 
5 days. 
 
 
2.12 DNA sequencing and analysis 
 
All sequenced DNA were prepared by the E. coli plasmid miniprep method with a 
phenol-chloroform extraction included prior to isopropanol extraction.  Sequencing 
was conducted by Inqaba Biotec.  Sequences were edited and analyzed using the 
Internet programs listed in Table 2.5. 
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Table 2.5 Internet addresses used for sequence analysis. 
Program Address 
BLAST http://www.ncbi.nlm.nih.gov/BLAST/ 
FASTA http://www.ebi.ac.uk/fasta33/ 
GeneMark http://opal.biology.gatech.edu/GeneMark/ 
FramePlot http://www.nih.go.jp/~jun/research/frameplot/ 
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3. RESULTS 
 
 
 
 
3.1 Phage isolation and preliminary characterization 
 
 
3.1.1 Isolation of nocardiophages from soil 
 
To isolate nocardiophages, 1 g of soil samples were agitated gently in broth for 16 hr.  
Based on previous observations (Shibayama, 2004) that longer agitation increased 
phage yield, it was hypothesized that most phages in soil exist as lysogens, whose 
induction was expected by the favourable growth conditions in rich medium.   
 
Following agitation and centrifugation, soil supernatants were assayed for 
nocardiophages that plaqued on R. erythropolis SQ1.  There were two reasons for 
using this species.  First, there was no health hazard associated with this non-
pathogenic species.  Secondly, it formed a confluent lawn in soft agar facilitating 
detection of plaques.  Sources of soil samples and their phage yield are shown in 
Table 3.1.  A representative assay plate is shown in Figure 3.1. 
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Table 3.1 Assayed soil samples and their phage yield. 
Soil source Plaques/plate 
Fairland, Johannesburg, South Africa > 350 
Wits, Johannesburg, South Africa 223 
Emmarentia, Johannesburg, South Africa 115 
Rain forest, Mpumalanga, South Africa 57 
Augrabies Falls, Northern Cape, South Africa 0 
Windhoek, Namibia 22 
Kadishi, Namibia 9 
Fish River Canyon, Namibia 4 
Lüderitz, Namibia 0 
 
 
 
 
Figure 3.1 Phage assay plate for Emmarentia soil. 
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Plaques of different sizes and morphologies were present, suggesting presence of 
different phages.  Individual plaques were picked and resuspended in 100 µl of LB.  
Phages were subjected to three rounds of single plaque purification in order to assure 
their purity. 
 
 
3.1.2 Divalent ion requirement 
 
Phage divalent ion requirements were determined by checking for their ability to 
plaque on R. erythropolis SQ1 on agar plates supplemented with no divalent ion, 
Ca
++
, or Mg
++
.  Three rounds of this experiment were conducted in order to eliminate 
the possibility of ion carry-over from the original plate on which the phage was 
isolated.  Divalent ion requirements are shown in Table 3.2.  Phages were named by 
their soil source followed by a number. 
 
Phages Kanazawa1 and Perouges1 were isolated by Dabbs (personal 
communication), from soil from Japan and France, respectively.  Phage Fairland1 
was isolated in my previous Honours work (Shibayama, 2004).  These three phages 
were also single plaque purified, and their divalent ion requirements tested. 
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Table 3.2 Phage divalent ion requirements. 
Phage Divalent ion requirement 
Kanazawa1 none 
Perouges1 none 
Fairland1  none 
Fairland2 none 
Fairland3 none 
Wits1 none 
Wits2 none 
Emmarentia1 none 
Rain Forest1 Ca
++
 or Mg
++
 
Rain Forest2 Ca
++
 or Mg
++
 
Windhoek1 none 
Windhoek2 none 
Kadishi1 none 
Fish River Canyon1 none 
 
 
3.1.3 Host range 
 
From Table 3.2, four phages were selected for further work – Fairland1, Kanazawa1, 
Perouges1, and Wits1.  They were selected to encompass the diversity in location of 
their origin, although there is usually no obvious relationship between geographical 
origin and DNA sequence similarity (Pedulla et al., 2003).  Phage Wits1 was selected 
because its relatively large plaques suggested a highly lytic potential.  Host ranges of 
these phages are shown in Table 3.3. 
 
 
   
 45 
Table 3.3 Host ranges of Fairland1, Wits1, Kanazawa1, and Perouges1. 
 Phage 
Host strain Fairland1 Wits1 Kanazawa1 Perouges1 
R. erythropolis SQ1 p p p p 
R. erythropolis ATCC 4277 p p p p 
R. erythropolis  DSM 1069 p  p  
R. rhodochrous Ri8 p p p p 
R. opacus HL PM-1 p c p  
R. equi ATCC 14487 p  p p 
G. australis A554     
G.  rubropertincta ATCC 25593    c 
G.  desulfuricans NB4     
N.  mexicana IFO 3927 c  c  
M.  smegmatis mc21155     
M.  parafortuitum 490     
p = plaqued; c = cleared at high multiplicity of infection but could not plaque;  
where nothing is indicated the phage had no visible effect. 
 
 
Table 3.3 shows that all four phages could only plaque on Rhodococcus species.  
Fairland1 and Kanazawa1 had identical host range, while those of Wits1 and 
Perouges1 clearly indicated that these two were different phages from the others. 
 
 
3.1.4 Efficiency of plaquing 
 
These four phages were propagated on R. erythropolis SQ1 and tested for their 
efficiency of plaquing on the other strains.  This was done by taking the ratio of the 
titre on the other strain to the titre on R. erythropolis SQ1 (Table 3.4). 
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Table 3.4 Efficiency of plaquing of Fairland1, Wits1, Kanazawa1, and Perouges1, 
propagated on R. erythropolis SQ1, on other strains. 
Phage 
Host strain 
Fairland1 Wits1 Kanazawa1 Perouges1 
R. erythropolis SQ1 1.0 1.0 1.0 1.0 
R. erythropolis ATCC 4277 1.2 0.7 0.7 4.0 
R. erythropolis DSM 1069 0.002  0.001  
R. rhodochrous Ri8 0.8 1.0 2.0 0.2 
R. opacus HL PM-1 0.1  0.005  
R. equi ATCC 14487 1.0  0.04 0.01 
Where nothing is indicated, the phage could not plaque on the strain. 
 
 
3.1.5 Cross-checking of phages using lysogens or phage resistant mutants 
 
Lysogen or phage resistant mutant isolation was attempted for each phage by 
selecting cells inside turbid plaques.  The host ranges and efficiencies of plaquing 
indicated that each phage was different from another.  As an additional measure to 
confirm this, they were cross-checked using phage resistant cells.  
  
No stable lysogens or resistant mutants for Fairland1 and Perouges1 were obtained. 
whereas cells resistant to Kanazawa1 and Perouges1 were successfully obtained.  
Table 3.5 shows the plaquing of the four phages on these cells. 
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Table 3.5 Plaquing of Fairland1, Wits1, Kanazawa1, and Perouges1 on 
lysogens/resistant mutants of Wits1 and Kanazawa1. 
Phage Lysogen / resistant mutant  
of phage Fairland1 Wits1 Kanazawa1 Perouges1 
Wits1 p  p p 
Kanazawa1 p p  p 
p = plaqued; where nothing is indicated the phage had no visible effect. 
 
 
These experiments confirmed that all four phages were different. 
 
 
3.2 Production of lysates and phage purification 
 
To extract a sufficient amount of phage DNA, production of a large volume of a high 
titre lysate and its purification were necessary.  High titre lysates were first produced 
on plates, which yielded a volume of 3 to 4 ml.  Thereafter, the lysates were scaled up 
in broth.  A small scale liquid lysate of 10 ml was first produced and then scaled up to 
≥ 500 ml. 
 
 
3.2.1 Plate lysates 
 
High titre plate lysates were produced by mixing R. erythropolis SQ1 and the phage 
at appropriate concentrations and overlaying them on an agar plate.  For each phage, 
the optimum condition is shown in Table 3.6. 
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Table 3.6 Conditions used to attain high titre plate lysates. 
Phage 
Amount of cells 
(cfu) 
Amount of phages 
(pfu) 
MOI 
Lysate titre 
(pfu/ml) 
Fairland1 1.5 × 10
8
 2.0 × 10
6
 0.01 4.8 × 10
10
 
Wits1 1.5 × 10
8
 6.0 × 10
5
 0.004 2.0 × 10
9
 
Kanazawa1 1.5 × 10
7
 4.0 × 10
4
 0.003 5.5 × 10
9
 
Perouges1 1.5 × 10
7
 4.0 × 10
5
 0.03 1.0 × 10
9
 
 
 
3.2.2 Liquid lysates 
 
Small scale liquid lysates were produced by mixing R. erythropolis SQ1 and the 
phage at appropriate concentrations in 10 ml broth and gently agitating them on a 
rotary shaker.  Optimum conditions for attaining high titres are shown in Table 3.7. 
 
Table 3.7 Conditions used to attain high titres in 10 ml liquid lysates. 
Phage 
Amount of cells 
(cfu) 
Amount of phages 
(pfu) 
MOI 
Lysate titre 
(pfu/ml) 
Fairland1 7.5 × 10
8
 3.0 × 10
7
 0.04 7.0 × 10
10
 
Wits1 3.0 × 108 2.0 × 104 0.00007 5.0 × 109 
Kanazawa1 3.0 × 10
8
 5.5 × 10
8
 1.8 4.0 × 10
7
 
Perouges1 3.0 × 10
8
 1.0 × 10
8
 0.3 4.0 × 10
7
 
 
 
For Kanazawa1 and Perouges1, maximum titres were 4.0 × 10
7
 pfu/ml so large scale 
lysate production was not attempted.  For Fairland1 and Wits1, conditions used to 
produce the small scale lysates were applied to produce large scale lysates of 500 ml;  
more host cells and phages were added, but at an identical MOI.  Conditions used for 
the production of large scale lysates are shown in Table 3.8. 
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Table 3.8 Conditions used to attain high titres in 500 ml liquid lysates for Fairland1 
and Wits1. 
Phage 
Amount of cells 
added (cfu) 
Amount of phages 
added (pfu) 
MOI 
Lysate titre 
(pfu/ml) 
Fairland1 3.75 × 10
10
 1.5 × 10
9
 0.04 7.0 × 10
10
 
Wits1 1.5 × 1010 1.0 × 106 0.00007 9.0 × 109 
 
 
3.2.3 Phage purification 
 
Phages from large scale lysates were precipitated by adding NaCl and PEG, 
resuspended in a smaller volume, and purified by CsCl gradient centrifugation.  
Phage purification may be done in either a step gradient or an equilibrium gradient of 
CsCl.  When using a step gradient, the gradient was manually loaded into a tube prior 
to centrifugation, forcing the phages to migrate to a position corresponding to their 
buoyant density.  When using an equilibrium gradient, the gradient was formed by 
the centrifugal force. 
 
Fairland1 was purified in a step gradient with densities of 1.70, 1.50, 1.45 and 1.15 
g/ml (Sambrook et al., 1989).  Following centrifugation, a bluish mass was visible at 
the bottom of the tube, indicating that the density of phage Fairland1 is ≥ 1.70 g/ml.  
Wits1 was purified in an equilibrium gradient with an initial density of 1.50 g/ml.  A 
bluish band of this phage was visible near the middle of the tube, indicating that its 
density is ~1.50 g/ml.  Post-purification titres and phage recovery are shown in Table 
3.9.  
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Table 3.9 Titres and volumes before and after purification and phage recovery. 
Pre-purification Post-purification  
Phage Titre 
(pfu/ml) 
Volume 
(ml) 
Titre 
(pfu/ml) 
Volume 
(ml) 
 
Recovery 
(%) 
Fairland1 7.0 × 10
10
 500 4.8 × 10
13
 0.5 68.6 
Wits1 9.0 × 10
9
 500 6.0 × 10
11
 0.5 6.7 
 
 
3.3 Phage morphology 
 
Phage morphology was observed by viewing negatively stained phages under the 
transmission electron microscope.  Electron micrographs of Fairland1 are shown in 
Figure 1.1, as they were obtained in my previous work (Shibayama, 2004).  Head 
diameter, tail diameter, and tail length of the four phages were estimated from the 
micrographs.  These are shown in Table 3.10.  
 
 
3.3.1 Wits1 morphology 
 
                     
        A                    B  C                D               E 
Figure 3.2 Electron micrographs of Wits1.   
Bar = 100 nm.  All micrographs were taken at ×100,000 magnification 
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According to morphology, Wits1 was assigned to the family Siphoviridae, 
characterized by their long non-contractile tails. 
 
 
3.3.2 Kanazawa1 morphology 
 
                  
      A    B           C    D 
 
 
E 
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F 
Figure 3.3 Electron micrographs of Kanazawa1.   
Bar = 100 nm.  Micrographs A – D were taken at ×100,000 magnification.  
Micrographs E and F were taken at ×40,000 and ×50,000 magnifications, 
respectively.  In E and F, arrows point to phages which are adsorbed to the host cell. 
 
Kanazawa1 was also assigned to the family Siphoviridae.   
 
 
3.3.3 Perouges1 morphology 
 
    
         A              B             C 
Figure 3.4 Electron micrographs of Perouges1.   
Bar = 100 nm.  All micrographs were taken at ×100,000 magnification. 
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Perouges1 was also assigned to the family Siphoviridae.   
 
 
3.3.4 Summary of phage morphologies 
 
Table 3.10 Summary of phage morphologies. 
Phage Family 
Head diameter 
(nm) 
Tail diameter 
(nm) 
Tail length 
(nm) 
Fairland1 60 14 280 
Wits1 60 10 250 
Kanazawa1 80 20 330 
Perouges1 
Siphoviridae 
85 15 380 
 
 
3.4 Phage genome size 
 
Fairland1 and Wits1 genomic DNA were extracted from purified phage particles.  
Kanazawa1 and Perouges1 DNA were extracted from plate lysates.  Gels from pulsed 
field electrophoresis of these DNAs are shown in Figure 3.5.  Phage genome sizes are 
shown in Table 3.11. 
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 MW  1     2                          MW      1                                  MW     1 
                                                        
          A                     B                                              C 
Figure 3.5 Pulsed field gel electrophoresis of phage DNA on 1% agarose gels. 
 
 
Table 3.11 Phage genome sizes.  
 Fairland1 Wits1 Kanazawa1 Perouges1 
Genome size (kb) 55 39 106 140 
 
48.5 
97.0 
145.5 
194.0 
23.1 
9.42 
kb 
9.42 
9.42 
23.1 
23.1 
48.5 
48.5 
97.0 
97.0 
145.5 
145.5 
194.0 
194.0 
kb 
kb 
Wits1 
Kanazawa1 Perouges1 
Fairland1 
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3.5 Restriction digestion of phage genomic DNA 
 
3.5.1 Endonucleases screening for library construction 
 
To select restriction endonucleases for phage genomic library construction, their 
DNA were subjected to digestion by those with unique recognition sites in the suicide 
(EcoRI) gene of the E.coli – Rhodococcus shuttle vector pDA71.  These enzymes 
were HindIII, BglII, PstI, and SfuI.  Various isocaudamers of these endonucleases 
were also tested.  These digestions are shown in Figure 3.6.  As a control, E. coli 
GM2929 and R. erythropolis SQ1 genomic DNA were subjected to digestion with the 
same endonucleases.  All were able to digest the DNA from both sources (data not 
shown). 
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    MW 1   2    3   4   5   6   7    8   9  10  11             MW  1   2   3   4   5   6   7   8    9  10 11 
            
                     A. Fairland1                                               B. Kanazawa1 
 
    MW 1   2    3   4   5    6   7   8   9  10  11            MW  1   2   3   4    5   6   7   8    9  10 11 
            
                        C. Wits1                                                     D. Perouges1 
Figure 3.6 Digestions of phage genomic DNA on 0.8% agarose gels.   
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Lane number corresponds to the same enzyme in all gels.  Lane 1, undigested DNA; 
2, HindIII; 3, BglII; 4, BamHI; 5, BclI; 6, PstI; 7, NsiI; 8, BmyI; 9, SfuI; 10, AccI; 11, 
ClaI. 
 
 
3.5.2 Further digestion of Wits1 DNA 
 
Many endonucleases used above did not digest the DNA from Wits1, Kanazawa1, 
and Perouges1.  Wits1 DNA was therefore subjected to digestions by other enzymes 
(Huang et al., 1982) to observe whether a pattern in recognition sequences existed for 
those which did not cut the DNA (Table 3.12). 
 
Table 3.12 Digestion of Wits1 DNA. 
Enzyme  Enzyme 
AluI +  BglII  
CfoI +  XhoII + 
DdeI   PvuI + 
HaeIII +  BstEII + 
HinfI +  BstNI + 
HpaI +  EcoRI  
Sau3A +  HindIII  
DpnI   HpaI  
Sau96I +  XbaI  
TaqI +  SacI  
BamHI +  Cfr42I  
BclI     
+ = digested; where nothing is indicated the enzyme did not digest the DNA. 
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3.6 Phage genomic library construction 
 
Construction of genomic library was attempted for all four phages.  All libraries were 
constructed in E. coli MM294-4 using pDA71.  Twenty clones from each library 
were screened for their insert sizes. 
 
 
3.6.1 Fairland1 library 
 
Two libraries – one with BglII and another with PstI – were constructed for 
Fairland1.   
 
3.6.1.1 Fairland1 BglII library 
 
Plasmid mini preparations were done on randomly chosen twenty clones, which are 
shown in Figure 3.7. 
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   MW  1    2    3   4    5    6   7    8    9   10            MW  11  12  13  14 15  16  17  18  19  20 
           
      A           B 
Figure 3.7 Twenty clones from Fairland1 BglII library, on 0.8% agarose gels. 
Inserts were released by BglII digestion.  The upper band was linearized pDA71, and 
the lower bands were inserts. 
 
 
To confirm heterogeneity of these twenty clones, they were also subjected to a double 
digestion by BglII and PstI (data not shown).  This revealed that clones [11 and 20] 
and [13 and 14] may have identical inserts (clone numbers correspond to the lanes in 
the gel in which they were run). 
 
Average insert size from this library was ~2.5 kb.  As shown below, number of 
transformants necessary to have 99% probability of any Fairland1 DNA sequence 
present in the library was calculated to be 99, and ~140 transformants were obtained. 
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N  =  ln (1 – p)   
         ln (1 – a/b)  
     =  ln (1 – 0.99) 
         ln (1 – 2.5/55) 
     =  99 clones 
 
 
3.6.1.2 Fairland1 PstI library 
 
Fairland1 genomic DNA was completely digested with PstI for another library 
construction.  Plasmid mini preparations were done on randomly chosen twenty 
clones, which are shown in Figure 3.8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
where N = number of clones required; p = probability 
of any given DNA being present in the library; a = 
average insert size; b = genome size 
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   MW  1   2    3    4   5    6   7    8    9   10   MW 11  12 13  14 15  16  17  18  19  20 
   
        A            B 
Figure 3.8 Twenty clones from Fairland1 PstI library, on 0.8% agarose gels. 
Inserts were released by PstI digestion.  
 
 
To confirm heterogeneity of these twenty clones, they were also subjected to a double 
digestion by PstI and BglII (data not shown).  This revealed that clones [1 and 9] and 
[3, 10, and 11] may have identical inserts. 
 
Average insert size from this library was ~2.7 kb.  Number of transformants 
necessary to have 99% probability of any Fairland1 DNA sequence present in the 
library was calculated to be 92, and ~95 transformants were obtained. 
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3.6.2 Wits1 library 
 
Wits1 library construction was attempted by XhoII (isocaudamer of BglII) partial 
digestion of its genome to generate fragments of > 2 kb (Figure 3.9A).   Plasmid 
minipreps were done on ten randomly chosen clones from the library.  However, 
these clones mostly possessed inserts of approximately 100 bp, as shown in Figure 
3.9B.  DNA partial digestion and library construction were repeated twice, with the 
same outcome, so these experiments were not continued. 
 
                MW  1   2   3    4   5    6             MW  1   2   3    4    5   6   7   8    9  10 
  
           A         B 
Figure 3.9 Wits1 genomic library construction with XhoII, on 0.8% agarose. 
A. Partial digestion of Wits1 genomic DNA with XhoII.  DNA digested with 1/16 
diluted enzyme (lane 4) was used for the library construction. 
Lane 1, undigested; 2, digestion with undiluted XhoII; 3, 1/4 dilution; 4, 1/16 
dilution; 5, 1/64 dilution; 6, 1/256 dilution. 
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B. Ten clones from Wits1 XhoII library.   
Inserts were released by double digestion with HindIII and PstI.  All inserts included 
a part of the vector between the HindIII and PstI sites, which was ~420 bp.   
Therefore, the actual inserts were approximately 100 bp. 
 
 
3.6.3 Perouges1 libraries 
 
Two Perouges1 libraires were constructed, one by complete digestion with HindIII 
and another with partial digestion with same enzyme.  The partial digestion was done 
because the library from the complete digestion did not contain many antimicrobial 
clones (reported below, in Table 3.15). 
 
 
3.6.3.1 Perouges1 HindIII (complete digest) library 
 
From Perouges1 HindIII (complete digest) library, plasmid mini preparations were 
done on twenty randomly chosen clones (Figure 3.10). 
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    MW  1   2    3   4    5    6   7    8   9   10                MW 11 12 13  14 15  16  17 18  19 20 
   
                 A                    B 
Figure 3.10 Twenty clones from Perouges1 HindIII (complete digest) library, on 
0.8% agarose gels. 
Inserts were released by HindIII digestion.   
 
 
To confirm heterogeneity of these twenty clones, they were also subjected to a double 
digestion by PstI and ClaI (data not shown).  This revealed that clones 7 and 8 
apparently had identical inserts. 
 
Average insert size from this library was ~1.3 kb.  Number of transformants 
necessary to have 99% probability of any given Perouges1 DNA sequence present in 
the library was 494, and ~1145 transformants were obtained. 
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3.6.3.2 Perouges1 HindIII (partial digest) library 
 
From Perouges1 HindIII (partial digest) library, plasmid mini preparations were done 
on randomly chosen twenty clones, which are shown in Figure 3.11. 
 
    MW 1    2   3    4   5    6   7    8    9   10                MW 11 12 13  14  15 16  17  18 19  20 
   
                A                                B 
Figure 3.11 Twenty clones from Perouges1 HindIII (partial digest) library, on 0.8% 
agarose gels. 
Inserts were released by HindIII digestion. 
 
 
Average insert size from this library was ~1.6 kb.  Number of transformants 
necessary to have 99% probability of any Perouges1 DNA sequence present in the 
library was 400, and ~2750 transformants were obtained. 
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4.6.4 Phage Kanazawa1 library 
 
Phage Kanazawa1 library construction was attempted with BamHI, since this was the 
only one enzyme of the ten tested that digested its DNA.  However, despite several 
attempts, cloning of its DNA was unsuccessful. 
 
 
3.6.5 Summary of phage library construction 
 
Restriction endonucleases used for the construction of phage libraries and their 
outcome are shown in Table 3.13. 
 
Table 3.13 Summary of phage library construction. 
Phage Endonuclease  Successful? 
BglII yes 
Fairland1 
PstI yes 
Wits1 XhoII no 
Kanazawa1 BamHI no 
Perouges1 HindIII yes 
 
 
3.6.6 Further analysis on phage Wits1 genomic DNA 
 
Upon attempting to construct Wits1 genomic library, there was a clone with an insert 
of ~4.5 kb.  This construct was re-cloned in E.coli GM2929 and subjected to 
digestion by the eight endonucleases which could not digest the phage DNA (Figure 
3.6C).  None of them were able to digest the insert of the clone (data not shown), 
thereby strengthening the possibility of lack of restriction sites. 
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3.7 Screening for clones with antimicrobial activity 
 
Clones from Fairland1 and Perouges1 libraries were screened for antimicrobial 
activity by transforming R. erythropolis SQ1 with each clone.  A clone was identified 
to be inhibitory to the host if no or few transformants grew up.  Vector pDA71* 
(suicide gene inactivated) was always included as a vector-only control.  From each 
library, the twenty clones previously screened for insert size were used for this 
experiment.  Ten clones were screened per agar plate.   
 
Screening of clones from Fairland1 BglII and PstI libraries is shown in Figures 3.12 
and 3.13, respectively.  Number of transformants/µg of DNA is shown in Table 3.14.   
 
Screening of clones from Perouges1 HindIII libraries is shown in Figures 3.14 
(complete digest) and 3.15 (partial digest).  Number of transformants/µg of DNA is 
shown in Table 3.15. 
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A 
 
 
B 
 
Figure 3.12 Screening of Fairland1 BglII library for clones inhibitory to R. 
erythropolis SQ1. 
On plate A, spots 1 – 10 correspond to clones 1 – 10 from the library.  On plate B, 
spots 1 – 10 correspond to clones 11 – 20.  On both plates, “+” was the vector-only 
control, while “–“ was the negative control with no DNA. 
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A 
 
 
B 
 
Figure 3.13 Screening of Fairland1 PstI library for clones inhibitory to R. 
erythropolis SQ1. 
On plate A, spots 1 – 10 correspond to clones 1 – 10 from the library.  On plate B, 
spots 1 – 10 correspond to clones 11 – 20.  On both plates, “+” was the vector-only 
control, while “–“ was the negative control with no DNA. 
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Table 3.14 Transformants/µg of DNA for clones from Fairland1 libraries. 
                 BglII library        PstI library 
Clone # 
# transformants  
(×10
4
)/µg of DNA 
 
Clone # 
# transformants  
(×10
4
)/µg of DNA 
1 0.56  1 0.03 
2 0.27  2 0.22 
3 0.74  3 0.63 
4 0.06  4 0.004 
5 0.56  5 0.12 
6 0.46  6 0.24 
7 0.02  7 0.22 
8 < 0.0017  8 0.006 
9 0.37  9 0.009 
10 < 0.0017  10 0.007 
11 0.83  11 0.007 
12 0.37  12 0.28 
13 1.01  13 0.006 
14 0.93  14 < 0.0017 
15 0.006  15 1.02 
16 0.007  16 0.006 
17 0.85  17 1.07 
18 0.007  18 0.46 
19 < 0.0017  19 0.006 
20 1.1  20 1.04 
Vector 
only 
2.22 
 Vector 
only 
2.59 
Clones with transformation efficiency of < 0.01×10
4
/µg of DNA are highlighted. 
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A 
 
 
B 
Figure 3.14 Screening of Perouges1 HindIII (complete digest) library for clones 
inhibitory to R. erythropolis SQ1. 
Spots 1 – 20 correspond to clones 1 – 20.  On both plates, “+” was the vector-only 
control, while “–“ was the negative control with no DNA. 
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A 
 
 
B 
Figure 3.15 Screening of Perouges1 HindIII (partial digest) library for clones 
inhibitory to R. erythropolis SQ1. 
Spots 1 – 20 correspond to clones 1 – 20.  On both plates, “+” was the vector-only 
control, while “–“ was the negative control with no DNA. 
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Table 3.15 Transformants/µg of DNA for clones from Perouges1 libraries. 
HindIII (complete digest) library          HindIII (partial digest) library 
Clone # 
# transformants  
(×10
4
)/µg of DNA 
 
Clone # 
# transformants  
(×10
4
)/µg of DNA 
1 0.004  1 0.05 
2 0.08  2 0.12 
3 0.15  3 0.04 
4 0.19  4 0.05 
5 0.46  5 < 0.0017 
6 0.03  6 0.07 
7 0.002  7 0.009 
8 0.07  8 0.07 
9 0.006  9 < 0.0017 
10 0.02  10 0.13 
11 0.96  11 0.03 
12 1.2  12 0.33 
13 0.19  13 0.13 
14 0.28  14 0.1 
15 0.28  15 0.88 
16 1.85  16 0.72 
17 0.37  17 0.39 
18 1.3  18 0.59 
19 0.19  19 0.24 
20 0.99  20 0.21 
Vector 
only 
1.29 
 Vector 
only 
1.11 
Clones with transformation efficiency of < 0.01×10
4
/µg of DNA are highlighted. 
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3.8 Analysis of inhibitory clones 
 
Clones with transformation efficiency of < 0.01×10
4
/µg of DNA in R. erythropolis 
SQ1 were selected for analysis.  Restriction maps of their inserts were constructed.  
Restriction endonucleases HindIII, BglII, PstI, SfuI, and their isocaudamers were 
screened, as the purpose was to later subclone them using pDA71.  Those which cut 
the insert once or twice were used for restriction map construction by single and 
double digestions of the purified inserts.  Orientation of inserts with respect to the 
vector was then identified by digestions with certain endonucleases and checking for 
the sizes of released fragments. 
 
Purified inserts were digested with the appropriate enzymes and subcloned in E. coli 
MM294-4 using pDA71, and subclones screened for retention of antimicrobial 
activity in R. erythropolis SQ1.  For transformations, pDA71* was always included 
as a vector-only control.  Once the minimum inhibitory DNA was identified, this was 
cloned into vector pUC18 or pUC19.  Sequencing was done by Inqaba Biotec. 
 
Sequences were analyzed using BLASTn for similar nucleotide sequences, while 
BLASTx was used to search for similar amino acid sequences.  An E value of 0.009 
was used as the cutoff for similarity searches.  This number is more lenient than those 
used by other phage studies; for example, Hatfull et al. (2006) and Kwan et al. (2006) 
used a cutoff E value of 10
-4
. 
 
ORFs were predicted on DNA sequences using FramePlot and GeneMark.  Prediction 
of genes by FramePlot is based on an analysis between overall GC content of a 
prokaryotic DNA sequence and base composition at each position in potential codons 
(Bibb et al., 1984).  Prediction of ORFs by GeneMark uses a heuristic method of 
Markov model (Besemer and Borodovsky, 1999) – it is the program of choice by 
many authors for predicting phage ORFs.  Only ORFs predicted by both programs 
were included in this report.  When a DNA sequence initially had a significant match 
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using BLAST, each predicted ORF was then translated and a similarity search was 
conducted using BLASTp in order to identify the specific ORF corresponding to the 
alignment.  GC content of sequenced DNA was also determined by both programs. 
 
In sections below, the analysis as mentioned above is reported for every selected 
inhibitory clone. 
 
 
3.8.1 Analysis of inhibitory clones from Fairland1 libraries 
 
From Fairland1 BglII library, clones 7, 8, 10, and 19 were selected for analysis.  From 
the PstI library, clones 8, 14, and 16 were selected. 
 
 
3.8.1.1 Clone 7 of Fairland1 BglII library 
 
3.8.1.1.1 DNA sequence 
 
Restriction map construction and subcloning of clone 7 from Fairland1 BglII library 
were not conducted due to its insert size of ~1600 bp.  The insert was cloned into the 
BamHI site of pUC19 and partially sequenced.  Front and back regions of the insert 
were sequenced, as shown in Figures 3.16 and 3.17, respectively. 
 
ggatctgtgt  ttgtgcaagg  caagtatggg  accgttgaaa  agatgctcgt  caccgagtac  
acgagaactg   ccgatgcaaa   cggcgtcagc   ggattcccaa  ctctagttag  atgggacaat 
cctaatgaca  aaatctgatg  gt ttgactga  cttgggtcta  agtggccttc  tcgctccaag 
tcctaagtgg  aaccatatca  agccctggaa   tcgacacggc   ctgat tc tac  tcacagccgg  
c t t cgc t t a t  a t tctaatcg  gcatcgctt t  ca tgc t t t c t  gaagagaccc   ctactcgaag 
agagaatcta  caccacatgc   t t t cgc t ca t  gccattcgat  tggtggtgta  t cggc t t t a t 
catagtcggt  gt t t t atcgg  t t c t c t c t t c  acgatggcct  tcgaaaccac   gaaccttggg 
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ttatggcgca  cttaccggat  ggactgctct  ttggtctggc  t t c t a t a t t c  tcggtggt t t 
gtcacatccc  t tgaattggg  gttacgttgc  tacaggcttg  ggttgggctat  gctaggcttt 
ctttggtggg  cagttagcgg  actaatctgt  cctccatctg  aaagggggag  tcatgggagc 
agtgcttccg  catatcgcca  ctgtgctcga  gcccttatag  aacgtggctg  cgatctcgac 
       ccaacgtc 
Figure 3.16 DNA sequence of the front region of the BglII 1600 bp insert. 
The BamHI – BglII hybrid site is shown in blue. 
 
 
gaacacggag acgatcatac  gcccagaacc  ggatgatcga  cgaactgaat  gaaagagtcg  
gataaactcc  gtc tcgt t gt  gagggatcaa   cgtcgccgac   tggagacata  cgagggtaac  
tcccattaag  ggta tat t t g  tgtccgcagg  aaaaacacgg   cctataatga  acccctatga 
aaggaaccca   ca tg t t t a t c  gaaaagactg   agtccaacaa   gaccaaagta   accgaagcca  
tcaacgct t t  gctcgatgag  atgtctggac  atcctgccga  t t c t t c tgaa  tacgccaaga  
tggtggaaca  gctgaccaag   ctc tatgctc  tgaaggaagt  tgactcaaaa  gtcgactccc 
ccagacgtgt  gagcgcggat  acgctggcca   tcgtcggcgg  caata t t ctc  ggaatcgtca 
tgatcgtcgg  acatgaacga   gcgagcgtgt  tgacctcgaa  gctctgacct  tgctgaccaa 
gctacggtag  actgtcgaac  ccacacagga   acaaaagttg  ggagggcttg  taagacacga  
a t t t a c a a g  cct tctcaat  t t t t c c g c g  gaggaatt tt  gggattctaa  a t t t t g t c t c 
gcataggaaa   cacgggttat  aatgagaccc   cacctatgaa  aggaattacc  atgcctgaga 
tcacttaccg  acagtggcgc   ggagaactca   cccagattca  gctcaagata  cgatgcattc 
gacgaagctt  tc tacgcct t  cccattcacg  aat tctgtaa  aaccgacgag   acagtgataa 
   ccgtataaca  agatcc  
Figure 3.17 DNA sequence of the back region of the BglII 1600 bp insert. 
The BamHI – BglII hybrid site is shown in blue. 
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3.8.1.1.2 DNA sequence analysis 
 
3.8.1.1.2a BLASTn result 
 
Sequences of both the front and back regions had no significant nucleotide match. 
 
 
4.8.1.1.2b BLASTx result 
 
Translated sequences of both the front and back regions had no significant protein 
match. 
 
 
4.8.1.1.2c ORF prediction 
 
On each of the front and back regions of the insert, one ORF was predicted, as shown 
in Figures 3.18 and 3.19, respectively.  GC content was 50.2% for the front and 
48.6% for the back region. 
 
 
 
    
    
bp     1                        167                        335                         502                      669                       
  
 
 
Figure 3.18 Predicted ORF on the front region of the BglII 1600 bp insert. 
The numbers inside and at the beginning of the arrow indicate the length and the 
frame of the ORF, respectively.   
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    bp     1                        199                         397                        596                      794 
 
 
 
Figure 3.19 Predicted ORF on the back region of the BglII 1600 bp insert. 
The numbers inside and at the beginning of the arrow indicate the length and the 
frame of the ORF, respectively. 
 
 
3.8.1.2 Clone 8 of Fairland1 BglII library 
 
3.8.1.2.1 Restriction map 
 
Single and double digestions for restriction map construction are shown in Figure 
3.20.  The restriction map is shown in Figure 3.21. 
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                                              MW  1    2    3    4    5   6    7    8    
 
Figure 3.20 Single and double digestions of purified insert from clone 8 of Fairland1 
BglII library, on 0.8% gel. 
Lane 1, undigested; 2, PstI; 3, EcoRI; 4, ScaI; 5, SalI; 6, PstI + EcoRI; 7, PstI + ScaI; 
8, PstI + SalI. 
 
 
 
 
          
bp      210        210             500                         660                             610 
 
 
 
 
 
          EcoRI 
Figure 3.21 Restriction map of the insert from clone 8 of Fairland1 BglII library.
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The orientation of the insert with respect to the suicide gene of pDA71 was identified 
by digesting the clone with PstI, which released a fragment of ~1400 bp (gel not 
shown). 
 
 
3.8.1.2.2 Screening of subclones 
 
DNA fragments generated by digestion of the insert with PstI were subcloned into 
pDA71, as shown in Figure 3.22. 
 
                MW     1   2 
 
Figure 3.22 Subcloned DNA fragments from clone 8 of Fairland1 BglII library, on 
0.8% agarose gel. 
Inserts were released by digestions with respective endonucleases as indicated below. 
Lane 1, BglII – PstI 920 bp fragment; 2, PstI – BglII 1270 bp fragment 
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Retention of antimicrobial activity in these subclones was tested in R. erythropolis 
SQ1.  Number of transformants/µg of DNA for each subclone is shown in Table 3.16. 
 
Table 3.16 Transformants/µg of DNA for each subclone from clone 8 of Fairland1 
BglII library. 
Restriction sites at the 
ends of subclone insert 
Subclone insert size 
(bp) 
# transformants  
(×10
4
)/µg of DNA 
BglII – PstI 920 0.004 
PstI – BglII 1270 0.26 
Vector only NA 1.11 
Subclone with transformation efficiency of < 0.01×10
4
/µg of DNA is highlighted. 
 
 
3.8.1.2.3 DNA sequence 
 
The BglII - PstI 920 bp fragment was cloned into the BamHI and PstI sites of pUC19 
and partially sequenced from the side containing the BamHI – BglII hybrid site.  This 
sequence is shown in Figure 3.23. 
 
ggatctctac   aagaagtcgg   ttcggatgag  t t t a t c t g t c  aggccgctcg   agtctcgacc 
aaggcgctga   tgctt tcggc  actggtgagt  ccgaaggtct  gt taaact tc  ttgatggagg 
gacggcatgg  gtcacccttc  gaacacggct   tgatgagctt  ccgaatcacg   gcgcctatat 
ttgtgtggcg  tgaattcatg  cgtcatcgca  tcggttggtc  gtacaacgag   cagtccggac  
gttacatgga  gatgcttccg  atc t tctacg  tccccaacat  cgagcgtcct  ctcgtccagg 
tcggtaaggc  cggcgcatat  tcgttcgtgc  ctggcgacgc   tgctcagtac  gatcagatgt 
tcaagtcgat  gagtatctcg  tacgagactg  tgtgggctga  gtacgtcaac  caactcaagg  
ccggcgtggc  caaggaggtt  gctcgcatgg  tgttgtcgac  gggcatatat  tcgtcggcgt 
acgtgacatg  caaccctcgt  tcgatgatga  gc t tc t t gtc  tctcagaacg  aaagacgaga  
c t t cgatgt t  cccgtcatat  cctcagtggg  agatcaatca  ggtcgccgac   aagatggaag  
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cagtcttcaa  ggagctctac  cctctcaccc  atgccacatt  ccaggccaac   ggccgagtat 
ctccgtaaag  gaacccaaga   tgaatctcat  tccagtaaca  gaaaaggtcg   atgtcaagac 
       cgcctgccat  ttcaacggat  cacccgtgcc  
Figure 3.23 Partial DNA sequence of the BglII - PstI 920 bp fragment. 
The BamHI – BglII hybrid site, EcoRI, and SalI sites are shown in blue, green, and 
red, respectively. 
 
 
3.8.1.2.4 DNA sequence analysis 
 
3.8.1.2.4a BLASTn result 
 
This DNA sequence had no significant nucleotide match. 
 
 
3.8.1.2.4b BLASTx result 
 
Translated protein sequence of the BglII – PstI fragment showed significant 
alignment with a putative thymidylate synthase complementing protein from 
Streptomyces coelicolor, with an E value of 2e-59, along with the same protein from 
various organisms.  Included were two mycobacteriophage proteins gp90 and gp91.  
BLASTx search results are shown in Table 3.17 and Figure 3.24.  Features on this 
protein are shown in Appendix D. 
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Table 3.17 BLASTx search result: proteins whose sequences aligned to the translated 
BglII - PstI fragment. 
                                                                   Score     E 
Sequences producing significant alignments:                        (Bits)  Value 
 
gi|3413826|emb|CAA20294.1|  conserved hypothetical protein SC9...   231    2e-59 
 
gi|29829059|ref|NP_823693.1|  thymidylate synthase [Streptomyc...   226    7e-58  
 
gi|88931859|ref|ZP_01137552.1|  Thymidylate synthase complemen...   218    2e-55 
gi|28410912|emb|CAD67297.1|  conserved hypothetical protein [T...   201    2e-50  
 
gi|28493583|ref|NP_787744.1|  thymidylate synthase [Tropheryma...   201    2e-50  
 
gi|109393301|ref|YP_656098.1|  gp90 [Mycobacteriophage Catera]...   186    7e-46  
 
gi|29566599|ref|NP_818164.1|  gp91 [Mycobacterium phage Bxz1] ...   186    1e-45  
 
gi|14916788|sp|Q9WYT0|THYX_THEMA  Thymidylate synthase thyX (T...   111    3e-23 
gi|33357640|pdb|1O2B|D  Chain D, Crystal Structure Of Thymidyl...   111    3e-23  
 
gi|20150963|pdb|1KQ4|D  Chain D, Crystal Structure Of Thy1-Com...   107    7e-22  
 
gi|94986126|ref|YP_605490.1|  Thymidylate synthase (FAD) [Dein...   100    2e-20  
  
Only results with an E value ≤ 1e-20 are shown. 
 
 
> gi|3413826|emb|CAA20294.1|  conserved hypothetical protein SC9A10.07 
[Streptomyces coelicolor  
A3(2)] 
 gi|21224089|ref|NP_629868.1|  thymidylate synthase [Streptomyces coelicolor 
A3(2)] 
 gi|24638242|sp|O86840|THYX_STRCO  Thymidylate synthase thyX (TS) (TSase) 
Length=246 
 
 Score =  231 bits (590),  Expect = 2e-59 
 Identities = 115/212 (54%), Positives = 144/212 (67%), Gaps = 2/212 (0%) 
 Frame = +3 
 
Query  30   VYLSGRSSLDQGADAFGTGESEGLLNFLMEGRHGSPFEHGLMSFRITAPIFVWREFMRHR  209 
            V  +G  SLD+         S+GL+N+LM  RHGSPFEH  M+F ++APIFV+REFMRHR 
Sbjct  37   VSTAGEQSLDELKK--DPERSKGLINYLMRDRHGSPFEHNSMTFFVSAPIFVFREFMRHR  94 
 
Query  210  IGWSYNEQSGRYMEMLPIFYVPNIERPLVQVGKAGAYSFVPGDAAQYDQMFKSMSISYET  389 
            +GWSYNE+SGRY E+ P+FY P+  R LVQ G+ G Y FV G   Q++ +  +M  SY   
Sbjct  95   VGWSYNEESGRYRELQPVFYAPDASRKLVQQGRPGKYVFVEGTPEQHELVGSAMEDSYRQ  154 
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Query  390  VWAEYVNQLKAGVAKEVARMVLSTGIYSSAYVTCNPRSMMSFLSLRTKDETSMFPSYPQW  569 
             +A Y   L AGVA+EVAR VL  G+YSS Y TCN RS+M FL LRT+ E +  PS+PQ  
Sbjct  155  AYATYQQMLAAGVAREVARAVLPVGLYSSMYATCNARSLMHFLGLRTQHELAKVPSFPQR  214 
 
Query  570  EINQVADKMEAVFKELYPLTHATFQANGRVSP  665 
            EI    +KMEA +  L PLTHA F ANGRV+P 
Sbjct  215  EIEMAGEKMEAEWARLMPLTHAAFNANGRVAP  246 
 
 
Figure 3.24 BLASTx search result: alignment between the translated BglII - PstI 
fragment and the thymidylate synthase complementing protein from Streptomyces 
coelicolor. 
 
 
3.8.1.2.4c ORF prediction 
 
On this DNA sequence, two ORFs were predicted, as shown in Figure 3.25.  One of 
these ORFs aligned with the thymidylate synthase complementing protein from 
Streptomyces coelicolor.  GC content of the DNA fragment was 53.9%. 
 
 
 
   
   bp            1                 194                                  461                                    750 
 
 
 
Figure 3.25 Predicted ORFs on the sequenced region of the BglII – PstI fragment. 
The numbers inside and at the bottom of each arrow indicate the length and the frame 
of the ORF, respectively.  ORF aligning with the thymidylate synthase 
complementing protein from Streptomyces coelicolor is shown in light green. 
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3.8.1.3 Clone 10 of Fairland1 BglII library 
 
3.8.1.3.1 Restriction map 
 
Single and double digestions for restriction map construction are shown in Figure 
3.26.  The restriction map is shown in Figure 3.27. 
 
                                          MW      1    2   3   4   5   6    7    8   9  10 
 
Figure 3.26 Single and double digestions of purified insert from clone 10 of 
Fairland1 BglII library, on 0.8% gel. 
Lane 1, undigested; 2, HindIII; 3, PstI; 4, SfuI; 5, AccI; 6, HindIII + PstI; 7, HindIII + 
SfuI; 8, HindIII + AccI; 9, PstI + SfuI; 10, PstI + AccI. 
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         bp                             2500                        620     240      740         500 
 
 
 
 
   
      EcoRI 
Figure 3.27 Restriction map of the insert from clone 10 of Fairland1 BglII library. 
The orientation of the insert with respect to the suicide gene of pDA71 was identified 
by digesting the clone with HindIII, which released a fragment of ~4500 bp (gel not 
shown). 
 
 
3.8.1.3.2 Screening of subclones 
 
DNA fragments generated by single digestions of the purified insert with PstI, 
HindIII, SfuI, and double digestion with PstI and HindIII, were subcloned into 
pDA71, as shown in Figure 3.28. 
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                                                     MW 1    2   3    4    5    6   
 
Figure 3.28 Subcloned DNA fragments from clone 10 of Fairland1 BglII library, on 
0.8% agarose gel. 
Inserts were released by digestions with respective endonucleases as indicated below. 
Lane 1, original clone 10, insert released by BglII; 2, BglII – PstI 2500 bp fragment; 
3, PstI – BglII 2100 bp fragment; 4, HindIII - BglII 500 bp fragment; 5, SfuI – BglII 
1240 bp fragment; 6, PstI – HindIII 1600 bp fragment. 
 
 
Retention of antimicrobial activity in each subclone was tested in R. erythropolis 
SQ1.  Transformants/µg of DNA for each subclone is shown in Table 3.18. 
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Table 3.18 Transformants/µg of DNA for each subclone from clone 10 of Fairland1 
BglII library. 
Restriction sites at the 
ends of subclone insert 
Subclone insert size 
(bp) 
# transformants  
(×10
4
)/µg of DNA 
BglII – PstI 2500 0.007 
PstI – BglII 2100 < 0.0017 
HindIII – BglII 500 0.08 
SfuI – BglII 1240 0.17 
PstI – HindIII 1600 0.002 
Vector only NA 1.3 
Subclones with transformation efficiency of < 0.01×10
4
/µg of DNA are highlighted. 
 
 
Both the BglII – PstI 2500 bp and the PstI – BglII 2100 bp fragments, which together 
made up the entire insert from the original clone, were inhibitory.  This suggested the 
presence of at least two different inhibitory determinants on the original insert, with 
at least one in each of these two fragments.  From the data in Table 3.18, the 
inhibitory region was narrowed down as shown in Figure 3.29. 
 
 
 
            
        bp                              2500                        620     240      740        500 
 
Figure 3.29 Region containing inhibitory determinants, as suggested by the screening 
of subclones. 
Inhibitory region is shown in yellow.  Region which was sequenced is indicated with 
the blue line. 
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3.8.1.3.3 DNA sequence 
 
The region between the PstI site and the second (from left) SfuI site, as indicated by 
the blue line in Figure 3.29, was selected for sequencing.  The PstI – HindIII 1600 bp 
fragment was cloned into pUC19 and sequenced from the side containing the PstI 
site.  This sequence is shown in Figure 3.30. 
 
 
ctgcagccgg   gaatatagag  cgtccaggtc  aggttgatct  tctcgt tggt  gtccatcggg  
acgagaatct  caggctcttc  gttggtcagg  acctcacgaa   cgctgtgctc  gtgttcgcga  
cgctct tcct  c t tctgcaat  cagctttgca  gccttgaacg  aggcctggcc   ggccaagatg   
gttgccgtaa  cagcacctgt  aacagccaca   gctgtcagga  tggcggggga  ct t tgaaatg  
gtgaaccgtt  cgaggttctt  tgccagatcg  gaaatcgaca   t t g t t t a c t c  cagtt tagtc  
ttgaatgatg  ggtgtcgtgc  taagtcaagc  gtcgtaatat  ggcatttgac  gttgttcggc  
t t c t t c tgcc  tcgaggagct  ctgcggcttt  ccggtattca  gcaaagaagc   gtgtggacac  
aacccatgtg  gctgcgagga  tgacggtgaa  gatgacggat  acagccaaga   tcccaagacc   
caagaggagg  tagaggaata  tggtccatac  gaactcgaga   acgctcatgc  tgctacgctt  
tcttccggga  t t t c a t t g t a  gaaccgatcg   atcattgcaa  agaactcctc  agcggtctgt  
tccttcgaac   gtcgatggcg  cggtgcggga  cggggagggc  tggtgtac t t  ggggttagtc  
cca t t t acct  tggcgcgacg  acgatcagtg  acgagaacgg  t tgatgtcac  caatgccaac    
       ggaagtccga   tgacctgc 
Figure 3.30 DNA sequence between the PstI and the second SfuI sites, in the PstI – 
HindIII 1600 bp fragment. 
The PstI site and the first SfuI site are shown in blue and green, respectively. 
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3.8.1.3.4 DNA sequence analysis 
 
3.8.1.3.4a BLASTn result 
 
The PstI – SfuI DNA sequence had no significant nucleotide match. 
 
 
3.8.1.3.4b BLASTx result 
 
Translated sequence of the PstI – SfuI DNA fragment had no significant protein 
match. 
 
 
3.8.1.3.4c ORF prediction 
 
Two ORFs were predicted on this sequence, as shown in Figure 3.31.  GC content 
was 53.8%. 
 
 
 
    
    bp     1                              202                               404                          606        738 
 
 
 
Figure 3.31 Predicted ORFs on the PstI –SfuI fragment. 
The numbers inside and at the beginning of each arrow indicate the length and the 
frame of the ORF, respectively. 
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3.8.1.4 Clone 19 of Fairland1 BglII library 
 
3.8.1.4.1 Restriction map 
 
Single and double digestions for the construction of a restriction map are shown in 
Figure 3.32.  The restriction map is shown in Figure 3.33. 
 
                                                           MW   1   2   3    4 
 
Figure 3.32 Single and double digestions of purified insert from clone 19 of 
Fairland1 BglII library, on 0.8% gel. 
Lane 1, undigested; 2, HindIII; 3, ClaI; 4, HindIII + ClaI. 
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bp                   810               590                        1680                           670 
 
 
 
 
 
 
          EcoRI 
Figure 3.33 Restriction map of the insert from clone 19 of Fairland1 BglII library. 
Orientation of the insert with respect to the suicide gene of pDA71 was identified by 
digesting the clone with HindIII, which released fragments of ~2300 bp and ~1000 bp 
(gel not shown). 
 
 
3.8.1.4.2 Screening of subclones 
 
DNA fragments generated by digestion of the purified insert with HindIII were 
subcloned into pDA71, as shown in Figure 3.34.   
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            MW 1  2   3   4    
 
Figure 3.34 Subcloned DNA fragments from clone 19 of Fairland1 BglII library, on 
0.8% agarose gel. 
Inserts were released by digestions with respective endonucleases as indicated below. 
Lane 1, original clone 19, insert released by BglII digestion; 2, HindIII 2270 bp 
fragment; 3, BglII - HindIII 810 bp fragment; 4, HindIII – BglII 670 bp fragment. 
 
 
Retention of antimicrobial activity in these subclones was tested in R. erythropolis 
SQ1.  Transformants/µg of DNA for each subclone is shown in Table 3.19. 
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Table 3.19 Transformants/µg of DNA for each subclone from clone 19 of Fairland1 
BglII library. 
Restriction sites at the 
ends of subclone insert 
Subclone insert size 
(bp) 
# transformants  
(×10
4
)/µg of DNA 
HindIII 2270 0.004 
BglII - HindIII 810 0.11 
HindIII – BglII 670 0.23 
Vector only NA 1.07 
Subclone with transformation efficiency of < 0.01×10
4
/µg of DNA is highlighted.   
 
 
 
3.8.1.4.3 DNA sequence 
 
The HindIII 2270 bp fragment was cloned into pUC18 and partially sequenced.  
Sequences of the front and back regions are shown in Figures 3.35 and 3.36, 
respectively. 
 
 
aagcttttca  gccaactcga   caggatcggc   aaactcaccg   gt c t t gt taa  gctggctgta 
atatagccgc  gccttggcga  c t t c t t c t t c  gatctgaccc  tcgtactgag  cgatcatt tg  
c t t c t tggt c  aagatgtggg  cgattgctgc  acccacaccg   agtgacacca   ctgaggatgc  
cactacgatg  ccagtgtttg  tcatcagtcc  tccagaagtt  cgagcacgtt  gccgtcgacg   
ttgaagtcaa  gccacaccga   gcggctgtct  ccgttgacaa  agcgagttcc  ctctgccaag  
ttgttgaaga  cgccgaagtc   gatgaagttg  tctccgt tac  cgttcagaac  ccatccgacg   
atctggccag  ccttggtacg  atccagtccg  agcatgtcgt  gaacatcgtt  caagaagaca   
acgcccttgg  cacgaagcaa   gtcgttggca  t agt tc tgc t  gcgacgagat   gaagaactgg   
t tgtactcag  t t g cc t t g t t  ccagttcggg  t tccgctcat  cgaagagaac   cttgtacggc  
gatccaccac   gagccgtcgg  aacagcgacc   t tgacc t t c t  tgcccgtctc  atcgattgca   
tcgacctgct  cgaccggctg   ccaaataaga   ga t t cc t t a t  cagccccgat   cgattcgatg   
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       acgcgtccgc   ggtactcacg  gaaggacttc  tcgacgccgg   cgtaagtcc 
Figure 3.35 DNA sequence of the front region of the HindIII 2270 bp fragment. 
The HindIII and the ClaI sites are shown in blue and green, respectively. 
 
 
gcggttgttg  tagctgacgt  aacccgagcc   agttcctgga  cgactgcttg  cgctggatcg  
agtacgactc  ctcgcctcac  cgaacagcat   cttctcgaca  ccctgagaaa   cagcatcagc   
catcatgtcc  ttggcagccg  gcaagagaac   gtccgtcgca  acgtagacca   agacgccctg   
agcatctccg  gcaccaaata   tctctgcgaa  gcgcttaccg  agcggcttct  tacgacgtgt  
aactgcaccg   acggtgattc  gt t cgatc t t  cttctcaggc  gctgccttct  cggcgacggg 
tgccggctgc  t taacggtct  tgctgt t gc t  ggggtagttc  t cca t t t t ag  t tcctcaact  
ttggtaggat  aaaacgtaga   taccgtgtta  gggtatctag  tttcgagatg  t t a t ga t t g t  
gcttgttcag  gattct tgaa  ggatttgatc  agtgcgaccg   c t t ca t c t a t  cttggtatcg  
gtgtagt tc t  tcgatgcgtc  ggccaccatc   gctccgatga  caactgatcc  tgcgtacacc  
gt t acgtgt t  caacgggtgt  t tcaggttcg  aca t t gt t t c  gaatgatggt  ggagacgatc  
t tggtggt tc  cgattccaac  aacagtggaa   acgacgttct  tgagtagatc  cagcttgttc  
atggcaggtc  ct t tcatagg  ggtctcatta  tagggtgtgt  t t t t ac tgcg  tttgcgtggg   
   cacatgt tct   actgt t tcac  gcgacatatc  agctcgaagg   gctcagtgat  taagctt 
Figure 3.36 DNA sequence of the back region of the HindIII 2270 bp fragment. 
The HindIII site is shown in blue. 
 
 
3.8.1.4.4 DNA sequence analysis 
 
3.8.1.4.4a BLASTn result 
 
DNA sequences of the forward and back regions of the HindIII 2270 bp fragment had 
no nucleotide match. 
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3.8.1.4.4b BLASTx result 
 
Translated sequences of both the forward and back regions of the HindIII 2270 bp 
fragment had no protein match. 
 
 
3.8.1.4.4c ORF prediction 
 
Two ORFs were predicted on the front region of the HindIII 2270 bp fragment, and 
one ORF was predicted on the back region, as shown in Figures 3.37 and 3.38, 
respectively.  GC content of the front and back regions were 54.9% and 51.4%, 
respectively. 
 
 
 
    
    bp     1                           198                               395                           593          709 
 
 
 
Figure 3.37 Predicted ORFs on the front region of the HindIII 2270 bp fragment. 
The numbers inside and at the bottom of each arrow indicate the length and the frame 
of the ORF, respectively. 
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    bp     1                        194                        389                         583                      777 
 
 
Figure 3.38 Predicted ORF on the back region of the HindIII 2270 bp fragment. 
The numbers inside and at the beginning of the arrow indicate the length and the 
frame of the ORF, respectively. 
 
 
3.8.1.5 Clone 8 of Fairland1 PstI library 
 
3.8.1.5.1 DNA sequence 
 
Subcloning of clone 8 from Fairland1 PstI library was not conducted due to its size of 
~1600 bp, and it was cloned directly into pUC19.  Sequences of the front and back 
regions are shown in Figures 3.39 and 3.40, respectively. 
 
ctgcaggtga   taccgtaata  catggtccat  gagctgtctt  cctgtgtgga  aaatgt tata 
ccactaacga   tgaaggcagc   caagcgtatc  gtaaacactc  cagcaagcgg  ctcgaagcca  
tcgctagaat  tggaacttag  ccgatgacag   cgaccaagtt  atattaccga  caatcgtcat 
tacaactcaa  agaaaggggg  cggtaaacat  ggaacatgat  ttcagcggtt  acgccacaaa  
agccaatatc  agatgctctg  atggccgaaa   t t t t c t t ggc  t tgacgcctt  caagcatatg 
gatggcgaac   gagttcctct  tgtgtggcag  catggacaca   atgaacccgg   taacgt tctc 
gggcatatga  atctcgaagc  tcgagatggt  gatgcctatg  gctacgcctt  cttcaacgat 
actccgactg  gtcagagtac  gaagttgatg  gtcaagcacg   gcgatattac  tgctctc tca 
atctacgcca  acaagctggt  tgagcgagat  aaggcagtca   tgcacggtca  gatccgtgaa 
gtcagcctag  tcctctcggg  tgcgaacccc   ggtgccttga  tcgacaacgt  caacttgccc 
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atggtgatgg  a tctat tacg  ttggccgatg  aagaggcagt   tat t tacacc  ggagctccac  
tcgaactcaa  ccaacccgaa   gagagtacta  tgtctcacag  caatcagtcc  ggtgaccttt 
agtc tgt tc t  cgactccctg  gacgagacac   agcgtggagc  agtcgacttc  ctccttgagc 
       aggctcttgc  tcatcg 
Figure 3.39 DNA sequence of the front region of the insert from clone 8 of Fairland1 
PstI library. 
The PstI site is shown in blue. 
 
 
ctgagcgagg  acgaagaagt   tctccggaag  attcatccgc  caagcactct  gacctcgccg   
gaaaaccctt  tggaaggaac   caactccagt  cgcacaacgc   cttcgaatcc  aacactctcg  
ccgccaccga   cgccggcaag  tcggctacgc  tcagccacgc   tgacactgct  tccatct tcg  
aaggcgcaaa   gcgtctcggt  tccatgaagg  aatccctcga  ggactacgct  ctgtcgcacg  
gcatccagga   catcgatatc  ctgttcccgg  acgccaaggc   aatctcgtcc  acccctgagt 
tcgagaagcg   tcgcaccgag   tgggtcgccg  aggtcatgaa  cggcacccgc   aaggacccgt   
tctcgcgcat  caagagcctg   acggccaacc   tggccctcga  ggaagctcgg  gcgaagggtt  
acatcaaggg   caacctgaag   aaggaagagt   tcttccgggt  gtcgaagcga   accaccaccc   
ctcagaccat  ctacaagaag   cagaagctgg   accgggatga   catcctggac  atcaccgact  
ttggatgtcg  tggctttggc  tcaagggtga  aaatgcgcct  catgctcgag  gaggagattg 
ctcgcgcagt  cctgctcggc  gatggccgtt  cggttggcga  cgacgacaag   atctccgagg  
atcacgttcg  tccgatcgct  acggatgctg  acctgtacgt  cacgtacgtc  aacgtcaacc   
tgggtgatgc  caattctcgg  ccgaagattc  ccagtgcaga   gttctgtaaa  accgacgagg   
      ccagtgatag  ccgtatactg  cag 
Figure 3.40 DNA sequence of the back region of the insert from clone 8 of Fairland1 
PstI library. 
The PstI site is shown in blue. 
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3.8.1.5.2 DNA sequence analysis 
 
3.8.1.5.2a BLASTn result 
 
Both the front and back regions of the PstI 1600 bp insert had no nucleotide match. 
 
 
3.8.1.5.2b BLASTx result 
 
A translated sequence of the front region aligned to a putative phage head maturation 
peptidase U35 from Mycobacterium sp. MCS and KMS, with an E value of 5e-4.  
BLASTx search result for the front region is shown in Table 3.20 and Figure 3.41.  
Features of this protein are shown in Appendix D. 
 
A translated sequence of the back region aligned to a putative phage capsid protein 
from Streptococcus agalactiae, with an E value of 4e-4.  In a different reading frame, 
the sequence also aligned to a putative dihydropteroate synthase from Nocardioides 
sp. JS614, with an E value of 0.003.  BLASTx search result for the back region is 
shown in Table 3.21 and Figure 3.42.  Features of these proteins are shown in 
Appendix D. 
 
Table 3.20 BLASTx search result: proteins whose sequences aligned to the translated 
front region of the PstI 1600 bp insert. 
 
                                                                 Score     E 
Sequences producing significant alignments:                        (Bits)  Value 
 
gi|108800480|ref|YP_640677.1|  peptidase U35, phage prohead HK...  47.8    5e-04  
 
gi|92916876|ref|ZP_01285493.1|  Peptidase U35, phage prohead H...  47.8    5e-04 
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> gi|108800480|ref|YP_640677.1|  peptidase U35, phage prohead HK97 
[Mycobacterium sp. MCS] 
 gi|108770899|gb|ABG09621.1|  peptidase U35, phage prohead HK97 [Mycobacterium 
sp. MCS] 
Length=526 
 
 Score = 47.8 bits (112),  Expect = 5e-04 
 Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 2/98 (2%) 
 Frame = +1 
 
Query  304  GERVPLVWQHGHNEPGNVLGHMN--LEARDGDAYGYAFFNDTPTGQSTKLMVKHGDITAL  477 
            G  VPL W+HGH++P  ++G +   +E   G         DT  G +    VK   I  L 
Sbjct  49   GGVVPLFWEHGHDDPRAIVGEVTAAVETTRGLEIVGKLDTDTERGAAAYRAVKGRRIRGL  108 
 
Query  478  SIYANKLVERDKAVMHGQIREVSLVLSGANPGALIDNV  591 
            S+       R  +++   + E+SLV+  +N  AL+++V 
Sbjct  109  SVGMRPTQRRGASIIAADLCEISLVMRPSNSRALVESV  146 
 
 
> gi|92916876|ref|ZP_01285493.1|  Peptidase U35, phage prohead HK97 
[Mycobacterium sp. KMS] 
 gi|92438995|gb|EAS96845.1|  Peptidase U35, phage prohead HK97 [Mycobacterium sp. 
KMS] 
Length=526 
 
 Score = 47.8 bits (112),  Expect = 5e-04 
 Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 2/98 (2%) 
 Frame = +1 
 
Query  304  GERVPLVWQHGHNEPGNVLGHMN--LEARDGDAYGYAFFNDTPTGQSTKLMVKHGDITAL  477 
            G  VPL W+HGH++P  ++G +   +E   G         DT  G +    VK   I  L 
Sbjct  49   GGVVPLFWEHGHDDPRAIVGEVTAAVETTRGLEIVGKLDTDTERGAAAYRAVKGRRIRGL  108 
 
Query  478  SIYANKLVERDKAVMHGQIREVSLVLSGANPGALIDNV  591 
            S+       R  +++   + E+SLV+  +N  AL+++V 
Sbjct  109  SVGMRPTQRRGASIIAADLCEISLVMRPSNSRALVESV  146 
 
Figure 3.41 BLASTx search result: alignment between the translated front region of 
the PstI 1600 bp insert and the phage head maturation peptidase U35 from 
Mycobacterium sp. MCS and KMS. 
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Table 3.21 BLASTx search result: proteins whose sequences aligned to the translated 
back region of the PstI 1600 bp insert. 
 
                                                                   Score     E 
Sequences producing significant alignments:                        (Bits)  Value 
 
gi|22534892|gb|AAN00715.1|  conserved domain protein [Streptoc...  48.1    4e-04  
 
gi|71369843|ref|ZP_00660252.1|  Dihydropteroate synthase [Noca...  45.1    0.003 
 
 
 
> gi|22534892|gb|AAN00715.1|  conserved domain protein [Streptococcus 
agalactiae 2603V/R] 
 gi|22537991|ref|NP_688842.1|  hypothetical protein SAG1852 [Streptococcus 
agalactiae 2603V/R] 
Length=420 
 
 Score = 48.1 bits (113),  Expect = 4e-04 
 Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 9/168 (5%) 
 Frame = +3 
 
Query  201  SMKESLEDYALSHGIQDIDILFPDAKAISSTPEFEKRRTEWVAEVMNGTRKDPFSRIKSL  380 
            S +++ E   +  G+ ++  + P+   I+    F          ++N   KDP   ++   
Sbjct  120  SARKAWEANLVEKGVTNLTKILPEPVLIAIQDAFTNYNG-----ILNHVSKDPRYAVR--  172 
 
Query  381  TANLALEEARAKGYIKGNLKKEEFFRVSKRTTTPQTIYKKQKLDRDDILDITDFGCRGFG  560 
               L  + ++AKG+  G  KK+E F     T    T+Y K   +  D+   T      +  
Sbjct  173  -VALQTQVSQAKGHKAGKTKKDEDFTFLDFTINSATVYIKYAFEYSDLKKDTTGAYFNYV  231 
 
Query  561  SRVKMRLMLEEEIARAVLLGDGRSVGDDDKISEDHVRPIATDADLYVT  704 
             +   +  +   I RAV++GDG+S   +DKI+E       T+A+L+ T 
Sbjct  232  MKELAQGFIRT-IERAVVIGDGKSNSAEDKITEIKSIAEETEANLFET  278 
 
 
> gi|71369843|ref|ZP_00660252.1|  Dihydropteroate synthase [Nocardioides sp. 
JS614] 
 gi|71154437|gb|EAO04955.1|  Dihydropteroate synthase [Nocardioides sp. JS614] 
Length=466 
 
 Score = 45.1 bits (105),  Expect = 0.003 
 Identities = 31/87 (35%), Positives = 38/87 (43%), Gaps = 16/87 (18%) 
 Frame = +2 
 
Query  188  KASRFHEGIPRGLRSVARHPGHRYPVPGRQGNLVHP*VREASHRVGRRGHERHPQGPVLA  367 
            +A++  + + RG R   RHP H  P  GR              R GR  H R P  PV A 
Sbjct  100  RAAQRADRVRRGARRPRRHPAH--PRAGRA-------------RPGRPRHPR-PPAPVAA  143 
 102 
 
Query  368  HQEPDGQPGPRGSSGEGLHQGQPEEGR  448 
              + DG P PRG  G G H  +   GR 
Sbjct  144  RPQRDGHPDPRGRPGPGRHPHRGRAGR  170 
 
Figure 3.42 BLASTx search result: alignment between the translated back region of 
the PstI 1600 bp fragment and the phage capsid protein from Streptococcus 
agalactiae, and the dihydropteroate synthase from Nocardioides sp. JS614. 
 
 
3.8.1.5.2c ORF prediction 
 
One ORF was predicted on each of the front and back regions of the PstI 1600 bp 
insert, as shown in Figures 3.43 and 3.44, respectively.  The ORF predicted on the 
front segment corresponded to the phage head maturation peptidase from 
Mycobacterium sp. MCS and KMS.  The ORF predicted on the back segment did not 
correspond to either of the aligned proteins from the BLASTx search.  GC content of 
the front and back regions were 50.4% and 58.3%, respectively. 
 
 
    
    bp     1                        199                      398                       597                          796 
 
 
 
Figure 3.43 Predicted ORF on the front segment of the PstI 1600 bp insert. 
The numbers inside and at the beginning of the arrow indicate the length and the 
frame of the ORF, respectively.  This ORF corresponded to the phage head 
maturation peptidase from Mycobacterium sp. MCS and KMS. 
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    bp     1                        201                       402                       603                         803 
 
 
 
Figure 3.44 Predicted ORF on the back segment of the PstI 1600bp insert. 
The number inside the arrow indicates the length of the ORF.  This ORF 
corresponded to neither of the aligned proteins from the BLASTx search. 
 
 
3.8.1.6 Clone 14 of Fairland1 PstI library 
 
3.8.1.6.1 Restriction map 
 
Single and double digestions for the construction of a restriction map are shown in 
Figure 3.45.  The restriction map is shown in Figure 3.46. 
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      MW 1   2   3   4   5   6   7    8   9  10 11 
 
Figure 3.45 Single and double digestions of purified insert from clone 14 of 
Fairland1 PstI library, on 0.8% gel. 
Lane 1, undigested; 2, BglII; 3, HindIII; 4, AccI; 5, SalI; 6, BglII + HindIII; 7, BglII + 
AccI; 8, BglII + SalI; 9, HindIII + AccI; 10, HindIII + SalI; 11, AccI + SalI. 
  
 
 
 
              
          bp  720          100   290   50                1170                       400   
 
 
 
 
   
      EcoRI 
Figure 3.46 Restriction map of the insert from clone 14 of Fairland1 PstI library. 
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Orientation of the insert with respect to the suicide gene of pDA71 was identified by 
digesting the clone with BglII and HindIII, individually, which released fragments of 
~1300 bp and ~2900 bp, respectively (gel not shown).  
 
 
3.8.1.6.2 Screening of subclones 
 
DNA fragments generated by single digestions of the purified insert with BglII and 
PstI, and double digestion with both enzymes, were subcloned into pDA71, as shown 
in Figure 3.47. 
 
         MW 1   2    3   4    5      
 
Figure 3.47 Subcloned DNA fragments from clone 14 of Fairland1 PstI library, on 
0.8% agarose gel. 
Inserts were released by digestions with respective endonucleases as indicated below. 
Lane 1, PstI – BglII 1160 bp fragment; 2, BglII – PstI 1570 bp fragment; 3, HindIII – 
PstI 400 bp fragment; 4, PstI – HindIII 2330 bp fragment; 5, BglII – HindIII 1170 bp 
fragment. 
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Retention of antimicrobial activity in these subclones was checked in R. erythropolis 
SQ1.  Transformants/µg of DNA for each subclone is shown in Table 3.22. 
 
Table 3.22 Transformants/µg of DNA for each subclone from clone 14 of Fairland1 
PstI library. 
Restriction sites at the 
ends of subclone insert 
Subclone insert size 
(bp) 
# transformants  
(×10
4
)/µg of DNA 
PstI – BglII 1160 0.9 
BglII – PstI 1570 < 0.0017 
HindIII – PstI 400 < 0.0017 
PstI – HindIII 2330 0.05 
BglII – HindIII 1170 0.24 
Vector only NA 1.13 
Subclones with transformation efficiency of < 0.01×104/µg of DNA are highlighted.   
 
 
The HindIII – PstI 400 bp fragment is part of the BglII – PstI 1570 bp fragment.  
Thus the smaller fragment was cloned into pUC19 and sequenced.  
 
  
3.8.1.6.3 DNA sequence 
 
DNA sequence of the HindIII – PstI 400 bp fragment is shown in Figure 3.48. 
 
aagcttgcga   atgaggatgg  tgtgcgcaag  acgaagtccg   t t g c t c t t c t  tgtagctcag 
gcctacttgg  caccacccaa   gaatcacctc  tacaa t tcta  t ga t cca t t t  ggatggggat 
cgtagtaacc  tcaatgctcg  caacttgatg  tggcgtccgc  gttggtacgc  gattcgctat 
caccagatgt  tcaatctcga  tcctatcgat  atctcggtca  tgatcgaaga  cacaggcgag 
gtctt tggaa  ccatcaggga   cctgtgtgta  aagtacggac   tcgaacaaca   cctcacctac 
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atggatcttc  tgaatgggaa  caagctct t t  cactatggat  accgcatcag   acgagtggat 
       tcctaaatag  ggtattaacc  ctgcag 
Figure 3.48 DNA sequence of the HindIII – PstI 400 bp fragment. 
HindIII and PstI sites are shown in blue and green, respectively. 
 
 
3.8.1.6.4 DNA sequence analysis 
 
3.8.1.6.4a BLASTn result 
 
The HindIII – PstI 400 bp DNA sequence had no nucleotide match. 
 
 
3.8.1.6.4b BLASTx result 
 
A translated sequence of the HindIII – PstI 400 bp fragment showed alignment to a 
putative HNH endonuclease from Lactobacillus plantarum bacteriophage LP65, with 
an E value of 0.006.  BLASTx search results are shown in Table 3.23 and Figure 
3.49.  Features of this protein are shown in Appendix D. 
 
Table 3.23 BLASTx search result: protein whose sequence aligned to the translated 
HindIII – PstI fragment. 
 
                                                                   Score     E 
Sequences producing significant alignments:                        (Bits)  Value 
 
gi|56693191|ref|YP_164778.1|  orf143 [Lactobacillus plantarum ...  42.4    0.006  
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> gi|56693191|ref|YP_164778.1|  orf143 [Lactobacillus plantarum 
bacteriophage LP65] 
 gi|54633692|gb|AAV35963.1|  orf143 [Lactobacillus plantarum bacteriophage 
LP65] 
Length=354 
 
 Score = 42.4 bits (98),  Expect = 0.006 
 Identities = 24/59 (40%), Positives = 31/59 (52%), Gaps = 2/59 (3%) 
 Frame = +1 
 
Query  16   DGVRKTKSVALLVAQAYLAPPKNHLYNSMIHLDGDRSNLNARNLMWRPRWYAIRYHQMF  192 
            DG   TK V  LVAQ ++  P N     + H DGD+SN N  NL W    Y  +Y ++F 
Sbjct  63   DGKYVTKKVHRLVAQTFIPNPNN--MPQVNHKDGDKSNNNVSNLEWCTNSYNDKYKKVF  119 
 
Figure 3.49 BLASTx search result: alignment between the translated HindIII – PstI 
fragment and the HNH endonuclease from Lactobacillus plantarum bacteriophage 
LP65. 
 
 
4.8.1.6.4c ORF prediction 
 
On the HindIII – PstI fragment one ORF was predicted, as shown in Figure 3.50, and 
it corresponded to the HNH endonuclease from Lactobacillus plantarum 
bacteriophage LP65.  GC content was 48.6%. 
 
 
 
    
    
bp     1              96                        192                      288          385 
 
 
 
Figure 3.50 Predicted ORF on the HindIII – PstI fragment. 
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The numbers inside and at the beginning of the arrow indicate the length and the 
reading frame of the ORF, respectively.  This ORF corresponded to the HNH 
endonuclease of Lactobacillus plantarum phage LP65. 
 
 
3.8.1.7 Clone 16 of Fairland1 PstI library 
 
3.8.1.7.1 DNA sequence 
 
Subcloning of the insert from clone 16 of Fairland1 PstI library was not conducted 
due to its size of ~2100 bp, and it was directly cloned into pUC18.  Sequences of the 
front and back regions are shown in Figures 3.51 and 3.52, respectively. 
 
ctgcaggtgc   ataccgt ta t  acatgctcac  t agcc tgt t t  cctgtgtgca  aatgttatgc 
cgcatat tct  cgttggtgtc  catcgggacg   agaatctcag  gc tct t cgt t  ggtcaggacc  
tcacgaacgc   tgtgctcgtg  ttcgcgacgc  t c t t c c t c t t  ctgcaatcag  ctttgcagcc 
ttgaacgagg  cctggccggc   caagatggtt  gccgtaacag   cacctgtaac  agccacagct  
gtcaggatgg  cgggggaatt  tggaaatggt  gaaccgttcg  aggt tct t t g  ccagatcgga  
aatcgacatt  gt t tactcca  g t t t a gt c t t  gaatgatggg  tgtcgtgcta  agtcaagcgt 
cgtaatatgg  catt tgacgt  tgt t cggc t t  ct tctgcctc  gaggagctct  gcggctttcc 
ggtattcagc  aaagaagcgt   gtggacacaa   cccatgtggc  tgcgaggatg  acggtgaaga  
tgacggatac  agccaagatc   ccaagaccca   agaggaggta  gaggaatatg  gtccatacga 
actcgagaac   gctcatgctg  ctacgct t tc  ttccgggatt  tcattgtaga  accgatcgat 
cattgcaaag  aactcctcag  cggtctgttc  ct tgctacgt  cgatggcgcg  gtgcgggacg 
gggagggctg  gtgtacttgg  ggttagtccc  a t t t acc t t g  gcgcgacgac  gatcagtgac 
       gagaacggtt  gatgtcacca  atgccaacgg   aagtccgatg  accatgaatg  c 
Figure 3.51 DNA sequence of the front region of the insert from clone 16 of 
Fairland1 PstI library. 
The PstI site is shown in blue. 
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tgatcgttcc  agattgatct  t tcatgatga  gcctttcaaa  tatggtgggg  gagaggatgt  
aaaagacaaa   gcttaaatac  cgtgctaggg  t a t t t a gc t t  t tgggcc t t t  act tgggt t t  
tgtagccgga  caatt t tcgg  tgcattcatg  tacagcgcta  ccaggaaggt   aacggtgaag   
caatggtgca  atgatggtgg  tcatggtaca  tcctctcata  gggggtctca  ttataggatg  
t g t t t t t t c t  gcgagacaaa   aatgaaaggg   cgagtactgt  taagtagctc  atc tcct tac 
cacggttgtg  gtgacaacat  tgaagttgtc  tgagcagttt  t cc t c t cc t t  tcattatagg  
ga t g tg t t t t  t tctgcgact  ctaatctcgc  tcgggatctt  gcttgtacaa  ggcgcccttg  
gtctcggatg  atcgtctcaa  gagcaatggc   gtcatactcg  c t ca t t t t cg  acaccgttct  
tgatcagaat  atcggcgtag  tagacaagca   tagcttcgag  ggtgtctgct  t c c t t t t t t c  
gatcgtcgct  gatcgtcaaa  gatcttgaac  agaagtgccg   tctcgagacc  tacgacaaat 
atgagcacca   gatcgaacgt  gtccttgcgt  aaccatctca  tgtgactcct  taagaaaact  
gagaaaccgt   gttagggtct  ctcaggtcgg  atcgactgtg  cgaatgcggg  t t gc a t c t t t  
tgcgaactcg  gtgctgctgc  a t tcccagt t  cacgaggttg  taaaagcgac   gagaccatga    
       tatccgtcat  aacactgcag  
Figure 3.52 DNA sequence of the back region of the insert from clone 16 of 
Fairland1 PstI library. 
The PstI site is shown in blue. 
 
 
3.8.1.7.2 DNA sequence analysis 
 
3.8.1.7.2a BLASTn result 
 
DNA sequences of the front and back regions of the PstI 2100 bp insert had no 
nucleotide match. 
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3.8.1.7.2b BLASTx result 
 
Translated sequences of the front and back regions of the PstI 2100 bp insert had no 
protein match. 
 
 
3.8.1.7.2c ORF prediction 
 
Two ORFs in the front, and one ORF in the back of the PstI 2100 bp fragment were 
predicted, as shown in Figures 3.53 and 3.54, respectively.  GC contents for the front 
and back regions were 52.9% and 46.3%, respectively. 
 
 
    
    bp     1                        193                      386                       578                          771 
 
 
 
Figure 3.53 Predicted ORFs on the front region of the PstI 2100bp insert. 
The numbers inside and at the beginning of each arrow indicate the length and the 
frame of the ORF, respectively. 
 
 
 
    
    bp     1                        200                      400                        600                         800 
 
 
 
Figure 3.54 Predicted ORF on the back region of the PstI 2100 bp insert. 
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The numbers inside and at the beginning of the arrow indicate the length and the 
frame of the ORF, respectively.  
 
 
3.8.2 Analysis of clones from Perouges1 libraries 
 
Clone 1 from Perouges1 HindIII (complete digest) library, and clone 7 from HindIII 
(partial digest) library were selected for analysis. 
 
 
3.8.2.1 Clone 1 of Perouges1 HindIII (complete digest) library 
 
3.8.2.1.1 Restriction map 
 
Single and double digestions for the construction of a restriction map are shown in 
Figure 3.55.  The restriction map is shown in Figure 3.56 
 
                MW 1   2   3   4    5   6   7 
 
Figure 3.55 Single and double digestions of purified insert from clone 1 of Perouges1 
HindIII (complete digest) library, on 0.8% gel. 
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Lane 1, undigested; 2, NsiI; 3, SfuI; 4, ClaI; 5, NsiI + SfuI; 6, NsiI + ClaI; 7, SfuI + 
ClaI. 
 
 
 
 
          
bp                    660          90                   1400                               530  
 
 
 
 
 
 
          EcoRI 
Figure 3.56 Restriction map of the insert from clone 1 of Perouges1 HindIII 
(complete digest) library. 
Orientation of the insert with respect to the suicide gene of pDA71 was identified by 
digesting the clone with SfuI, which released a fragment of ~2500 bp (gel not shown).   
 
 
3.8.2.1.2 Screening of subclones 
 
DNA fragments generated by single digestions of the purified insert with SfuI and 
NsiI, and double digestion with both enzymes, were subcloned into pDA71, as shown 
in Figure 3.57. 
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                                                          MW   1    2    3    4       
 
Figure 3.57 Subcloned DNA fragments from clone 1 of Perouges1 HindIII (complete 
digest) library, on 0.8% agarose gel. 
As the purified insert was digested with NsiI and ligated to the PstI site of pDA71, 
resulting subclone inserts were released by different endonucleases in flanking 
restriction sites, as indicated below, thereby increasing their sizes. 
Lane 1, original clone 14, insert released by HindIII; 2, HindIII – SfuI 750 bp 
fragment; 3, NsiI - HindIII 530 bp fragment, insert released by SfuI + HindIII; 4, SfuI 
– NsiI 1400 bp fragment, insert released by SfuI + HindIII. 
 
 
Retention of antimicrobial activity in these subclones was tested in R. erythropolis 
SQ1.  Transformants/µg of DNA for each subclone is shown in Table 3.24. 
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Table 3.24 Transformants/µg of DNA for each subclone from clone 1 of Perouges1 
HindIII library. 
Restriction sites at the 
ends of subclone insert 
Subclone insert size 
(bp) 
# transformants  
(×10
4
)/µg of DNA 
HindIII – SfuI 750 1.9 
NsiI - HindIII 530 0.56 
SfuI – NsiI 1400 < 0.0017 
Vector only NA 1.56 
Subclone with transformation efficiency of < 0.01×10
4
/µg of DNA is highlighted.   
 
 
4.8.2.1.3 DNA sequence 
 
The SfuI – NsiI 1400 bp fragment was cloned into the AccI and PstI site of pUC18.   
The sequence is shown in Figure 3.58. 
 
 
ctgcatatca  c t tatctgac  tcaaagtatg  agtatgagcg  gtgggagcaa  aggtagtagg  
ct tatcggta  atatcagccc  atagatgagt  atgactggta  t t agc t t t ac  cagctaatga  
ggcggttagt  ccagtaacat  cagcttctac  gtgtgagtga  gcactcggag   cgaatgtact  
aggaattcct  gtcaaagtat  tgtaggcatg  agtatgggca  ctaggagtaa  atgtagcagg  
aatgctggta  atagcactcc  aatctacgcc  aacatttaca  gcaccgagac   catcaggact  
cacaccattt  actgtc t taa  tgtactcggg  atgagtatga  gaagtacttg  acttaccact  
tagtgcagtt  gcagtagcat  tactgatagg  ct t a t t caaa  tcggaggtat  t a t c tacgt t  
acccaatccg   atatcagcct  tggtgctagg  aatggtaggc  ttggcagtaa  ggtcgttgta  
tgatccgctg  gtagcgacag   catgcaacga   agtaatgttc  accttaagat  taagtgcagt  
ttgtgtagca  cttgatacag  gct ta t taac  gtctgaggta  t tgtc tacgt  tgcctagtcc  
tacggcaccc   t tggt taatc  cggcaggctg  gacactagta  tcagcctt tg  atagcgtggt  
acgtacgtca  ggatgcaact  tagctgatgt  aatct tatcg  ttaccaatga  caatagcgtt  
ggcattaccg  gctaggtcac  cagcgataag   aatct tacca  aaaacacttt  gataggcgtg  
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gtacgtacgt  caggatgcaa   ct tagctgat  gt aa t c t t a t  cgttaccaat  gacaatagcg   
t tggcat t t c  cggctaggtc  accagcggat   aagaatctta  ccc t t t t a c t  tcgggtggta  
gcatcaacaa   cgccaccctc   actaccgtcc  ccggactggt  agcgcaaaag   gtgtt tgtgg  
taccatcatc  gtaatgtacg  gtaagctacg  agtccctgtg  tggtaatctc  aacaatgccc   
gcgtccagtg  tcacccttgg  tgat taatga  aaccaggcac   ctcggcggca   ccaaaggaag   
tcattcaagt  caataggggc   cggtaccagc   attaaacagg  tacactagca  acacgctcgc   
cccagctagg   aacaacccgg   tagggtccag  ccgttgttag  gagttatgcc  aggctgatta  
gtaatgatag  cttcaaatga  gaacgtaccg   tctggttcaa  t t tctacacg  ctgaggatag  
atgcttgaca  gatcaaggat  caacccggta   ctgtctacac  gt a tgctc t t  agcactagga   
taaaccatca  cgaaaccgtg   cttaggacgt  gacttgtact  gctgatctat  ttgatcaaaa  
tacaggtcag  cgtactggcc  tgtgacgatt  cgggatgcaa   ttcctgctgg  ataactcata  
c a t c aa t t t t  aacacaaaac   aaaggaacga   gattaaatgg  aactcagtgg  atacgacttc 
       gac 
Figure 3.58 DNA sequence of the SfuI – NsiI 1400 bp fragment. 
The PstI – NsiI hybrid site and the AccI – SfuI hybrid site are shown in blue and 
green, respectively. 
 
 
3.8.2.1.4 DNA sequence analysis 
 
3.8.2.1.4a BLASTn result 
 
The SfuI – NsiI fragment had no nucleotide match. 
 
 
3.8.2.1.4b BLASTx result 
 
Translated sequence of the SfuI – NsiI fragment had several protein matches.  It 
aligned to a putative head decoration protein of prophage MuMc02 from Roseobacter 
sp. MED193, with an E value of 8e-7.  Another alignment was found to a putative 
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phage-related tail protein from Xanthomonas axonopodis, with an E value of 4e-5.  It 
also aligned to gp4 from mycobacteriophage Bethlehem and gp133 from 
mycobacteriophage Catera, with E values of 3e-4 and 4e-4, respectively.  These two 
proteins were also hypothetical.  Lastly, an alignment was found to a putative cell 
wall surface anchor family protein from Streptococcus agalactiae, with an E value of 
5e-4.  All of alignments were in the same reading frame.  BLASTx search results are 
shown in Table 3.25 and Figure 3.59.  Features on these proteins are shown in 
Appendix D. 
 
 
Table 3.25 BLASTx search result: proteins whose sequences aligned to the translated 
SfuI - NsiI fragment. 
 
                                                                   Score     E 
Sequences producing significant alignments:                        (Bits)  Value 
 
gi|86139877|ref|ZP_01058443.1|  prophage MuMc02, head decorati...  58.5    8e-07 
gi|21107209|gb|AAM35948.1|  phage-related tail protein [Xantho...  52.8    4e-05  
 
gi|40769419|gb|AAR89725.1|  gp4 [Mycobacteriophage Bethlehem]      50.1    3e-04 
gi|109393343|ref|YP_656141.1|  gp133 [Mycobacteriophage Catera...  49.7    4e-04  
 
gi|22534491|gb|AAN00330.1|  cell wall surface anchor family pr...  49.3    5e-04  
 
 
 
 
> gi|86139877|ref|ZP_01058443.1|  prophage MuMc02, head decoration protein, 
putative [Roseobacter sp. MED193] 
 gi|85823506|gb|EAQ43715.1|  prophage MuMc02, head decoration protein, putative 
[Roseobacter sp. MED193] 
Length=419 
 
 Score = 58.5 bits (140),  Expect = 8e-07 
 Identities = 57/189 (30%), Positives = 82/189 (43%), Gaps = 24/189 (12%) 
 Frame = -1 
 
Query  627  PAGLTKGAVGLGNVDNTSDVNKPVSSATQTALNLKVNITSLHAVATSGSYNDLTAKPTIP  448 
            PA L  G V    VD+T  + K              N TS+ A+A SG +   T   TI  
Sbjct  18   PAALKSGEVAHNEVDDTLYIGKGDDGGG--------NATSIVAIAGSGGFVAKTGTQTIA  69 
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Query  447  STKAD--IGLGNVDNTSDLNKPISNATATALSGKSSTSHTHPEYIKTVNGV--SPDGLGA  280 
              K    +   + D  +  +    +   T L GK++TSH+H   I  V G+  + DG  A 
Sbjct  70   GKKTFSLVPTASQDAAAGSDLVRKSQLDTLLGGKANTSHSHA--IADVTGLQGALDGKAA  127 
 
Query  279  V---NVGVDWSAITSIPATFTPSAHTHAYNTLTGI-------PSTFAPSAHSHVEADVTG  130 
            V   +   + S  TS   T   +A   A +T  G+        + FA +AH H  +DV+G 
Sbjct  128  VSHDHTAAEISDSTSAGRTLLKAADVAAQHTALGLGTAALMSSTAFAAAAHGHAISDVSG  187 
 
Query  129  LTASLAGKA  103 
            L  +L GKA 
Sbjct  188  LQTALNGKA  196 
 
 
 Score = 42.0 bits (97),  Expect = 0.075 
 Identities = 20/36 (55%), Positives = 25/36 (69%), Gaps = 0/36 (0%) 
 Frame = -1 
 
Query  171  APSAHSHVEADVTGLTASLAGKANTSHTHLWADITD  64 
            A ++HSH  ADVTGL  +L GKA  SH H  A+I+D 
Sbjct  104  ANTSHSHAIADVTGLQGALDGKAAVSHDHTAAEISD  139 
 
 
 Score = 40.8 bits (94),  Expect = 0.17 
 Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 15/154 (9%) 
 Frame = -1 
 
Query  552  SATQTALNLK----VNITSLHAVATSGSYNDLTAKPTIPSTKADIGLGNVDNTSDLNKPI  385 
            +A  TAL L     ++ T+  A A   + +D++   T  + KA +   +   T        
Sbjct  154  AAQHTALGLGTAALMSSTAFAAAAHGHAISDVSGLQTALNGKAPLASPSFTGTP------  207 
 
Query  384  SNATATALSGKSSTSHTHPEYIKTVNGVSPDGLGAVNVGVDWSAITSIPATFTPSAHTHA  205 
              A  TA  G ++T      ++++   ++  G G + +   + +           A   A 
Sbjct  208  --AAPTAAGGTNTTQIATTAFVQSA--IASFGAGDM-LKATYDSDNDGKVDAAELADAVA  262 
 
Query  204  YNTLTGIPSTFAPSAHSHVEADVTGLTASLAGKA  103 
            +  +TG P+TF PSAH+H  + VTGL ++L  KA 
Sbjct  263  WTGVTGKPATFPPSAHNHPISQVTGLQSALDAKA  296 
 
 
> gi|21107209|gb|AAM35948.1|  phage-related tail protein [Xanthomonas 
axonopodis pv. citri str. 306] 
 gi|21241830|ref|NP_641412.1|  phage-related tail protein [Xanthomonas 
axonopodis pv. citri str. 306] 
Length=686 
 
 Score = 52.8 bits (125),  Expect = 4e-05 
 Identities = 37/93 (39%), Positives = 49/93 (52%), Gaps = 10/93 (10%) 
 Frame = -1 
 
Query  600  GLGNVDNTSDVNKPVSSATQTALNLKVNITSLHAVATSGSYN---DLTAKPTI--PS---  445 
            G  ++DNT  V      +    L +  +I+ L  +AT  S +    +T KP    PS    
Sbjct  291  GWDHIDNTEQVTSVAGKSGAVQL-VPSDISGLGTLATRDSVDFSSHVTNKPASYPPSGHM  349 
 
Query  444  -TKADIGLGNVDNTSDLNKPISNATATALSGKS  349 
 119 
             TK D+GL NVDNTSD NKP+SNA   AL  K+ 
Sbjct  350  HTKGDVGLSNVDNTSDANKPVSNAQQAALDTKA  382 
 
 
 Score = 50.1 bits (118),  Expect = 3e-04 
 Identities = 28/54 (51%), Positives = 34/54 (62%), Gaps = 2/54 (3%) 
 Frame = -1 
 
Query  669  DVRTTLSKADTSVQPAGL--TKGAVGLGNVDNTSDVNKPVSSATQTALNLKVNI  514 
            D  + ++    S  P+G   TKG VGL NVDNTSD NKPVS+A Q AL+ K  I 
Sbjct  331  DFSSHVTNKPASYPPSGHMHTKGDVGLSNVDNTSDANKPVSNAQQAALDTKAPI  384 
 
 
> gi|40769419|gb|AAR89725.1|  gp4 [Mycobacteriophage Bethlehem] 
Length=356 
 
 Score = 50.1 bits (118),  Expect = 3e-04 
 Identities = 27/79 (34%), Positives = 38/79 (48%), Gaps = 26/79 (32%) 
 Frame = -1 
 
Query  264  DWSAITSIPATFTPSAHTH--------------------------AYNTLTGIPSTFAPS  163 
            DW A++++P  F PSAH H                          A++ +TG P+TF PS 
Sbjct  113  DWDALSNVPVEFPPSAHDHVAADVTDLDAAIADYLADNPPESSSVAWDDVTGKPTTFTPS  172 
 
Query  162  AHSHVEADVTGLTASLAGK  106 
             H+H  A+VTGL  +L  K 
Sbjct  173  THTHSIANVTGLQTALDEK  191 
 
 
 Score = 38.1 bits (87),  Expect = 1.1 
 Identities = 21/56 (37%), Positives = 28/56 (50%), Gaps = 1/56 (1%) 
 Frame = -1 
 
Query  267  VDWSAITSIPATFTPSAHTHAYNTLTGIPSTFAPSA-HSHVEADVTGLTASLAGKA  103 
            V W  +T  P TFTPS HTH+   +TG+ +          V+A V   TA+L   A 
Sbjct  157  VAWDDVTGKPTTFTPSTHTHSIANVTGLQTALDEKLDEDAVDARVAVGTAALVDSA  212 
 
 
> gi|109393343|ref|YP_656141.1|  gp133 [Mycobacteriophage Catera] 
 gi|91981165|gb|ABE67880.1|  gp133 [Mycobacteriophage Catera] 
 gi|29566641|ref|NP_818207.1|  gp134 [Mycobacterium phage Bxz1] 
 gi|29425366|gb|AAN16790.1|  gp134 [Mycobacterium phage Bxz1] 
Length=489 
 
 Score = 49.7 bits (117),  Expect = 4e-04 
 Identities = 23/36 (63%), Positives = 29/36 (80%), Gaps = 0/36 (0%) 
 Frame = -1 
 
Query  456  TIPSTKADIGLGNVDNTSDLNKPISNATATALSGKS  349 
            T+  TK+D+GL NVDNTSD  KPIS+ATA AL+ K+ 
Sbjct  186  TVTLTKSDVGLNNVDNTSDAAKPISSATALALAAKA  221 
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 Score = 48.1 bits (113),  Expect = 0.001 
 Identities = 60/216 (27%), Positives = 84/216 (38%), Gaps = 27/216 (12%) 
 Frame = -1 
 
Query  690  TSAKLHPDVRTTLSKADTSVQ----PAGLTKGAVGLGNVDNTSDVNKPVSSATQTALNLK  523 
            T+ K + D R   +    SV        LTK  VGL NVDNTSD  KP+SSAT  AL  K 
Sbjct  161  TTNKYYTDARAAAAAPVQSVAGRTGTVTLTKSDVGLNNVDNTSDAAKPISSATALALAAK  220 
 
Query  522  VNITSLHA------VATSGSYNDLTAKPTIPST-----KADIG-LGNVDNTSDLNKPISN  379 
             ++ S         +     Y DL++ P           AD G L   D+ ++  + I + 
Sbjct  221  ADLVSGRVPPEQLPIPPVAEYADLSSFPAPGEAGTLYIAADTGNLYRWDSVAENFELIVS  280 
 
Query  378  ATATALS-------GKSSTSHTHPEYIKTVNGVSPDGLGAVNVGVDWSAITSIPATFTPS  220 
            AT    +       G ++   T+      V  +  D  G V  G D      +  T TP+ 
Sbjct  281  ATGGGAASTDELPEGGTNLYFTNARVTARVEAMFGDAAGTVTQGND----PRLSNTRTPT  336 
 
Query  219  AHTHAYNTLTGIPSTFAPSAHSHVEADVTGLTASLA  112 
             +T +   L  +  T    A   V  D       LA 
Sbjct  337  DNTVSTAKLVDLAVTTDKIADEAVTLDKLAEDVQLA  372 
 
 
> gi|22534491|gb|AAN00330.1|  cell wall surface anchor family protein 
[Streptococcus agalactiae 2603V/R] 
 gi|22537606|ref|NP_688457.1|  cell wall surface anchor family protein 
[Streptococcus agalactiae 2603V/R] 
Length=970 
 
 Score = 49.3 bits (116),  Expect = 5e-04 
 Identities = 51/241 (21%), Positives = 100/241 (41%), Gaps = 10/241 (4%) 
 Frame = -1 
 
Query  789  RTYHAYQSVFGKILIAGDLAGNANAIVIGNDKITSAKLHPDVRTTLS---KADTSVQPAG  619 
            +TY +  S +G   I+GD   NA   ++     TSA        ++S    A TS   +  
Sbjct  615  QTYGSKYS-YGHTNISGDSDANAEIKLLSESASTSASTSASTSASMSASTSASTSASMSA  673 
 
Query  618  LTKGAVGL---GNVDNTSDVNKPVSSATQTALNLKVNITSLHAVATSGSYNDLTAKPTIP  448 
             T  +       ++  ++  +   S++  T+ +   ++++  + +TS S +  T+  T   
Sbjct  674  STSASTSASTSASMSASTSASTSASTSASTSASTSASMSASTSASTSASTSASTSASTSA  733 
 
Query  447  STKADIGLGNVDNTS---DLNKPISNATATALSGKSSTSHTHPEYIKTVNGVSPDGLGAV  277 
            ST A +      +TS     +   S + +T+ S  +STS +    +      S     +  
Sbjct  734  STSASMSASTSASTSASTSASTSASMSASTSASTSASTSASTSASMSASTSASTSASTSA  793 
 
Query  276  NVGVDWSAITSIPATFTPSAHTHAYNTLTGIPSTFAPSAHSHVEADVTGLTASLAGKANT  97 
            +     SA TS   + + SA T A  + +   ST A ++ S   +     +AS++   +  
Sbjct  794  STSASMSASTSASTSASTSASTSASMSASTSASTSASTSASMSASTSASTSASMSASTSA  853 
 
Query  96   S  94 
            S 
Sbjct  854  S  854 
 
Figure 3.59 BLASTx search result: alignment between the translated SfuI – NsiI 
fragment and the various proteins. 
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3.8.2.1.4.3 ORF prediction 
 
Two ORFs were predicted on the SfuI – NsiI fragment, as shown in Figure 3.60.  One 
of them corresponded to the various proteins to which the alignments were found.  
GC content was 46.2%. 
 
 
    
    bp     1                         376                      752                       1127                      1503 
 
 
 
Figure 3.60 Predicted ORFs on the SfuI – NsiI fragment. 
The numbers inside and at the beginning of each arrow indicate the length and the 
frame of the ORF, respectively.  The ORF corresponding to the various proteins to 
which the alignments were found, is shown in light green. 
 
 
3.8.2.2 Clone 7 of Perouges1 HindIII (partial digest) library 
 
3.8.2.2.1 Restriction map 
 
Single and double digestions for the construction of a restriction map are shown in 
Figure 3.61.  The restriction map is shown in Figure 3.62. 
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                                                   MW  1    2   3    4   5    6   7   
 
Figure 3.61 Single and double digestions of purified insert from clone 7 of Perouges1 
HindIII (partial digest) library, on 0.8% gel. 
Lane 1, undigested; 2, NsiI; 3, SfuI; 4, AccI; 5, NsiI + SfuI; 6, NsiI + AccI; 7, SfuI + 
AccI. 
 
 
 
              
bp                 1650                    200             1150                                        1040     
  
 
 
 
 
 
     EcoRI 
Figure 3.62 Restriction map of clone 7 from Perouges1 HindIII (partial digest) 
library. 
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The orientation of the insert with respect to the suicide gene of pDA71 was identified 
by digesting the clone with SfuI, which released two fragments of ~1700 bp (gel not 
shown). 
 
 
3.8.2.2.2 Screening of subclones 
 
DNA fragments generated by single digestions of the purified insert with SfuI and 
NsiI were subcloned into pDA71, as shown in Figure 3.63.   
 
       MW  1    2    3    4    5    
 
Figure 3.63 Subcloned DNA fragments from clone 7 of Perouges1 HindIII (partial 
digest) library, on 0.8% agarose gel. 
As the purified insert was digested with NsiI and ligated to the PstI site of pDA71, 
resulting subclone inserts were released by different endonucleases in flanking 
restriction sites, as indicated below, thereby increasing their sizes.  
Lane 1, original clone 7, insert released by HindIII; 2, HindIII – SfuI 1320 bp 
fragment; 3, SfuI - HindIII 1650 bp fragment; 4, NsiI 1350 bp fragment, insert 
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released by BglII + SfuI;5, HindIII – NsiI 1510 bp fragment, insert released by 
HindIII + SfuI. 
 
 
Retention of antimicrobial activity in these subclones was tested in R. erythropolis 
SQ1.  Transformants/µg of DNA for each subclone is shown in Table 3.26. 
 
Table 3.26 Transformants/µg of DNA for each subclone from clone 7 of Perouges1 
HindIII library. 
Restriction sites at the 
ends of subclone insert 
Subclone insert size 
(bp) 
# transformants  
(×10
4
)/µg of DNA 
HindIII - SfuI 1320 0.03 
SfuI - HindIII 1650 0.29 
NsiI 1350 0.06 
HindIII - NsiI 1510 0.15 
Vector only NA 0.93 
Subclone with the most retention of antimicrobial activity is highlighted. 
 
 
The inhibitory activity was retained the most in the HindIII – SfuI 1320 bp fragment, 
although its transformation efficiency was > 0.01×10
4
/µg of DNA.  This fragment 
was cloned into the HindIII and AccI sites of pUC18 and sequenced. 
 
 
3.8.2.2.3 DNA sequence 
 
Sequence of the entire HindIII - SfuI 1320 bp fragment is shown in Figure 3.64. 
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aagctttaag   catgtcgctt  ttatgcgagg  tagctgtacc  gaagatgcag   aactctatcg  
agaggactgg  ggactatacc  taggagccac   agagcaccag   gcccccggac   gcgacggatt  
ccaggcacgc   gcattggata  cagaagagct   tgaaggcgca   gactgggcac   aggagcagca  
tatcgaaaac  ccacgtctag  gatggggaaa  gcgtgaaaac   t tctacatca  ctgtagccgt  
agaatcat t t  cgatatcggc  acaggagaaa   aggtagttgt  accagcaatc   cta tctcgtc  
caatcggaca   cgaattcgta  gggaaagatc   at tcagt tca  acgatgagtc  taatggtgag  
ggaatcactg  gcaagactta  ctggctaact  agaacaggtc   agaagaccga   aactaagtgg  
cttatcgagg  aagagaaaga   tccagacaag   cagatcgtat  tcggagatat  cgctccgtac  
gatttgaagg  agacagcagt   tatccacgta  ccttatgaca  agcagaagga  at tctacatg  
cgtaaggcag   atatcgaggg  tgcacagaag   gccgcagatg   cccgtgcagc   taagagaaac  
ggtggagaga  ccaacaacag   ctcatctaac  ggagactcac   agggtggtaa  caagcccgca   
gcatccggtg  gcaagcgtta  tagctggtaa  tccagtt tga  tcggggaggc  tctacaatac  
gtggagcctc  cctaaactaa  tactagacac  gaccaaggtc   gctaaagagg   agaagaatga   
c taaattatg  ggatggtaaa  gagttcgttg  aacttcataa  ccacacttat  tacagcccac   
tggacggatt  gagttcgcca  gaggtatact   t tat tcgagc  acatgagcta  ggactcacta 
agctcgccat  tacagaccac   ggcacattgg  ccgggtatcg  ccactttcag  agggcagcca  
aagaagcagg  cat tgatcct  attcttggcg  tagaagcata  cattagtcag  accaaccgct   
ttgaccgtcg  taccaaggca   aatcgtcagg  acggcaccga   ggtctacaat  cacattatcc  
tgttggcaaa  gaatgatgcc  ggggtgcaca  gccttaacgt  cttgtcagag  attggctgga   
       ccgaaggatt  ctacaagaag   ccacgtatcg  attttcgac 
Figure 3.64 DNA sequence of the HindIII – SfuI fragment. 
The HindIII, AccI, and AccI – SfuI hybrid sites are shown in blue, green, and red, 
respectively. 
 
 
3.8.2.2.4 DNA sequence analysis 
 
3.8.2.2.4a BLASTn result 
 
The HindIII – SfuI fragment had no significant match. 
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3.8.2.2.4b BLASTx result 
 
A translated sequence of the HindIII – SfuI fragment showed significant alignment to 
the alpha subunit of DNA polymerase III from various organisms.  The highest E 
value of 2e-24 was observed with the protein from Aquifex aeolicus.  BLASTx results 
are shown in Table 3.27 and Figure 3.65.  Features of this protein are shown in 
Appendix D. 
 
Table 3.27 BLASTx result: proteins whose sequences aligned to the translated 
HindIII – SfuI fragment. 
 
                                                                   Score     E 
Sequences producing significant alignments:                        (Bits)  Value 
 
gi|6014991|sp|O67125|DPO3A_AQUAE  DNA polymerase III subunit a...   116    2e-24 
gi|106886892|ref|ZP_01354219.1|  DNA polymerase III, alpha sub...   109    2e-22 
gi|73660858|emb|CAI83465.1|  DNA polymerase III, alpha subunit...   108    6e-22  
 
gi|88932976|ref|ZP_01138658.1|  DNA polymerase III, alpha subu...   108    6e-22 
gi|3676693|gb|AAC62072.1|  DNA polymerase; DnaE [Treponema dentic   107    8e-22 
 
Only the top five hits are shown. 
 
 
> gi|6014991|sp|O67125|DPO3A_AQUAE  DNA polymerase III subunit alpha 
 gi|2983510|gb|AAC07087.1|  DNA polymerase III alpha subunit [Aquifex aeolicus 
VF5] 
 gi|15606309|ref|NP_213688.1|  DNA polymerase III alpha subunit [Aquifex 
aeolicus VF5] 
Length=1161 
 
 Score =  116 bits (291),  Expect = 2e-24 
 Identities = 59/127 (46%), Positives = 83/127 (65%), Gaps = 1/127 (0%) 
 Frame = +3 
 
Query  798   KEFVELHNHTYYSPLDGLSSPEEYFIRAHELGLTKLAITDHGTLAGYRHFQRAAKEAGID  977 
             K+FV LH HT +S LDG    +E   +A E G   + ++DHG L G   F +A K  GI  
Sbjct  3     KDFVHLHLHTQFSLLDGAIKIDELVKKAKEYGYKAVGMSDHGNLFGSYKFYKALKAEGIK  62 
 
Query  978   PILGVEAYISQTNRFDRRTKANRQDGTEVYN-HIILLAKNDAGVHSLNVLSEIGWTEGFY  1154 
 127 
             PI+G+EAY +  +RFDR+TK +  + T+ YN H+IL+AK+D G+ +L  LS + + EGFY 
Sbjct  63    PIIGMEAYFTTGSRFDRKTKTSEDNITDKYNHHLILIAKDDKGLKNLMKLSTLAYKEGFY  122 
 
Query  1155  KKPRIDF  1175 
              KPRID+ 
Sbjct  123   YKPRIDY  129 
 
 
> gi|106886892|ref|ZP_01354219.1|  DNA polymerase III, alpha subunit 
[Clostridium phytofermentans ISDg] 
 gi|106765595|gb|EAT22347.1|  DNA polymerase III, alpha subunit [Clostridium 
phytofermentans ISDg] 
Length=1186 
 
 Score =  109 bits (273),  Expect = 2e-22 
 Identities = 56/123 (45%), Positives = 76/123 (61%), Gaps = 4/123 (3%) 
 Frame = +3 
 
Query  804   FVELHNHTYYSPLDGLSSPEEYFIRAHELGLTKLAITDHGTLAGYRHFQRAAKEAGIDPI  983 
             F  LH HT +S LDG    +E   +A +LG+  LAITDHG + G   F RA    GI PI 
Sbjct  3     FTHLHVHTEFSLLDGSGKIKEMAAQAKKLGMDALAITDHGVMYGVIDFYRACLAEGIKPI  62 
 
Query  984   LGVEAYISQTNRFDRRTKANRQDGTEVYNHIILLAKNDAGVHSLNVLSEIGWTEGFYKKP  1163 
             +G E Y++  +RFD+   A+     E Y+H++LLA+ND G H+L  +   G+TEGFY KP 
Sbjct  63    IGCEVYVAPNSRFDKEGSASE----ERYHHLVLLAENDIGYHNLIKIVSRGFTEGFYYKP  118 
 
Query  1164  RID  1172 
             R+D 
Sbjct  119   RVD  121 
 
 
> gi|73660858|emb|CAI83465.1|  DNA polymerase III, alpha subunit 
[Dehalococcoides sp. CBDB1] 
 gi|73749142|ref|YP_308381.1|  DNA polymerase III, alpha subunit 
[Dehalococcoides sp. CBDB1] 
Length=1170 
 
 Score =  108 bits (269),  Expect = 6e-22 
 Identities = 60/123 (48%), Positives = 77/123 (62%), Gaps = 6/123 (4%) 
 Frame = +3 
 
Query  804   FVELHNHTYYSPLDGLSSPEEYFIRAHELGLTKLAITDHGTLAGYRHFQRAAKEAGIDPI  983 
             F  LH HT +S LDG+    +  +RA ELG+  LAITDHGT+ G   F + AKEAGI PI 
Sbjct  2     FCHLHVHTEFSLLDGMCRISQLVVRAKELGMEALAITDHGTMHGIPRFYKEAKEAGIKPI  61 
 
Query  984   LGVEAYISQTNRFDRRTKANRQDGTEVYNHIILLAKNDAGVHSLNVLSEIGWTEGFYKKP  1163 
             LG E Y++  +R   +T A++      Y H++LLAKN+ G H+L  LS     EGFY KP 
Sbjct  62    LGSEFYLAYGDR-TAKTAADKN-----YYHLVLLAKNNKGYHNLIQLSSRSHLEGFYYKP  115 
 
Query  1164  RID  1172 
             RID 
Sbjct  116   RID  118 
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> gi|88932976|ref|ZP_01138658.1|  DNA polymerase III, alpha subunit 
[Dehalococcoides sp. BAV1] 
 gi|88914829|gb|EAR34210.1|  DNA polymerase III, alpha subunit [Dehalococcoides 
sp. BAV1] 
Length=1170 
 
 Score =  108 bits (269),  Expect = 6e-22 
 Identities = 60/123 (48%), Positives = 77/123 (62%), Gaps = 6/123 (4%) 
 Frame = +3 
 
Query  804   FVELHNHTYYSPLDGLSSPEEYFIRAHELGLTKLAITDHGTLAGYRHFQRAAKEAGIDPI  983 
             F  LH HT +S LDG+    +  +RA ELG+  LAITDHGT+ G   F + AKEAGI PI 
Sbjct  2     FCHLHVHTEFSLLDGMCRISQLVVRAKELGMEALAITDHGTMHGIPRFYKEAKEAGIKPI  61 
 
Query  984   LGVEAYISQTNRFDRRTKANRQDGTEVYNHIILLAKNDAGVHSLNVLSEIGWTEGFYKKP  1163 
             LG E Y++  +R   +T A++      Y H++LLAKN+ G H+L  LS     EGFY KP 
Sbjct  62    LGSEFYLAYGDR-TAKTAADKN-----YYHLVLLAKNNKGYHNLIQLSSRSHLEGFYYKP  115 
 
Query  1164  RID  1172 
             RID 
Sbjct  116   RID  118 
 
 
> gi|3676693|gb|AAC62072.1|  DNA polymerase; DnaE [Treponema denticola] 
Length=361 
 
 Score =  107 bits (268),  Expect = 8e-22 
 Identities = 56/124 (45%), Positives = 78/124 (62%), Gaps = 4/124 (3%) 
 Frame = +3 
 
Query  801   EFVELHNHTYYSPLDGLSSPEEYFIRAHELGLTKLAITDHGTLAGYRHFQRAAKEAGIDP  980 
             +FV LH H+ +S LDG +S +    +A +LG T LA+TDHG + G  +F  A KE  I P 
Sbjct  4     DFVHLHVHSDFSLLDGAASVKALAAKAEKLGQTALALTDHGNMFGAINFYNACKEKNIKP  63 
 
Query  981   ILGVEAYISQTNRFDRRTKANRQDGTEVYNHIILLAKNDAGVHSLNVLSEIGWTEGFYKK  1160 
             I+G E Y++  +RF+++       G + Y H+ILLAKN+ G  +L VL   G+TEG Y K 
Sbjct  64    IIGCEFYVAPESRFEKK----ETPGGKKYYHLILLAKNETGYRNLMVLCSKGYTEGMYYK  119 
 
Query  1161  PRID  1172 
             PRID 
Sbjct  120   PRID  123 
 
Figure 3.65 BLASTx search result:  alignment between the translated HindIII - SfuI 
fragment and the alpha subunit of DNA polymerase III from various organisms. 
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3.8.2.2.4c ORF prediction 
 
On the HindIII – SfuI fragment one ORF was predicted, which corresponded to the 
alpha subunit of DNA polymerase III, as shown in Figure 3.66.  GC content was 
49.5%. 
 
 
 
    
    bp     1                        289                      577                       866                         1179 
 
 
 
Figure 3.66 Predicted ORF on the HindIII – SfuI fragment. 
The numbers inside and at the beginning of the arrow indicate the length and the 
frame of the ORF. 
 
 
3.8.3 Summary of DNA sequence analyses 
 
Average length of ORF from the sequenced regions of Fairland1 and Perouges1 DNA 
was 342.6 bp.  Average GC content of Fairland1 and Perouges1 DNA was 51.8% and 
47.9%, respectively.  A summary of all DNA sequence analyses is presented in Table 
3.28. 
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3.8.4 Modification and absence of restriction sites on phage DNA 
 
As was shown in Figure 3.6D, Perouges1 genomic DNA was only susceptible to 
digestions by HindIII, BclI, SfuI, and ClaI.  However, DNA from clones 1 and 7 of its 
library in E. coli were digested by NsiI and AccI, which were used for the construction of 
their restriction maps (except for AccI for clone 1, as it cut the insert many times).  
Cloned DNA turning sensitive to these endonucleases suggests that Perouges1 DNA had 
an unusual base or a modification.  The recognition sequence of NsiI is ATGCAT, while 
those of AccI are GTATAC and GTCGAC.  No obvious pattern was present in these 
sequences.  Endonucleases, such as BglII, BamHI, PstI, and BmyI, did not digest these 
inserts from the clones, whose total length was ~7.2 kb, so absence of restriction sites 
was probably the reason in these cases.   
 
BamHI and BmyI digested neither Fairland1 genomic DNA (Figure 3.6A) nor the clones 
from its library in E. coli, which in total were ~13 kb, so absence of their restriction sites 
was definitely the reason. 
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4. DISCUSSION 
 
 
 
 
4.1 Characteristics of novel nocardiophages 
 
Although nocardioform infections are rare, treatment is challenging, as the pathogens 
are manifested in a variety of diseases.  Number of reported cases is increasing 
mainly due to rise in number of immunocompromised HIV/AIDS patients.  Both 
phylogenetically and pathogenically, they are closely related to M. tuberculosis, one 
of the leading causes of death worldwide.  Nocardioforms themselves are also now 
considered as important human pathogens associated with a high mortality rate.  
Combination antibiotic therapy may no longer be a solution, as reported cases of 
multidrug resistant strains are increasing.  However, novel antibacterial drug 
discovery faces challenges at a time when they are desperately needed. 
 
Abundance of bacteriophages in nature and their genetic heterogeneity suggest a huge 
number of undiscovered lethal genes targeting essential host metabolism, which can 
be studied to identify novel bactericidal mechanisms.  Nocardiophage isolation was 
therefore undertaken, with the aim of identifying novel genes inhibitory to the host. 
 
Nocardiophages were readily isolated from various soil samples using R. erythropolis 
as the host.  Most of these phages had no divalent ion requirement.  All of the four 
selected phages – Fairland1, Wits1, Kanazawa1, and Perouges1- could infect other 
species of Rhodococcus, including the pathogenic R. equi (except for Wits1), 
confirming that studies using non-pathogenic species can be applied to closely related 
pathogenic ones.   
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Although there is strong pressure to incorporate DNA or RNA sequence information 
into phage classification, morphology is still the principal basis.  As shown in Figure 
4.1, 21 phage morphologies have been recorded (Ackermann, 2001).  Characteristics 
and family name associated with each morphotype is summarized in Table 4.1.   
 
 
 
 
Figure 4.1 Phage morphotypes. 
(Taken from Ackermann, 2001) 
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Table 4.1 Basic properties associated with phage morphotypes in Figure 4.1. 
Morphotype Shape Nucleic acid Family Description 
A1 to A3 Myoviridae Tail contractile 
B1 to B3 Siphoviridae 
Tail long, 
noncontractile 
C1 to C3 
Tailed Linear dsDNA 
Podoviridae Tail short 
D1 Circular ssDNA Microviridae 
Conspicuous 
capsomers 
D3 
Circular dsDNA, 
superhelical 
Corticoviridae 
Complex capsid, 
lipid 
D4 Linear dsDNA Tectiviridae 
Lipid vesicle, 
pseudotail 
E1 Linear ssRNA Leviviridae 
No envelope, no 
lipids 
E2 
Polyhedral 
Linear segmented 
dsRNA 
Cystoviridae Envelope, lipids 
F1 Long filaments 
F2 
Circular ssDNA Inoviridae 
Short rods 
F3 Linear dsDNA Lipothrixviridae Envelope, lipids 
F4 
Filamentous 
Linear dsDNA Rudiviridae TMV-like 
G1 Plasmaviridae 
G2 
Pleomorphic 
Circular dsDNA, 
superhelical Fuselloviridae 
Envelope, lipids, 
no capsid 
Morphotype D2 was excluded as it is awaiting classification; TMV = Tobacco 
Mosaic Virus.  
(Modified from Ackermann, 2001). 
 
 
All four phages in this study were assigned to the family Siphoviridae in the order 
Caudovirales.  This was not surprising, as the majority of recorded phages belong to 
this family.  In fact, all Rhodococcus phages included in the records of the Félix 
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d’Hérelle Reference Center for Bacterial Viruses belong to Siphoviridae (Ackermann, 
2001). 
 
 
4.2 Phage genome size and GC content 
 
Phage genome sizes ranged from 39 kb (Wits1) to 140 kb (Perouges1).  In 
comparison to mycobacteriophages (Hatfull et al., 2006), Wits1 genome was smaller 
than the smallest sequenced mycobacteriophage genome (42 kb of phage Halo), while 
that of Perouges1 was smaller than the largest sequenced mycobacteriophage genome 
(156 kb of phage Bxz1).  Average ORF length of 342.6 bp from Fairland1 and 
Perouges1 was significantly shorter than that from the mycobacteriophages, which is 
600 bp (Hatfull et al., 2006).  However, the ORFs in this work may be biased towards 
shorter sizes as each sequenced region was short.   
 
Average GC contents of 51.8% from Fairland1 and 47.9% from Perouges1, although 
these may not be accurate representations of their genomes, are significantly lower 
than what is known of their host, which is > 60% (Geize et al., 2002; Stecker et al., 
2003).  GC contents of phages for E. coli (Miller et al., 2003), M. smegmatis (Hatfull 
et al., 2006), S. pneumoniae (Kwan et al., 2005), and S. aureus (Kwan et al., 2005) 
are very similar to those of their hosts.  On the other hand, GC content of P. 
aeruginosa phages is significantly lower than that of the host (Kwan et al., 2006).  
Discrepancy in GC content between phage and host genomes may be due to 1) 
horizontal gene transfer from other hosts or phages, 2) recent invasion of phages into 
R. erythropolis from other hosts, or 3) presence of selective pressures which have 
maintained such GC content (Kwan et al., 2006). 
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4.3 Phage anti-restriction 
 
Bacteria have evolved protective mechanisms against attacking phages at almost all 
stages of phage life cycle.  One of these is the restriction and modification system, 
which attacks foreign DNA inside the cells while protecting their own.  This function 
is important enough to have apparently evolved independently several times, as 
exhibited by the presence of different classes of restriction modification systems.  In 
order to survive restriction, phages have evolved anti-restriction mechanisms 
including 1) blocking of restriction enzyme, 2) phage-encoded modification of DNA, 
3) stimulation of host modification functions, 4) possession of unusual bases, 5) co-
injection of protective proteins, 6) destruction of endonuclease co-factors, and 7) loss 
of restriction sites (Krüger and Bickle, 1983).  Of these mechanisms, ones that are 
functional in vitro are the modification of DNA, presence of unusual bases, and 
absence of restriction sites.  These have been mostly studied in E. coli phages and B. 
subtilis phages.   
 
Modified bases refer to those whose modifications take place after the synthesis of 
normal DNA.  B. subtilis phages SPβ and ф3T possess a methyltransferase gene that 
methylates the central cytosine in the sequence GGCC, which is the recognition 
sequence of endonuclease BsuRI of B. subtilis (Cregg et al., 1980).  E. coli phage Mu 
produces the Mom protein, which acetimidates ~15% of its adenine residues, thereby 
producing N
6
-(1-acetamido)adenine, making its DNA resistant to type I and III 
enzymes and partially resistant to type II enzymes (Hattman, 1980).  E. coli phages 
T2 and T4 encode a methyltransferase that methylates a fraction of adenine residues 
to produce 6-methylaminopurine (Gold et al., 1966).  Shigella sonnei phage, DDVI, 
methylates the 7 position of guanine in about a quarter of its DNA, producing 7-
methylguanine (Nikolskaya et al., 1979). 
 
Unusual bases are those which are not adenine, cytosine, guanine, or thymine, and are 
produced at the level of nucleotide metabolism.  Various unusual bases in phages 
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have been discovered, summarized in Table 4.2.  Their structures are illustrated in 
Figure 4.2. 
Table 4.2 Unusual bases in phage DNA. 
Phage Host Base change % change 
T4 E. coli 
5-hydroxymethylcytosine 
(glucosylated) replacing  cytosine  
100% 
SPO1 B. subtilis 
5-hydroxymethyluracil replacing 
thymine 
100% 
PBS1 B. subtilis Uracil replacing thymine 100% 
SP15 B. subtilis 
5-dihydroxypentyluracil replacing 
thymine 
41% 
SP10 B. subtilis α-glutamylthymine replacing thymine 15 – 20% 
XP12 Xanthomonas oryzae 5-methylcytosine replacing cytosine 100% 
S2L 
Synechococcus 
elongatus 
2-aminoadenine replacing adenine 100% 
фW14 
Pseudomonas 
acidovorans 
α-putrescinylthymine replacing thymine 50% 
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Figure 4.2 Structures of unusual bases in phage DNA (Modified from Warren, 1980). 
 
Loss of endonuclease restriction sites has been shown in many phages, by comparing 
the actual number of recognition sites to its statistically expected number.  For 
example, the recognition sequence of B. subtilis endonuclease BsuRI, GGCC, does 
not occur once in B. subtilis phage ф1, although 400 such sites can be predicted 
statistically in its genome (Kawamura et al., 1981).  Phage SPO1, which possesses 
the unusual base hydroxymethyluracil, also lacks the same recognition sequence 
(Reeve et al., 1980), showing multiple strategies used to counter restriction.   
 
None of the phage genomic DNA in this study was digested by all restriction 
endonucleases.  BamHI and BmyI were unable to digest Fairland1 DNA, while most 
were unable to digest Wits1, Kanazawa1, and Perouges1 DNA, confirming the 
presence of anti-restriction mechanisms.  Absence of restriction sites for BamHI and 
BmyI was observed in Fairland1 DNA, perhaps a result of selection pressure imposed 
by restriction enzymes in their natural hosts.  Known Rhodococcus restriction 
endonucleases are listed in Table 4.3.  Five enzymes, RhsI, Rlu4I, RspLKII, Rlu1I, 
and Rlu3I, are isoschizomers of BamHI, whose recognition sequence is GGATCC.  
5-hydroxymethylcytosine 5-methylcytosine Uracil 
5-hydroxymethyluracil α-putrescinylthymine 5-dihydroxypentyluracil 
α-glutamylthymine 2-aminoadenine 
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Therefore it is highly credible that Fairland1 lost this palindromic sequence due to the 
presence of such restriction enzymes in its hosts. 
 
Table 4.3 Rhodococcus restriction endonucleases. 
Enzyme Recognition sequence Organism 
RcaI TCATGA R. capsulatum 
RerORFAP Unknown R. erythropolis BD2 
RerPR4ORFAP Unknown R. erythropolis PR4 
Rlu1I GATC R. luteus RFL1 
Rlu3I GGNNCC R. luteus RFL3 
Rlu4I GGATCC R. luteus RFL4 
RrhI GTCGAC R. rhodochrous 
RrhII Unknown R. rhodochrous 
Rrh4273I R. rhodochrous 
RroI R. rhodochrous 
RheI Rhodococcus species 
RhpI 
GTCGAC 
R. species 
RhpII Unknown R. species 
RhsI GGATCC R. species 
RspXI TCATGA R. species 
RspLKI GCATGC R. species LK2 
RspLKII GGATCC R. species LK2 
RhcI TCATGA R. species SE1991 
(Modified from Roberts et al., 2005). 
 
 
Presence of a modification or an unusual base was detected in Perouges1 DNA, in 
addition to potential loss of recognition sites.  In DNA of phages infecting the closely 
related Mycobacterium, modified or unusual bases have also been found (Coene et 
al., 1993).  Detection is usually made when a discrepancy exists between values of 
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%GC from thermal transition temperature and buoyant density, as modified or 
unusual bases only influence the latter (Warren, 1980).     
 
Wits1 DNA was subjected to digestion by additional enzymes to observe any 
similarity to known unusual bases (Huang et al., 1982), as shown in Table 4.4. 
 
Table 4.4 Digestion of phage DNA containing unusual bases and Wits1 DNA. 
Phage Enzyme Recognition 
Sequence XP12 T4 SP15 SPO1 PBS1 Wits1 
AluI AGCT - - - s s + 
CfoI GCGC - - - + + + 
HhaI GCGC - - - + +  
DdeI CTNAG - - s s + - 
HaeIII GGCC - - - + s + 
HinfI GANTC s - - s s + 
HpaII CCGG - - - + +  
MspI CCGG - - - + +  
MboI GATC s - - + +  
Sau3AI GATC - - - s + + 
Sau96I GGNCC - - - + s + 
TaqI TCGA + s s + + + 
ThaI CGCG - - s - s  
AvaII GG(A/T)CC - - - s +  
BamHI GGATCC - - - - + + 
BclI TGATCA - - - s + - 
BglI CCCNNNNNGGC - - - s s  
BglII AGATCT - - - s - - 
BstEII GGTNACC s - - s s + 
BstNI CC(A/T)GG s - s + s + 
EcoRII CC(A/T)GG - - - s s  
EcoRI GAATTC - - - s s - 
HaeII (A/G)GCGC(T/C) - - - s s  
HincII GT(T/C)(A/G)AC - - - s s  
HindIII AAGCTT - - - s s - 
HpaI CTTAAC - - - s - - 
SstI GAGCTC - - - - s  
SstII CCGCGG - - - s s  
XbaI TCTAGA - - - s s - 
XorII CGATCG - - - - -  
+ = digested; - = did not digest; s = digested more slowly than normal DNA; where 
nothing is indicated the digestion was not done; when a highlighted base is 
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methylated the enzyme no longer recognizes the sequence.  Unusual bases possessed 
by each phage are listed in Table 4.2.  
(Huang et al., 1982). 
 
The digestion pattern of Wits1 DNA does not match those of the known unusual 
bases.  However, potential presence of multiple anti-restriction mechanisms in phages 
makes it difficult to establish a link between unusual or modified bases and digestion 
patterns.   
 
Presence of anti-restriction mechanisms hindered phage library construction, which 
has also been experienced with some well known phages.  For example, it was not 
possible to clone T4 DNA (containing glucosylated hydroxymethylcytosine) until 
mutant strain defective in the synthesis of the unusual base was constructed (Snyder 
et al., 1976).  For phage Kanazawa1, whose library construction was unsuccessful, it 
is not certain which step in cloning was affected.  However, there have been reports 
of T4 DNA ligase (used in this work) not being able to ligate DNA containing certain 
modified or unusual bases (Cao et al., 1983).  With phage Wits1, a great majority of 
cloned DNA fragments were very small (~100 bp).  No conclusions concerning their 
nature were made of Wits1 DNA and Kanazawa1 DNA, despite the obvious presence 
of anti-restriction mechanisms. 
 
 
4.4 Non-annotated phage genes 
 
Thirteen phage DNA fragments were sequenced in this study.  In these a total of 18 
ORFs were predicted, 13 of which had no nucleotide or amino acid sequence match 
in the databases.  A relaxed cutoff E value of 0.009 was used in this study because 
even such alignment may possibly indicate the potential function of those genes.  In 
other similar studies (Hatfull et al., 2006; Kwan et al., 2006; Kwan et al., 2005), a 
more stringent cutoff E value of 10
-4
 has been used.  If this value were to be used, 16 
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out of the 18 ORFs (89%) would not be annotated for structure or function, which 
illustrates the amount of unknown phage genes. 
 
 
4.5 Frequency of lethal genes 
 
For phage Fairland1, 30% of 20 randomly chosen clones from the BglII library and 
45% from the PstI library were significantly inhibitory to R. erythropolis SQ1, which 
emphasizes the frequency of potential lethal genes in a single phage genome.  For 
phage Perouges1, 15% of clones from the HindIII libraries were inhibitory.  When 
screening the libraries, many inhibitory clones gave rise to a few transformants 
(where the transformation efficiencies were > 0 but < 0.01×10
4
/µg of DNA).  These 
were probably mutants in either the antimicrobial gene of plasmid or in a gene of the 
target in the host.  This could be determined by extracting their plasmids and using 
them to transform R. erythropolis; high transformation efficiency would imply 
plasmid mutants, as the non-mutated plasmids should be inhibitory.  In parallel 
experiments, the original transformants could be cured of their plasmids and re-
transformed with the inhibitory plasmids extracted prior to curing; high 
transformation efficiency here would mean a mutation in the host chromosome. 
 
 
4.6 Inhibitory genes 
 
In Rhodococcus, vector pDA71 has a low copy number of ~5/cell (Dabbs, personal 
communication).  It was unlikely that genes were expressed off the lambda promoter 
at the beginning of the cloning site of the vector.  Thus all genes should have been 
expressed off respective phage promoters, which usually allow high levels of 
expression that is necessary during infection.   
 
The genes for which potential functions were found could be grouped into three 
categories: 1) essential components of DNA metabolism, 2) protein with functions 
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related to phage structure, and 3) other proteins.  Most were hypothetical genes and 
lacked experimental evidence, but their potential mechanisms in cellular inhibition 
are speculated upon below.   
 
 
4.6.1 Essential components of DNA metabolism 
 
Inhibitory genes which are essential components of DNA metabolism were 
dihydropteroate synthase, thymidylate synthase complementing protein, and α 
subunit of DNA polymerase III.   
 
 
4.6.1.1 Dihydropteroate synthase 
 
An inhibitory DNA from phage Fairland1 was most similar to dihydropteroate 
synthase gene from Nocardioides sp. JS614.  The same DNA, in a different ORF, was 
also similar to a phage capsid protein from Streptococcus agalactiae.  It is uncertain 
whether the dihydropteroate synthase or the capsid protein, or both, were involved in 
the inhibitory effect.  However, each of these proteins will be discussed as a potential 
antimicrobial agent.   
 
As shown in Figure 4.3, dihydropteroate synthase catalyses the condensation of 6-
hydroxymethyl-7,8-dihydropterin pyrophosphate (DHPPP) with para-aminobenzoic 
acid (pABA) to form dihydropteroate and pyrophosphate, a key step in folate 
biosynthesis pathway (Vinnicombe and Derrick, 1999).  This pathway is unique and 
essential to bacterial cells, which require folate derivatives as cofactors in the 
synthesis of nucleic acids.  It is no coincidence that dihydropteroate synthase is the 
target for sulphonamide class of antibiotics, which are analogues of pABA and act as 
substrates for the enzyme.  Sulphonamides therefore deplete cells of folate cofactors. 
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Figure 4.3 Catalytic action of dihydropteroate synthase. 
 
It is possible that expression of Fairland1 dihydropteroate synthase is disrupting the 
balance of enzymes in the folate biosynthesis pathway, leading to nucleotide 
depletion.  In some organisms, the enzyme is expressed together with hydroxyl-
methylpterin pyrophosphate and dihydroneopterin aldolase, two preceding enzymes 
in the pathway, on the same polypeptide (Brooks et al., 1994), suggesting a tight 
regulation of their concentration. 
 
 
4.6.1.2 Thymidylate synthase complementing protein 
 
Another inhibitory DNA from Fairland1 was most similar to Streptomyces coelicolor 
thymidylate synthase complementing protein, which is distinct from the classical 
thymidylate synthase.  Thymidylate synthase, encoded by thyA, catalyses the 
conversion of deoxyuridine monophosphate (dUMP) to thymidine monophosphate 
6-hydroxymethyl-7,8-dihydropterin pyrophosphate 
para-aminobenzoic acid 
dihydropteroate 
dihydropteroate synthase 
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(dTMP), which requires the replacement of the 5-hydrogen on the dUMP pyrimidine 
ring with a methyl group of a cofactor 5,10-methylenetetrahydrofolate (MTF) 
(Carreras and Santi, 1995).  This catalysis is only a few reactions ahead of where 
dihydropteroate synthase is used, and ThyA is also an essential enzyme in the 
production of dTMP.  Deprivation of thymine in both prokaryotic and eukaryotic 
cells leads to an activation of genetic suicide mechanism in which DNA cleavage 
accumulates (Ahmad et al., 1998), leading to what has been known as “thymineless 
cell death” (Barner and Cohen, 1954).   
 
Recent genomic and proteomic analyses have revealed that some organisms possess 
thymidylate synthase complementing protein (Thy1 or ThyX) instead of thymidylate 
synthase (Myllykallio et al., 2002).  Although its function is to produce dTMP, the 
thymidylate synthase complementing protein shares no sequence or structural 
homology to thymidylate synthase, and the details of its catalytic mechanism are yet 
to be discovered.  Thy1 is currently being investigated as a potential antimicrobial 
drug target, as its distribution is mostly within bacteria and archaea.  Simultaneous 
occurrence of Thy1 and ThyA is observed only in a small number of organisms, 
including M. tuberculosis, M. leprae (Mathews et al., 2003), and Rhodococcus sp. 
RHA1 (McLeod et al., 2006), although the coordination, if any, between the two 
enzymes is unknown. 
 
Many phages are known to possess thyA, as it plays a role in the increased rate dNTP 
synthesis during infection.  There has been no report of ThyA or Thy1 directly being 
deleterious to the host, although mutations in these essential genes may lead to 
thymineless cell death.  Therefore, one possibility is that Fairland1 thy1 expression in 
R. erythropolis is interfering with dTMP production, leading to cell death.  
Possession of both thyA and thy1 by R. sp. RHA1 makes it credible for R. 
erythropolis to also have both enzymes.  Should there be a tight regulation in the 
activity of these enzymes, the expression of thy1 from pDA71 may be disrupting their 
coordination.  In fact, even when a functional ThyA is present in a cell, expression of 
an inactive mutant protein from a plasmid has been shown to be lethal (West et al., 
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2004).  This occurs as the mutant ThyA protein folds with the subunits of the 
functional host ThyA, forming an inactive dimer (West et al., 2004).  
 
During phage T4 infection of E. coli cells, T4 thymidylate synthase is known to 
interact directly with host nucleoside diphosphate (NDP) kinase, which is a 
multifunctional enzyme involved in dNTP/NTP synthesis, genetic and metabolic 
regulation, DNA repair, and signal transduction (Shen et al., 2004).  Therefore, it is 
also possible that the expression of phage Fairland1 thy1 in R. erythropolis may be 
depriving host NDP kinase or other similar proteins which are essential in other 
cellular processes, thereby killing the cell.   
 
 
4.6.1.3 α subunit, DNA polymerase III 
 
Another inhibitory gene involved in DNA metabolism was most similar to the α 
subunit of DNA polymerase III (PolIII) from Aquifex aeolicus.  PolIII is a ten-
subunit, 18-polypeptide holoenzyme responsible for most of DNA replication in 
bacteria and occur in many phage genomes.  Aquifex PolIII has been shown to be 
similar to that of E. coli (Bruck et al., 2002).  The α subunit, encoded by dnaE, is the 
catalytic polymerase lacking an exonuclease (Maki and Kornberg, 1985).  The 
proofreading exonuclease activity belongs to the ε subunit, which forms a 1:1 
complex with the α subunit (O’Donnell and Studwell 1990).  Recent sequencing of 
bacterial genomes has revealed the presence of more than one type of subunit 
responsible for the catalytic polymerase activity in many species.  Some organisms 
possess two types of dnaE, while others have polC in addition to dnaE (Le Chatelier 
et al., 2004).  In Rhodococcus sp. RHA1, dnaE1 and E2 have been found (McLeod et 
al., 2006).   
 
Besdies PolIII, there are alternative DNA polymerases in bacterial cells such as E. 
coli PolII, PolIV, and PolV (Tang et al., 1999).  Interference of DNA replication by 
alternative polymerases is sometimes mutagenic or even lethal (Viguera et al., 2003), 
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so their activities are tightly regulated in the cell.  One of the ways in which these 
polymerases are coordinated is by their intracellular concentration (Becherel and 
Fuchs, 2001); in an E. coli cell usually there are only 10 to 20 copies of PolIII 
(Witkin and Roegner-Maniscalco, 1992).  This regulation extends to the subunit level 
(Delmas and Matic, 2006); therefore it is highly likely that this balance is disrupted 
by the expression of phage Perouges1 α subunit in R. erythropolis. 
 
Another factor for the coordination of alternative polymerases is their binding to the β 
clamp, which clamps onto DNA and tethers the polymerase for high processivity 
(Stukenberg et al., 1991).  All polymerases compete for binding to the same β clamp.  
It has been shown that sub-optimal interactions between the different PolIII subunits 
lead to interference of DNA synthesis by PolII and PolIV, which take over the 
binding to available β clamps (Delmas and Matic, 2006).  This may be occurring 
when the phage Perouges1 α subunit is expressed in the Rhodococcus cell.  When 
PolII and PolIV out-compete PolIII for β clamp binding and take part in 
chromosomal replication, translesion DNA synthesis could occur, which is the 
potentially mutagenic or lethal replication over DNA lesions that usually act as 
blocks to continued replication (Delmas and Matic, 2006).  In addition, the α subunit 
is crucial in activation of translesion synthesis (Sutton and Walker, 2001). 
 
Another possible inhibitory mechanism by the α subunit is sequestration of the ε 
subunit, thereby arresting replication.  This is implicated as a regulatory mechanism 
when PolIII encounters damaged DNA, whose synthesis should be halted (Sutton and 
Walker, 2001).  On the other hand, accumulation of the α subunit in the cell may lead 
to polymerase activity without the proofreading exonuclease activity by the ε subunit, 
causing frameshift mutations (Le Chatelier et al., 2004) and eventually cell death. 
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4.6.2 Proteins involved in phage structure assembly 
 
Inhibitory proteins with similarity to functions related to phage structure were head 
maturation peptidase from Mycobacterium sp. MCS and KMS, capsid protein from 
Streptococcus agalactiae, head decoration protein from Roseobacter sp. MED193, 
and tail protein from Xanthomonas axonopodis. 
 
 
4.6.2.1 Phage capsid and head maturation peptidase 
 
The head maturation peptidase from Mycobacterium sp. MCS and KMS belong to the 
U35 family of peptidases, represented by that from E. coli phage HK97.  This gene 
was found on an inhibitory Fairland1 DNA fragment together with a capsid protein.  
For phage HK97, a pro-head is formed from 415 copies of a coat protein which are in 
an uncleaved form (Duda et al., 1995).  The U35 peptidase removes an N-terminal 
portion from these coat proteins, which then allows them to cross-react, leading to 
head expansion and maturation (Duda et al., 1995).  The catalytic mechanisms of the 
U35 peptidase are undiscovered, although the coat protein is processed at the lysyl 
bond (Rawlings et al., 2002).  There is no report of this peptidase alone being 
inhibitory to a host cell.   
 
The capsid protein that was present on the same DNA fragment belongs to family 
05065, which is a group of hypothetical capsid proteins.  Although information on 
this family is scarce, it is reasonable to assume that this capsid protein, with help 
from the U35 peptidase, forms a mature head of phage Fairland1.  There have been 
many reports on viral coat proteins associating with host translation factors.  For 
example, phage T4 head protein has the Gol peptide, which binds to and activates the 
proteolysis of host elongation factor EF-Tu, leading to cell death (Bingham et al., 
2000).  Similar mechanisms have been observed with eukaryotic viruses including 
HIV-1 and herpesvirus 1 (Cimarelli and Luban, 1999; Kawaguchi et al., 1997).  Thus 
it has been speculated that association of viral capsids with host translation factors is 
 149 
a normal process in viral maturation (Bingham et al., 2000).  In addition, the U35 
peptidase is homologous to the herpesvirus protease used in coat maturation (Cheng 
et al., 2004).  These observations strengthen the possibility that the mature capsid of 
phage Fairland1 associates and inhibits a Rhodococcus elongation factor. 
 
 
4.6.2.2 Head decoration protein and tail protein 
 
Sequence of an inhibitory DNA fragment from phage Perouges1 aligned with the 
head decoration protein from Roseobacter sp. MED193.  This fragment also aligned 
with a phage-related tail protein from Xanthomonas axonopodis and cell wall anchor 
family protein from Streptococcus agalactiae, all in the same ORF.  The differences 
in E values between these proteins were insignificant, suggesting a similarity between 
these proteins. 
 
Head decoration proteins are semiessential or nonessential proteins that stabilize the 
coat protein by binding to its outer side (Gilcrease et al., 2005).  There is no report of 
such proteins being bactericidal.  On the other hand, phage tail-like structures are 
well-known features of many bacteriocins produced by both Gram-positive and 
negative bacteria.  Phage tail-like bacteriocins generally belong to two families: 
contractile (R-type) and non-contractile (F-type).  Genetic analyses have shown the 
similarity of these structures to actual phage tails (Nakayama et al., 2000).  They are 
believed to be variations of defective phages whose tails have been evolutionarily 
specialized as bacteriocins (Nakayama et al., 2000).  Treatment of cells with SOS 
response inducing agents, such as mitomycin C and UV, which causes phage 
induction, usually leads to the production of these bacteriocins, often together with 
detached, empty head particles.  Phage tail-like bacteriocins being encoded by viable 
phages have also been reported (Pond et al., 1989).  Although the protein from X. 
axonopodis is a hypothetical one, other related species have been shown to produce 
functional bacteriocins (Pham et al., 2004).  Both types of phage tail-like bacteriocins 
kill sensitive cells by depolarizing the plasma membrane (Gillor et al., 2005), and are 
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being investigated as potential therapeutic agents, as they lack nucleic acid and are 
specific in their target organisms.   
 
Cell wall surface anchor family protein from Streptococcus agalactiae is the M 
protein which is covalently anchored in the cell wall (Bergmann and 
Hammerschmidt, 2006).  This protein is recognized as the major virulence 
determinant of group A Streptococcus, as it is vital in escaping phagocytosis 
(Fischetti, 1989), although its mode of action has not been determined.  In addition, 
the M protein is responsible for enhanced attachment to epithelial cells, which is also 
necessary for its virulence (Ellen and Gibbons, 1972).  Therefore, it is possible that 
membrane binding, similar to the phage-tail like bacteriocins, is involved, causing 
cellular inhibition.  Various membrane-associated proteins have been shown in phage 
T4, including baseplate proteins of its tail.  During infection, T4 baseplate is 
assembled on the host cell membrane and remains attached until lysis (Simon, 1969).  
Other examples include the holin gene, responsible for membrane disruption during 
lysis, and the ndd gene, which is believed to be responsible for binding bacterial 
DNA to the membrane (Miller et al., 2003).  Phage фX174 encodes protein E, which 
is associated with host membrane and halts cell wall synthesis by blocking the 
activity of MraY, a membrane protein that transfers murein precursors to lipid 
carriers (Bernhardt et al., 2000). 
 
 
4.6.3 Other proteins 
 
Inhibitory genes which were neither essential components of DNA metabolism nor 
proteins involved in phage structure assembly were the cell wall surface anchor 
family protein from Streptococcus agalactiae (discussed above) and HNH 
endonuclease from Lactobacillus plantarum phage LP65. 
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4.6.3.1 HNH endonuclease 
 
HNH endonuclease is a member of the family of rare-cutting enzymes called homing 
endonucleases encoded by introns and inteins.  They initiate homing, or transport, of 
these mobile elements into intronless/inteinless sites of DNA.  Homing 
endonucleases are present in all three biological kingdoms and differ from restriction 
endonucleases in many features (Belfort and Roberts, 1997).  So-called because of 
the three invariant amino acids that span the core motif, HNH endonucleases, along 
with introns and inteins, occur in many phages.  Translocation of these mobile 
elements is site-specific; most phage introns and inteins are found within genes of 
DNA metabolism such as DNA polymerase (Derbyshire and Belfort, 1998) and 
ribonucleotide reductase (Lazarevic, 2001), suggesting selective cleavage at these 
sites by these nucleases.  Therefore one possibility is that the endonuclease from 
phage Fairland1 is cleaving important genes in R. erythropolis. 
 
Besides their role in homing, HNH endonucleases are responsible for the cytotoxic 
activity of colicins E2, E7, E8, and E9 (James et al., 2002).  After binding to cell 
surface receptors, they are translocated to the cytoplasm where they degrade 
chromosomal DNA non-specifically (James et al., 2002).  These nucleases are thus 
reported to have both specific and non-specific activity.  Whichever the case, their 
nuclease activity should be responsible for the inhibition of Rhodococcus host. 
 
 
4.7 Conclusion 
 
Inhibitory genes for which putative functions could be assigned may be directly 
interfering with nucleotide metabolism, DNA synthesis, protein synthesis, and 
integrity of the plasma membrane and DNA.  Indirectly interfered processes may 
include genetic and metabolic regulation, signal transduction and DNA repair.  Many 
of these are well-appreciated targets of antibiotics; however, further studies are 
required to identify the specific inhibitory mechanisms and target molecules.  That 
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most E values were rather low may make the above speculations out-of-context; 
however most genes had convincing connection to inhibitory mechanisms.   
 
It would be possible to screen phage genomes for lethal genes very rapidly, by 
excluding some steps in this work.  A plate lysate provides enough DNA for 
construction of a phage library, so large scale lysate production, purification, and 
electron microscopy can be sacrificed if the sole purpose is to identify inhibitory 
DNA.  One obstacle, however, may be the difficulty in cloning some phage DNA.  
To succeed, mechanical shearing followed by chemical modification of the sheared 
ends may be necessary. 
 
Host inhibition by a phage in vivo cannot be simulated in vitro by expressing a 
limited number of genes in a plasmid in the host.  Regulation of phage gene 
expression by operons and temporally modified RNA polymerases for recognition of 
specific promoters may interfere with identification of some lethal genes.  However, 
obvious inhibitory mechanisms suggested by a few genes in this work validate the 
effectiveness of the screening experiment.  Thus, the large number of inhibitory genes 
with no assigned function confirms that phages provide an untapped pool of novel 
bactericidal mechanisms. 
 
Exact molecular targets of these genes can be identified by both biochemical and 
genetic methods.  A biochemical approach would involve affinity chromatography 
and mass spectrometry.  A genetic approach would involve construction of a genomic 
library of a mutant resistant to the inhibitory gene, followed by screening for the 
resistant gene.  This gene should be a mutant in the target molecule, which may then 
be identified by its sequence.   
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5. APPENDICES 
 
 
 
 
APPENDIX A - MEDIA AND SOLUTIONS 
 
 
1. MEDIA 
 
LB 
  3 g tryptone 
  1.5 g sodium chloride 
  1.5 g yeast extract 
  300 ml distilled water 
 
LA 
  3 g tryptone 
  1.5 g sodium chloride 
  1.5 g yeast extract 
  4.5 g agar 
  300 ml distilled water 
 
Sloppy agar 
  1 g tryptone 
  0.5 g sodium chloride 
  0.5 g yeast extract 
  0.75 g agar 
  100 ml distilled water 
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LBG 
  1 g tryptone 
  0.5 g sodium chloride 
  0.5 g yeast extract 
  2 g glycine 
  100 ml distilled water 
LBSG 
  1 g tryptone 
  0.5 g sodium chloride 
  0.5 g yeast extract 
  10.3 g sucrose 
  2 g glycine 
  100 ml distilled water 
 
Rhodococcus regeneration medium 
  3 g tryptone 
  1.5 g yeast extract 
  0.9 g sodium chloride 
  30.9 g sucrose 
  1 g glucose 
  1 g magnesium chloride hexahydrate 
  250 ml distilled water 
Solution was microwaved to dissolve sucrose.  Then, 5.5 g agar was added, 
autoclaved, and cooled to 60°C, after which the following were added: 
  10 ml 0.25 M TES pH 7.2 
  6 ml 1 M calcium chloride 
  3 ml 0.5% potassium dihydrogen orthophosphate 
  1.5 ml 10 mg/ml nystatin 
  0.9 ml 10 mg/ml rifampicin 
Plates of constant volume of 25 ml were poured on a horizontal surface. 
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2. SOLUTIONS FOR PHAGE PURIFICATION 
 
SC buffer 
  0.58 g sodium chloride 
  0.2 g calcium chloride hexahydrate 
  5 ml 1 M Tris-hydrochloride pH 8.0 
  0.5 ml 2% gelatin 
  95 ml distilled water 
 
2% Gelatin 
  0.02 g gelatin 
  1 ml distilled water 
 
Caesium chloride solutions for gradient centrifugation 
(Density values are relative to that of water at 20°C) 
 
 1.45 g/ml 
  3.53 g caesium chloride 
  5 ml SC buffer 
  
 1.50 g/ml 
  4.09 g caesium chloride 
  5 ml SC buffer 
 
 1.70 g/ml 
  6.33 g caesium chloride 
  5 ml SC buffer 
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3. SOLUTIONS FOR TRANSMISSION ELECTRON MICROSCOPY 
 
0.35% Formvar 
  0.35 g Formvar  
  100 ml chloroform 
 
1% uranyl acetate 
  0.05 g uranyl acetate 
  5 ml distilled water 
 
 
4. SOLUTIONS FOR DNA PREPARATION 
 
Solution I 
  0.9 g glucose 
  2.5 ml 1 M Tris-hydrochloride pH 8.0 
  2 ml 0.5 M EDTA  
  95.5 ml distilled water 
 
Solution II 
  0.8 g sodium hydroxide 
  1 g SDS 
  100 ml distilled water 
 
Solution III 
  60 ml 5 M potassium acetate 
  11.5 ml glacial acetic acid 
  28.5 ml distilled water 
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1 M Tris-hydrochloride pH 8.0 
  12.1 g Tris base, dissolved in distilled water 
  pH adjusted to 8.0 with hydrochloric acid 
  Distilled water added to 100 ml 
 
0.5 M EDTA pH 8.0 
  18.61 g EDTA, dissolved in distilled water 
  pH adjusted to 8.0 with sodium hydroxide 
  Distilled water added to 100 ml 
 
TE 
  1 ml 1M Tris-hydrochloride pH 8.0 
  2 ml 0.5 M EDTA pH 8.0 
  100 ml distilled water 
 
10% SDS in water 
  1 g SDS 
  10 ml distilled water 
 
10% SDS in TE 
  1 g SDS 
  10 ml TE buffer 
 
5 M potassium acetate pH 6.0 
  4.9 g potassium acetate 
  pH adjusted to 6.0 with acetic acid 
  Distilled water added to 10 ml 
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TE-saturated phenol 
  10 g phenol 
  10 ml TE 
 
1 M sodium chloride 
  5.8 g sodium chloride 
  100 ml distilled water 
 
1% Ribonuclease 
  0.01 g ribonuclease 
  1 ml distilled water 
 Solution was boiled for 10 min before use. 
 
Dialysis buffer 
  0.58 g sodium chloride 
  2.2 g calcium chloride hexahydrate 
  50 ml 1 M Tris-hydrochloride pH 8.0 
  950 ml distilled water 
 
 
5. SOLUTIONS FOR ELECTROPHORESIS 
 
5× TBE 
  54 g Tris base 
  27.5 g boric acid 
  20 ml 0.5 M EDTA pH 8.0 
  Distilled water added to 1000 ml 
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Agarose gel 
  0.8 g (for 0.4%), 1.6 g (for 0.8%), or 2.4 g (for 1.2%) agarose 
  20 ml 5× TBE 
  180 ml distilled water 
 
Running buffer 
  20 ml 5× TBE 
  180 ml distilled water 
  20 µl 1% EtBr  
 
1% EtBr 
  0.1 g EtBr 
  10 ml distilled water 
 
Tracking dye 
  0.01 g bromophenol blue 
  0.01 g xylene cyanol 
  10 ml 30% glycerol in TE 
   
 
6. SOLUTIONS FOR TRANSFORMATION 
 
Calcium chloride transformation buffer 
  4.38 g calcium chloride hexahydrate 
  2 ml 1 M Tris-hydrochloride pH 8.0 
  198 ml distilled water 
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Basal (B) buffer 
  10.3 g sucrose 
  0.025 g potassium sulfate 
  0.202 g magnesium chloride hexahydrate 
  10 ml 0.25 M TES pH 7.2 
 
Protoplast (P) buffer 
  2 ml B buffer 
  20 µl 0.5% potassium dihydrogen orthophosphate 
  50 µl 1 M calcium chloride 
 
P-PEG buffer 
  0.5 g PEG 6000 
  1 ml P buffer 
  PEG sterilized by UV irradiation for 10 min and vortexed vigorously  
  to dissolve. 
 
20% glucose 
  4 g glucose 
  20 ml distilled water 
 
0.25 M TES pH 7.2 
  17.2 g TES, dissolved in distilled water 
  pH adjusted to 7.2 with sodium hydroxide 
  Distilled water added to 300 ml 
 
1 M calcium chloride 
  21.9 g calcium chloride hexahydrate 
  100 ml distilled water 
 
 161 
0.5% potassium dihydrogen orthophosphate 
  0.5 g potassium dihydrogen orthophosphate 
  100 ml distilled water 
 
 
7. ANTIMICROBIAL AGENTS 
 
Table 5.1 Antimicrobial agents. 
Agent 
Stock concentration 
(mg/ml) 
Solvent 
Ampicillin 100 70% ethanol, 30% distilled water 
Chloramphenicol 4 ethanol 
Kanamycin 100 distilled water 
Nalidixic acid 10 70% ethanol, 30% distilled water 
Nystatin 10 methanol 
Rifampicin 10 methanol 
Streptomycin 20 distilled water 
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APPENDIX B - RESTRICTION MAPS OF PLASMIDS  
 
 
 
 
 
 
 
Figure 5.1 Restriction map of pDA71. 
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Figure 5.2 Restriction map of pUC18/19. 
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APPENDIX C – MOLECULAR WEIGHT MARKERS 
 
                                                 
             A                                                B                                               C 
 
Figure 5.4 Molecular weight markers. 
A. Roche Lambda EcoRI+HindIII Marker III 
B. Fermentas GeneRuler DNA Ladder Mix  
C. New England Biolabs PFG Low Range Marker 
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APPENDIX D – FEATURES OF PROTEINS SIMILAR   
  TO INHIBITORY PHAGE PRODUCTS 
 
 
Table 5.2 Features of thymidylate synthase complementing protein from Streptomyces coelicolor. 
LOCUS       CAA20294                 246 aa            linear   BCT 16-APR-2005 
DEFINITION  conserved hypothetical protein SC9A10.07 [Streptomyces coelicolor 
            A3(2)]. 
ACCESSION   CAA20294 
VERSION     CAA20294.1  GI:3413826 
DBSOURCE    embl locus SCO939124, accession AL939124.1 
KEYWORDS    . 
SOURCE      Streptomyces coelicolor A3(2) 
  ORGANISM  Streptomyces coelicolor A3(2) 
            Bacteria; Actinobacteria; Actinobacteridae; Actinomycetales; 
            Streptomycineae; Streptomycetaceae; Streptomyces. 
REFERENCE   1 
  AUTHORS   Bentley,S.D., Chater,K.F., Cerdeno-Tarraga,A.M., Challis,G.L., 
            Thomson,N.R., James,K.D., Harris,D.E., Quail,M.A., Kieser,H., 
            Harper,D., Bateman,A., Brown,S., Chandra,G., Chen,C.W., Collins,M., 
            Cronin,A., Fraser,A., Goble,A., Hidalgo,J., Hornsby,T., Howarth,S., 
            Huang,C.H., Kieser,T., Larke,L., Murphy,L., Oliver,K., O'Neil,S., 
            Rabbinowitsch,E., Rajandream,M.A., Rutherford,K., Rutter,S., 
            Seeger,K., Saunders,D., Sharp,S., Squares,R., Squares,S., 
            Taylor,K., Warren,T., Wietzorrek,A., Woodward,J., Barrell,B.G., 
            Parkhill,J. and Hopwood,D.A. 
  TITLE     Complete genome sequence of the model actinomycete Streptomyces 
            coelicolor A3(2) 
  JOURNAL   Nature 417 (6885), 141-147 (2002) 
   PUBMED   12000953 
REFERENCE   2  (residues 1 to 246) 
  AUTHORS   Bentley,S.D. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (09-MAY-2002) Submitted on behalf of the Streptomyces 
            sequencing team, Sanger Institute, Wellcome Trust Genome Campus, 
            Hinxton, Cambridge CB10 1SA E-mail: sdb@sanger.ac.uk 
FEATURES             Location/Qualifiers 
     source          1..246 
                     /organism="Streptomyces coelicolor A3(2)" 
                     /strain="A3(2)" 
                     /db_xref="taxon:100226" 
     Protein         1..246 
                     /product="conserved hypothetical protein SC9A10.07" 
     Region          6..229 
                     /region_name="Thy1" 
                     /note="Thymidylate synthase complementing protein; 
                     pfam02511" 
                     /db_xref="CDD:42487" 
     CDS             1..246 
                     /gene="SCO5743" 
                     /coded_by="AL939124.1:284793..285533" 
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                     /note="SC9A10.07, unknown, len: 246 aa; similar to e.g. 
                     Dictyostelium discoideum THY1_DICDI THY1 protein (260 aa), 
                     fasta scores; opt: 308 z-score: 443.0 E(): 2.1e-17, 35.4% 
                     identity in 198 aa overlap" 
                     /transl_table=11 
                     /db_xref="GOA:O86840" 
                     /db_xref="InterPro:IPR003669" 
                     /db_xref="UniProtKB/Swiss-Prot:O86840" 
ORIGIN       
        1 mtdipaddpk ielrsditve lvksaatdsd vlfaarvsta geqsldelkk dperskglin 
       61 ylmrdrhgsp fehnsmtffv sapifvfref mrhrvgwsyn eesgryrelq pvfyapdasr 
      121 klvqqgrpgk yvfvegtpeq helvgsamed syrqayatyq qmlaagvare varavlpvgl 
      181 yssmyatcna rslmhflglr tqhelakvps fpqreiemag ekmeaewarl mplthaafna 
      241 ngrvap 
 
 
Table. 5.3 Features of phage head maturation peptidase from Mycobacterium sp. MCS. 
LOCUS       YP_640677                526 aa            linear   BCT 13-JUN-2006 
DEFINITION  peptidase U35, phage prohead HK97 [Mycobacterium sp. MCS]. 
ACCESSION   YP_640677 
VERSION     YP_640677.1  GI:108800480 
DBSOURCE    REFSEQ: accession NC_008146.1 
KEYWORDS    . 
SOURCE      Mycobacterium sp. MCS 
  ORGANISM  Mycobacterium sp. MCS 
            Bacteria; Actinobacteria; Actinobacteridae; Actinomycetales; 
            Corynebacterineae; Mycobacteriaceae; Mycobacterium. 
REFERENCE   1  (residues 1 to 526) 
  AUTHORS   Copeland,A., Lucas,S., Lapidus,A., Barry,K., Detter,J.C., Glavina 
            del Rio,T., Hammon,N., Israni,S., Dalin,E., Tice,H., Pitluck,S., 
            Martinez,M., Schmutz,J., Larimer,F., Land,M., Hauser,L., 
            Kyrpides,N., Kim,E., Miller,C.D., Hughes,J.E., Anderson,A.J., 
            Sims,R.C. and Richardson,P. 
  CONSRTM   US DOE Joint Genome Institute 
  TITLE     Complete sequence of chromosome of Mycobacterium sp. MCS 
  JOURNAL   Unpublished 
REFERENCE   2  (residues 1 to 526) 
  CONSRTM   NCBI Genome Project 
  TITLE     Direct Submission 
  JOURNAL   Submitted (12-JUN-2006) National Center for Biotechnology 
            Information, NIH, Bethesda, MD 20894, USA 
REFERENCE   3  (residues 1 to 526) 
  AUTHORS   Copeland,A., Lucas,S., Lapidus,A., Barry,K., Detter,J.C., Glavina 
            del Rio,T., Hammon,N., Israni,S., Dalin,E., Tice,H., Pitluck,S., 
            Martinez,M., Schmutz,J., Larimer,F., Land,M., Hauser,L., 
            Kyrpides,N., Kim,E., Miller,C.D., Hughes,J.E., Anderson,A.J., 
            Sims,R.C. and Richardson,P. 
  CONSRTM   US DOE Joint Genome Institute 
  TITLE     Direct Submission 
  JOURNAL   Submitted (05-JUN-2006) US DOE Joint Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-1698, USA 
COMMENT     PROVISIONAL REFSEQ: This record has not yet been subject to final 
            NCBI review. The reference sequence was derived from ABG09621. 
            Method: conceptual translation. 
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FEATURES             Location/Qualifiers 
     source          1..526 
                     /organism="Mycobacterium sp. MCS" 
                     /strain="MCS" 
                     /db_xref="taxon:164756" 
     Protein         1..526 
                     /product="peptidase U35, phage prohead HK97" 
                     /calculated_mol_wt=55053 
     Region          3..150 
                     /region_name="COG3740" 
                     /note="Phage head maturation protease [General function 
                     prediction only]; COG3740" 
                     /db_xref="CDD:33535" 
     CDS             1..526 
                     /locus_tag="Mmcs_3514" 
                     /coded_by="complement(NC_008146.1:3740139..3741719)" 
                     /note="PFAM: peptidase U35, phage prohead HK97 
                     KEGG: nse:NSE_0554 phage prohead protease, HK97 family" 
                     /transl_table=11 
                     /db_xref="InterPro:IPR006433" 
                     /db_xref="GeneID:4112346" 
ORIGIN       
        1 mhtravelte vrtdddagtf tglaagydnv dthgtvlqrg afasslaggg vvplfwehgh 
       61 ddpraivgev taavettrgl eivgkldtdt ergaaayrav kgrrirglsv gmrptqrrga 
      121 siiaadlcei slvmrpsnsr alvesvrsad dalqtraasa vatfetiakd ttmtepitte 
      181 rrdelvaetr glvaaaqgrt ltaeevatie tntetirrhd eqaletrnda qaaniaralg 
      241 qaidtrsggr qspfmlsadn vttletarkr fenitvletr aalattdmgt areygpnglq 
      301 aprslwrsag ipttapdgys gvvpqftlpg gavlvgegvd hqefdgvnpd avtigragaw 
      361 stltsealls tsitevsaah ariiarnvdr atvakiedas pdtmsidqal vtvaaecacd 
      421 vsdlwivgap aavaalvgna tftpanggda esyasrygga avypttsata dtltvfhpqs 
      481 frafasplss gvfvdpksgk qdfgqwmfyg lgqalvgaai tvdttp 
 
 
Table 5.4 Features of phage capsid protein from Streptococcus agalactiae. 
LOCUS       AAN00715                 420 aa            linear   BCT 23-SEP-2002 
DEFINITION  conserved domain protein [Streptococcus agalactiae 2603V/R]. 
ACCESSION   AAN00715 
VERSION     AAN00715.1  GI:22534892 
DBSOURCE    accession AE014275.1 
KEYWORDS    . 
SOURCE      Streptococcus agalactiae 2603V/R 
  ORGANISM  Streptococcus agalactiae 2603V/R 
            Bacteria; Firmicutes; Lactobacillales; Streptococcaceae; 
            Streptococcus. 
REFERENCE   1  (residues 1 to 420) 
  AUTHORS   Tettelin,H., Masignani,V., Cieslewicz,M.J., Eisen,J.A., 
            Peterson,S., Wessels,M.R., Paulsen,I.T., Nelson,K.E., Margarit,I., 
            Read,T.D., Madoff,L.C., Wolf,A.M., Beanan,M.J., Brinkac,L.M., 
            Daugherty,S.C., DeBoy,R.T., Durkin,S., Kolonay,J.F., Umayam,L.A., 
            Madupu,R., Lewis,M.R., Radune,D., Fedorova,N.B., Scanlan,D., 
            Khouri,H., Mulligan,S., Carty,H.A., Cline,R.T., Gill,J., 
            Scarselli,M., Mora,M., Iacobini,E.T., Brettoni,C., Galli,G., 
            Mariani,M., Vegni,F., Maione,D., Rinaudo,D., Rappuoli,R., 
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            Telford,J.L., Kasper,D.L., Grandi,G. and Fraser,C.M. 
  TITLE     Complete genome sequence and comparative genomic analysis of an 
            emerging human pathogen, serotype V Streptococcus agalactiae 
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 99 (19), 12391-12396 (2002) 
   PUBMED   12200547 
REFERENCE   2  (residues 1 to 420) 
  AUTHORS   Tettelin,H., Masignani,V., Cieslewicz,M.J., Eisen,J.A., 
            Peterson,S., Wessels,M.R., Paulsen,I.T., Nelson,K.E., Margarit,I., 
            Read,T.D., Madoff,L.C., Wolf,A.M., Beanan,M.J., Brinkac,L.M., 
            Daugherty,S.C., DeBoy,R.T., Durkin,S., Kolonay,J.F., Umayam,L.A., 
            Madupu,R., Lewis,M.R., Radune,D., Fedorova,N.B., Scanlan,D., 
            Khouri,H., Mulligan,S., Carty,H.A., Cline,R.T., Gill,J., 
            Scarselli,M., Mora,M., Iacobini,E.T., Brettoni,C., Galli,G., 
            Mariani,M., Vegni,F., Maione,D., Rinaudo,D., Rappuoli,R., 
            Telford,J.L., Kasper,D.L., Grandi,G. and Fraser,C.M. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (18-JUL-2002) The Institute for Genomic Research, 9712 
            Medical Center Dr, Rockville, MD 20850, USA 
COMMENT     Method: conceptual translation. 
FEATURES             Location/Qualifiers 
     source          1..420 
                     /organism="Streptococcus agalactiae 2603V/R" 
                     /strain="2603V/R" 
                     /serotype="V" 
                     /db_xref="taxon:208435" 
     Protein         1..420 
                     /product="conserved domain protein" 
     Region          <254..387 
                     /region_name="Phage_capsid" 
                     /note="Phage capsid family; pfam05065" 
                     /db_xref="CDD:44968" 
     CDS             1..420 
                     /gene="SAG1852" 
                     /coded_by="complement(AE014275.1:18904..20166)" 
                     /note="identified by Glimmer2; putative" 
                     /transl_table=11 
ORIGIN       
        1 mkkslielle arqkatdela evklkkatie akmksstied ddleqlktda eslvsqatai 
       61 ketiagldsd ieeteeelsk aakiikekqk gntpmdylkt kaaaldfvri lmdnegsans 
      121 arkaweanlv ekgvtnltki lpepvliaiq daftnyngil nhvskdprya vrvalqtqvs 
      181 qakghkagkt kkdedftfld ftinsatvyi kyafeysdlk kdttgayfny vmkelaqgfi 
      241 rtieravvig dgksnsaedk iteiksiaee teanlfetqe invagvfdna vletlvagid 
      301 kmvpnttpil vtskaiarkl klvkdaegry idpqpfapia tngnviagfq vyiydwmdga 
      361 tnpiiafadq aykmigdeaa adrfddydvt vnrrhielas vmggrlaqyk savkftnpag 
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Table 5.5 Features of dihydropteroate synthase from Nocardioides sp. JS614. 
LOCUS       ZP_00660252              466 aa            linear   BCT 28-JUL-2005 
DEFINITION  Dihydropteroate synthase [Nocardioides sp. JS614]. 
ACCESSION   ZP_00660252 
VERSION     ZP_00660252.1  GI:71369843 
DBSOURCE    REFSEQ: accession NZ_AAJB01000146.1 
KEYWORDS    . 
SOURCE      Nocardioides sp. JS614 
  ORGANISM  Nocardioides sp. JS614 
            Bacteria; Actinobacteria; Actinobacteridae; Actinomycetales; 
            Propionibacterineae; Nocardioidaceae; Nocardioides. 
REFERENCE   1  (residues 1 to 466) 
  AUTHORS   Copeland,A., Lucas,S., Lapidus,A., Barry,K., Detter,J.C., 
            Glavina,T., Hammon,N., Israni,S., Pitluck,S. and Richardson,P. 
  CONSRTM   US DOE Joint Genome Institute (JGI-PGF) 
  TITLE     Sequencing of the draft genome and assembly of Nocardioides sp. 
            JS614 
  JOURNAL   Unpublished 
REFERENCE   2  (residues 1 to 466) 
  AUTHORS   Larimer,F. and Land,M. 
  CONSRTM   US DOE Joint Genome Institute (JGI-ORNL) 
  TITLE     Annotation of the draft genome assembly of Nocardioides sp. JS614 
  JOURNAL   Unpublished 
REFERENCE   3  (residues 1 to 466) 
  AUTHORS   Copeland,A., Lucas,S., Lapidus,A., Barry,K., Detter,J.C., 
            Glavina,T., Hammon,N., Israni,S., Pitluck,S. and Richardson,P. 
  CONSRTM   US DOE Joint Genome Institute (JGI-PGF) 
  TITLE     Direct Submission 
  JOURNAL   Submitted (26-JUL-2005) US DOE Joint Genome Institute, 2800 
            Mitchell Drive, Walnut Creek, CA 94598, USA 
COMMENT     PREDICTED REFSEQ: The mRNA record is supported by experimental 
            evidence; however, the coding sequence is predicted. The reference 
            sequence was derived from EAO04955. 
            URL -- http://www.jgi.doe.gov/ 
            Source DNA and bacteria available from James Gossett 
            (jmg18@cornell.edu) 
            Whole genome sequencing and draft assembly at JGI-PGF 
            Annotation by JGI-ORNL 
            Contact: Paul Richardson (microbes@cuba.jgi-psf.org). 
            Method: conceptual translation. 
FEATURES             Location/Qualifiers 
     source          1..466 
                     /organism="Nocardioides sp. JS614" 
                     /strain="JS614" 
                     /db_xref="taxon:196162" 
     Protein         1..466 
                     /product="Dihydropteroate synthase" 
                     /EC_number="2.5.1.15" 
                     /calculated_mol_wt=49552 
     Region          194..450 
                     /region_name="DHPS" 
                     /note="DHPS subgroup of Pterin binding enzymes; cd00739" 
                     /db_xref="CDD:29545" 
     Region          194..450 
                     /region_name="DHPS" 
                     /note="DHPS subgroup of Pterin binding enzymes; cd00739" 
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                     /db_xref="CDD:29545" 
     CDS             1..466 
                     /locus_tag="NocaDRAFT_4752" 
                     /coded_by="NZ_AAJB01000146.1:4589..5989" 
                     /inference="non-experimental evidence, no additional 
                     details recorded" 
                     /transl_table=11 
                     /db_xref="InterPro:IPR000489" 
                     /db_xref="InterPro:IPR006390" 
ORIGIN       
        1 megavrdhrr rarvhgrrpa rlghplrarp arpaahpprg ragqgllraa dalrrrrgpv 
       61 rgrpghragr aaadpavvpr argpapaarg rvggttrpvr aaqradrvrr garrprrhpa 
      121 hpragrarpg rprhprppap vaarpqrdgh pdprgrpgpg rhphrgragr ratagggram 
      181 tlklgrhtfp dtatlmmaiv nrtpdsfydk gatwaedkaf ervalvageg aeivdiggik 
      241 aapgveisea eekarvvdfv arvrasypdl visvdtwrae vgsavcaaga dlindawgga 
      301 dpeladaaae agaaivctht ggvtprtrpy rmeyddvvaa aiadtvayae raiaagvdpa 
      361 svvidpahdf gkntfhslev trrlgemvat gypvlvslsn kdfvgesldl pvgerltgtl 
      421 aatavcalag ariyrvhevv etrqtvdmvd tiagrrpprl airglq 
 
 
Table 5.6 Features of HNH endonuclease from Lactobacillus plantarum phage LP65. 
LOCUS       YP_164778                354 aa            linear   PHG 07-APR-2006 
DEFINITION  orf143 [Lactobacillus plantarum bacteriophage LP65]. 
ACCESSION   YP_164778 
VERSION     YP_164778.1  GI:56693191 
DBSOURCE    REFSEQ: accession NC_006565.1 
KEYWORDS    . 
SOURCE      Lactobacillus plantarum bacteriophage LP65 
  ORGANISM  Lactobacillus plantarum bacteriophage LP65 
            Viruses; dsDNA viruses, no RNA stage; Caudovirales; Myoviridae; 
            SPO1-like viruses; unclassified SPO1-like viruses. 
REFERENCE   1  (residues 1 to 354) 
  AUTHORS   Chibani-Chennoufi,S., Dillmann,M.L., Marvin-Guy,L.,Rami-Shojaei,S. 
            and Br. 
  TITLE     Lactobacillus plantarum Bacteriophage LP65: a New Member of the 
            SPO1-Like Genus of the Family Myoviridae 
  JOURNAL   J. Bacteriol. 186 (21), 7069-7083 (2004) 
   PUBMED   15489418 
REFERENCE   2  (residues 1 to 354) 
  CONSRTM   NCBI Genome Project 
  TITLE     Direct Submission 
  JOURNAL   Submitted (17-DEC-2004) National Center for Biotechnology 
            Information, NIH, Bethesda, MD 20894, USA 
REFERENCE   3  (residues 1 to 354) 
  AUTHORS   Chibani-Chennoufi,S., Dillmann,M.-L., Marvin-Guy,L., 
            Rami-Shojaei,S. and Brussow,H. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (09-JUL-2004) Nutrition & Health, Nestle Research Centre, 
            Lausanne 26, Vers-chez-les-Blanc CH-1000, Switzerland 
COMMENT     PROVISIONAL REFSEQ: This record has not yet been subject to final 
            NCBI review. The reference sequence was derived from AAV35963. 
            Method: conceptual translation. 
FEATURES             Location/Qualifiers 
     source          1..354 
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                     /organism="Lactobacillus plantarum bacteriophage LP65" 
                     /virion 
                     /db_xref="taxon:298338" 
     Protein         1..354 
                     /product="orf143" 
                     /calculated_mol_wt=39890 
     Region          71..114 
                     /region_name="HNH" 
                     /note="HNH endonuclease; pfam01844" 
                     /db_xref="CDD:41868" 
     Region          200..247 
                     /region_name="IENR1" 
                     /note="Intron encoded nuclease repeat motif; Repeat of 
                     unknown function, but possibly DNA-binding via 
                     helix-turn-helix motif (Ponting, unpublished); smart00497" 
                     /db_xref="CDD:47801" 
     Region          272..321 
                     /region_name="IENR1" 
                     /note="Intron encoded nuclease repeat motif; Repeat of 
                     unknown function, but possibly DNA-binding via 
                     helix-turn-helix motif (Ponting, unpublished); smart00497" 
                     /db_xref="CDD:47801" 
     CDS             1..354 
                     /locus_tag="orf143" 
                     /coded_by="NC_006565.1:121037..122101" 
                     /note="similar to SPO1 gene 112" 
                     /transl_table=11 
                     /db_xref="GeneID:3197340" 
ORIGIN       
        1 mkkpvelwkt fpgsagieis sfgnvrsldg vkcsegyehy isgnyytnsr issgyrgvci 
       61 pidgkyvtkk vhrlvaqtfi pnpnnmpqvn hkdgdksnnn vsnlewctns yndkykkvfg 
      121 kslerpvyai nlstlevswf psqieagrsl gvnvghvnsv vkgkmkklsg ywfvedngdn 
      181 fnldkdrlre irvraqfryg vyainldtqe afhfksqqea gqslgvdsss insvlkgrlk 
      241 qaggyyfved tggdfkldkd klreikdemr fkggvyaidl etleafyfkt qrvagqelgi 
      301 dnsninkvlk gkqktakgyw fisdnekive ivrekfgdtv aneiamliak rqai 
 
 
Table 5.7 Features of head decoration protein of prophage MuMc02 from Roseobacter sp. MED193. 
LOCUS       ZP_01058443              419 aa            linear   BCT 30-JAN-2006 
DEFINITION  prophage MuMc02, head decoration protein, putative [Roseobacter sp. 
            MED193]. 
ACCESSION   ZP_01058443 
VERSION     ZP_01058443.1  GI:86139877 
DBSOURCE    REFSEQ: accession NZ_AANB01000014.1 
KEYWORDS    . 
SOURCE      Roseobacter sp. MED193 
  ORGANISM  Roseobacter sp. MED193 
            Bacteria; Proteobacteria; Alphaproteobacteria; Rhodobacterales; 
            Rhodobacteraceae; Roseobacter. 
REFERENCE   1  (residues 1 to 419) 
  AUTHORS   Pinhassi,J., Pedros-Alio,C., Ferriera,S., Johnson,J., Kravitz,S., 
            Halpern,A., Remington,K., Beeson,K., Tran,B., Rogers,Y.-H., 
            Friedman,R. and Venter,J.C. 
  TITLE     Direct Submission 
 173 
  JOURNAL   Submitted (26-JAN-2006) J Craig Venter Institute, 9704 Medical 
            Center Drive, Rockville, MD 20850, USA 
COMMENT     PREDICTED REFSEQ: The mRNA record is supported by experimental 
            evidence; however, the coding sequence is predicted. The reference 
            sequence was derived from EAQ43715. 
            Annotation was added by the NCBI Prokaryotic Genomes Automatic 
            Annotation Pipeline Group.  Information about the Pipeline can be 
            found here: 
            http://www.ncbi.nlm.nih.gov/genomes/static/Pipeline.html. Please be 
            aware that the annotation is done automatically with little or no 
            manual curation. 
            Method: conceptual translation. 
FEATURES             Location/Qualifiers 
     source          1..419 
                     /organism="Roseobacter sp. MED193" 
                     /strain="MED193" 
                     /db_xref="taxon:314262" 
     Protein         1..419 
                     /product="prophage MuMc02, head decoration protein, 
                     putative" 
                     /calculated_mol_wt=40699 
     CDS             1..419 
                     /locus_tag="MED193_12628" 
                     /coded_by="NZ_AANB01000014.1:95778..97037" 
                     /note="COG5295 Autotransporter adhesin" 
                     /transl_table=11 
ORIGIN       
        1 mantiqlkrr vsgnagapaa lksgevahne vddtlyigkg ddgggnatsi vaiagsggfv 
       61 aktgtqtiag kktfslvpta sqdaaagsdl vrksqldtll ggkantshsh aiadvtglqg 
      121 aldgkaavsh dhtaaeisds tsagrtllka advaaqhtal glgtaalmss tafaaaahgh 
      181 aisdvsglqt alngkaplas psftgtpaap taaggtnttq iattafvqsa iasfgagdml 
      241 katydsdndg kvdaaelada vawtgvtgkp atfppsahnh pisqvtglqs aldakapkvs 
      301 ptftgtptap taaggtsntq iattafvsaa iaalidaapg amdtlnelaa algddpdfat 
      361 tvtnglagkl ektsnlsdlt naatarsnlg lgsmatqaan nvaitggsis gialdggtf 
 
 
Table 5.8 Features of phage-related tail protein from Xanthomonas axonopodis. 
LOCUS       AAM35948                 686 aa            linear   BCT 29-MAY-2002 
DEFINITION  phage-related tail protein [Xanthomonas axonopodis pv. citri str. 
            306]. 
ACCESSION   AAM35948 
VERSION     AAM35948.1  GI:21107209 
DBSOURCE    accession AE011736.1 
KEYWORDS    . 
SOURCE      Xanthomonas axonopodis pv. citri str. 306 
  ORGANISM  Xanthomonas axonopodis pv. citri str. 306 
            Bacteria; Proteobacteria; Gammaproteobacteria; Xanthomonadales; 
            Xanthomonadaceae; Xanthomonas. 
REFERENCE   1  (residues 1 to 686) 
  AUTHORS   da Silva,A.C.R., Ferro,J.A., Reinach,F.C., Farah,C.S., Furlan,L.R., 
            Quaggio,R.B., Monteiro-Vitorello,C.B., Van Sluys,M.A., Almeida,N.F. 
            Jr., Alves,L.M.C., do Amaral,A.M., Bertolini,M.C., Camargo,L.E.A., 
            Camarotte,G., Cannavan,F., Cardozo,J., Chambergo,F., Ciapina,L.P., 
            Cicarelli,R.M.B., Coutinho,L.L., Cursino-Santos,J.R., El-Dorry,H., 
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            Faria,J.B., Ferreira,A.J.S., Ferreira,R.C.C., Ferro,M.I.T., 
            Formighieri,E.F., Franco,M.C., Greggio,C.C., Gruber,A., 
            Katsuyama,A.M., Kishi,L.T., Leite,R.P. Jr., Lemos,E.G.M., 
            Lemos,M.V.F., Locali,E.C., Machado,M.A., Madeira,A.M.B.N., 
            Martinez-Rossi,N.M., Martins,E.C., Meidanis,J., Menck,C.F.M., 
            Miyaki,C.Y., Moon,D.H., Moreira,L.M., Novo,M.T.M., Okura,V.K., 
            Oliveira,M.C., Oliveira,V.R., Pereira,H.A. Jr., Rossi,A., 
            Sena,J.A.D., Silva,C., de Souza,R.F., Spinola,L.A.F., Takita,M.A., 
            Tamura,R.E., Teixeira,E.C., Tezza,R.I.D., Trindade dos Santos,M., 
            Truffi,D., Tsai,S.M., White,F.F., Setubal,J.C. and Kitajima,J.P. 
  TITLE     Comparison of the genomes of two Xanthomonas pathogens with 
            differing host specificities 
  JOURNAL   Nature 417 (6887), 459-463 (2002) 
   PUBMED   12024217 
REFERENCE   2  (residues 1 to 686) 
  AUTHORS   da Silva,A.C.R., Ferro,J.A., Reinach,F.C., Farah,C.S., Furlan,L.R., 
            Quaggio,R.B., Monteiro-Vitorello,C.B., Van Sluys,M.A., Almeida,N.F. 
            Jr., Alves,L.M.C., do Amaral,A.M., Bertolini,M.C., Camargo,L.E.A., 
            Camarotte,G., Cannavan,F., Cardozo,J., Chambergo,F., Ciapina,L.P., 
            Cicarelli,R.M.B., Coutinho,L.L., Cursino-Santos,J.R., El-Dorry,H., 
            Faria,J.B., Ferreira,A.J.S., Ferreira,R.C.C., Ferro,M.I.T., 
            Formighieri,E.F., Franco,M.C., Greggio,C.C., Gruber,A., 
            Katsuyama,A.M., Kishi,L.T., Leite,R.P. Jr., Lemos,E.G.M., 
            Lemos,M.V.F., Locali,E.C., Machado,M.A., Madeira,A.M.B.N., 
            Martinez-Rossi,N.M., Martins,E.C., Meidanis,J., Menck,C.F.M., 
            Miyaki,C.Y., Moon,D.H., Moreira,L.M., Novo,M.T.M., Okura,V.K., 
            Oliveira,M.C., Oliveira,V.R., Pereira,H.A. Jr., Rossi,A., 
            Sena,J.A.D., Silva,C., de Souza,R.F., Spinola,L.A.F., Takita,M.A., 
            Tamura,R.E., Teixeira,E.C., Tezza,R.I.D., Trindade dos Santos,M., 
            Truffi,D., Tsai,S.M., White,F.F., Setubal,J.C. and Kitajima,J.P. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (28-NOV-2001) Departmento de Bioquimica, Universidade de 
            Sao Paulo, Av. Prof. Lineu Prestes 748, Sao Paulo, SP 05508-900, 
            Brazil 
COMMENT     Method: conceptual translation supplied by author. 
FEATURES             Location/Qualifiers 
     source          1..686 
                     /organism="Xanthomonas axonopodis pv. citri str. 306" 
                     /strain="306" 
                     /db_xref="taxon:190486" 
                     /note="pathovar: citri" 
     Protein         1..686 
                     /product="phage-related tail protein" 
     CDS             1..686 
                     /gene="stf" 
                     /coded_by="complement(AE011736.1:3489..5549)" 
                     /note="identified by sequence similarity; putative; ORF 
                     located using Blastx/Glimmer/Genemark" 
                     /transl_table=11 
ORIGIN       
        1 mdsskdsdne elmaetpgyv snaklaeris alvdrwntre gqmialltqp qgavtvtdgl 
       61 gkdhvlpsfl qlskdvselv deltgavsga sefanmarly aegaqasand aqtsaedaaq 
      121 qladatdqae asaasatasa asasasessn qsaglhdsaa sasaadadad aiqaanskaq 
      181 avasasaaas seaqaasyah qaedwsdhaq swanapagte iepgafsakh wseqakaslt 
      241 gtlvyrggwd agtgsfpsgg ntgafykvtt ggsiggrqyn pgdqivhngs gwdhidnteq 
      301 vtsvagksga vqlvpsdisg lgtlatrdsv dfsshvtnkp asyppsghmh tkgdvglsnv 
      361 dntsdankpv snaqqaaldt kapidkpsft ggvtvrnssl rlsgwggian dgvvyfgasd 
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      421 swlfkqgdaf rfqiegkfna sldssgtvwt sgnfnpaskv dmggqprfag vfvganndqy 
      481 fyaedanqsv vlrfgygtsf kyakwngvtg aftaphliag gsgngayvqi gddvrlvdig 
      541 rshttaiqst angnigflqf gtgptigwdg ttlqaagqel khagntgyyg vsgrqhsdwn 
      601 tcvtqgiwma vgatnspdns dwwlghvtvh ngdwvqqevi nftsnppkqf rrqrqggswg 
      661 acqqcgmviv sttdpggadg vlwiqp 
 
 
Table 5.9 Features of cell wall surface anchor family protein from Streptococcus agalactiae. 
LOCUS       AAN00330                 970 aa            linear   BCT 23-SEP-2002 
DEFINITION  cell wall surface anchor family protein [Streptococcus agalactiae 
            2603V/R]. 
ACCESSION   AAN00330 
VERSION     AAN00330.1  GI:22534491 
DBSOURCE    accession AE014259.1 
KEYWORDS    . 
SOURCE      Streptococcus agalactiae 2603V/R 
  ORGANISM  Streptococcus agalactiae 2603V/R 
            Bacteria; Firmicutes; Lactobacillales; Streptococcaceae; 
            Streptococcus. 
REFERENCE   1  (residues 1 to 970) 
  AUTHORS   Tettelin,H., Masignani,V., Cieslewicz,M.J., Eisen,J.A., 
            Peterson,S., Wessels,M.R., Paulsen,I.T., Nelson,K.E., Margarit,I., 
            Read,T.D., Madoff,L.C., Wolf,A.M., Beanan,M.J., Brinkac,L.M., 
            Daugherty,S.C., DeBoy,R.T., Durkin,S., Kolonay,J.F., Umayam,L.A., 
            Madupu,R., Lewis,M.R., Radune,D., Fedorova,N.B., Scanlan,D., 
            Khouri,H., Mulligan,S., Carty,H.A., Cline,R.T., Gill,J., 
            Scarselli,M., Mora,M., Iacobini,E.T., Brettoni,C., Galli,G., 
            Mariani,M., Vegni,F., Maione,D., Rinaudo,D., Rappuoli,R., 
            Telford,J.L., Kasper,D.L., Grandi,G. and Fraser,C.M. 
  TITLE     Complete genome sequence and comparative genomic analysis of an 
            emerging human pathogen, serotype V Streptococcus agalactiae 
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 99 (19), 12391-12396 (2002) 
   PUBMED   12200547 
REFERENCE   2  (residues 1 to 970) 
  AUTHORS   Tettelin,H., Masignani,V., Cieslewicz,M.J., Eisen,J.A., 
            Peterson,S., Wessels,M.R., Paulsen,I.T., Nelson,K.E., Margarit,I., 
            Read,T.D., Madoff,L.C., Wolf,A.M., Beanan,M.J., Brinkac,L.M., 
            Daugherty,S.C., DeBoy,R.T., Durkin,S., Kolonay,J.F., Umayam,L.A., 
            Madupu,R., Lewis,M.R., Radune,D., Fedorova,N.B., Scanlan,D., 
            Khouri,H., Mulligan,S., Carty,H.A., Cline,R.T., Gill,J., 
            Scarselli,M., Mora,M., Iacobini,E.T., Brettoni,C., Galli,G., 
            Mariani,M., Vegni,F., Maione,D., Rinaudo,D., Rappuoli,R., 
            Telford,J.L., Kasper,D.L., Grandi,G. and Fraser,C.M. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (18-JUL-2002) The Institute for Genomic Research, 9712 
            Medical Center Dr, Rockville, MD 20850, USA 
COMMENT     Method: conceptual translation. 
FEATURES             Location/Qualifiers 
     source          1..970 
                     /organism="Streptococcus agalactiae 2603V/R" 
                     /strain="2603V/R" 
                     /serotype="V" 
                     /db_xref="taxon:208435" 
     Protein         1..970 
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                     /product="cell wall surface anchor family protein" 
     CDS             1..970 
                     /gene="SAG1462" 
                     /coded_by="complement(AE014259.1:196..3108)" 
                     /note="identified by match to PFAM protein family HMM 
                     PF00746" 
                     /transl_table=11 
ORIGIN       
        1 msqktfgkql tvvdtksrvk mhkseknwvr tvmshfnlfk aikgratvea dvciqdveke 
       61 drlssgnlty lkgilaagal vggasltsrv yadetpvvqe qsssvptlae qtevtvkttt 
      121 vqnhqdgtvs kniidsnsvs msesaststs esvsmsmsgs tltsvsesvs tsaltsases 
      181 istsasesvs kstsisevsn iletqasltd kgresfsanq ivtesslvtd agknasvssl 
      241 ieitkpksel qtskmsnesl itpeksqvmi asdktgnesl tptirlksvi qprsmnlmtl 
      301 ssemdliple evsdtemlgk dvsselqkvn ialkdntlse pgtvkldsse nlvlnfafsi 
      361 asvnegdvft vklsdnldtq gigtilkvqd imdetgqlla tgsysplthn itytwtryas 
      421 tlnnikarvn mpvwpdqrii skttsdkqcf tatlnnqvas ieervqynsp svtehtnvkt 
      481 nvrsrimkld derqtetyit qinpegkemy fasglgnlyt iigsdgtsgs pvnllnaevk 
      541 ilktnsknlt dsmdqnydsp efedvtsqys ytndgskiti dwktnsisst tsyvvlvkip 
      601 kqsgvlystv sdinqtygsk ysyghtnisg dsdanaeikl lsesastsas tsastsasms 
      661 astsastsas msastsasts astsasmsas tsastsasts astsastsas msastsasts 
      721 astsastsas tsastsasms astsastsas tsastsasms astsastsas tsastsasms 
      781 astsastsas tsastsasms astsastsas tsastsasms astsastsas tsasmsasts 
      841 astsasmsas tsastsasms astsastsas msastsasts asmsastsas msattsasts 
      901 vstsastsas tsastsssss vtsnsskekv ysalpstgdq dysvtatalg lglmtgatll 
      961 grkkskkdkd 
 
 
Table 5.10 Features of α subunit of DNA polymerase III from Aquifex aeolicus. 
LOCUS       O67125                  1161 aa            linear   BCT 13-JUN-2006 
DEFINITION  DNA polymerase III subunit alpha. 
ACCESSION   O67125 
VERSION     O67125  GI:6014991 
DBSOURCE    swissprot: locus DPO3A_AQUAE, accession O67125; 
            class: standard. 
            created: Dec 15, 1998. 
            sequence updated: Aug 1, 1998. 
            annotation updated: Jun 13, 2006. 
            xrefs: AE000657.1, AAC07087.1, B70387 
            xrefs (non-sequence databases): GenomeReviews:AE000657_GR, 
            BioCyc:AAEO63363:AQ_1008-MONOMER, InterPro:IPR011708, 
            InterPro:IPR012340, InterPro:IPR004365, InterPro:IPR004013, 
            InterPro:IPR003141, InterPro:IPR004805, Pfam:PF07733, Pfam:PF02811, 
            Pfam:PF01336, SMART:SM00481, TIGRFAMs:TIGR00594 
KEYWORDS    Complete proteome; DNA replication; DNA-directed DNA polymerase; 
            Nucleotidyltransferase; Transferase. 
SOURCE      Aquifex aeolicus 
  ORGANISM  Aquifex aeolicus 
            Bacteria; Aquificae; Aquificales; Aquificaceae; Aquifex. 
REFERENCE   1  (residues 1 to 1161) 
  AUTHORS   Deckert,G., Warren,P.V., Gaasterland,T., Young,W.G., Lenox,A.L., 
            Graham,D.E., Overbeek,R., Snead,M.A., Keller,M., Aujay,M., 
            Huber,R., Feldman,R.A., Short,J.M., Olsen,G.J. and Swanson,R.V. 
  TITLE     The complete genome of the hyperthermophilic bacterium Aquifex 
            aeolicus 
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  JOURNAL   Nature 392 (6674), 353-358 (1998) 
   PUBMED   9537320 
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. 
            STRAIN=VF5 
COMMENT     On Jan 20, 2006 this sequence version replaced gi:7434831. 
            [FUNCTION] DNA polymerase III is a complex, multichain enzyme 
            responsible for most of the replicative synthesis in bacteria. This 
            DNA polymerase also exhibits 3' to 5' exonuclease activity. The 
            alpha chain is the DNA polymerase (By similarity). 
            [CATALYTIC ACTIVITY] Deoxynucleoside triphosphate + DNA(n) = 
            diphosphate + DNA(n+1). 
            [SUBUNIT] DNA polymerase III contains a core (composed of alpha, 
            epsilon and theta chains) that associates with a tau subunit. This 
            core dimerizes to form the PolIII' complex. PolIII' associates with 
            the gamma complex (composed of gamma, delta, delta', psi and chi 
            chains) and with the beta chain to form the complete DNA polymerase 
            III complex (By similarity). 
            [SUBCELLULAR LOCATION] Cytoplasm (By similarity). 
            [SIMILARITY] Belongs to the DNA polymerase type-C family. DnaE 
            subfamily. 
FEATURES             Location/Qualifiers 
     source          1..1161 
                     /organism="Aquifex aeolicus" 
                     /db_xref="taxon:63363" 
     gene            1..1161 
                     /gene="dnaE" 
                     /locus_tag="aq_1008" 
     Protein         1..1161 
                     /gene="dnaE" 
                     /locus_tag="aq_1008" 
                     /product="DNA polymerase III subunit alpha" 
                     /EC_number="2.7.7.7" 
     Region          1..1161 
                     /gene="dnaE" 
                     /locus_tag="aq_1008" 
                     /region_name="Mature chain" 
                     /experiment="experimental evidence, no additional details 
                     recorded" 
                     /note="DNA polymerase III subunit alpha. 
                     /FTId=PRO_0000103308." 
     Region          2..1138 
                     /gene="dnaE" 
                     /locus_tag="aq_1008" 
                     /region_name="DnaE" 
                     /note="DNA polymerase III, alpha subunit [DNA replication, 
                     recombination, and repair]; COG0587" 
                     /db_xref="CDD:30932" 
     Region          6..70 
                     /gene="dnaE" 
                     /locus_tag="aq_1008" 
                     /region_name="POLIIIAc" 
                     /note="DNA polymerase alpha chain like domain; DNA 
                     polymerase alpha chain like domain, incl; smart00481" 
                     /db_xref="CDD:47787" 
     Region          115..222 
                     /gene="dnaE" 
                     /locus_tag="aq_1008" 
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                     /region_name="PHP_C" 
                     /note="PHP domain C-terminal region; pfam02811" 
                     /db_xref="CDD:42765" 
     Region          1000..1075 
                     /gene="dnaE" 
                     /locus_tag="aq_1008" 
                     /region_name="tRNA_anti" 
                     /note="OB-fold nucleic acid binding domain; pfam01336" 
                     /db_xref="CDD:41388" 
ORIGIN       
        1 mskdfvhlhl htqfslldga ikidelvkka keygykavgm sdhgnlfgsy kfykalkaeg 
       61 ikpiigmeay fttgsrfdrk tktsednitd kynhhlilia kddkglknlm klstlaykeg 
      121 fyykpridye llekygegli altaclkgvp tyyasinevk kaeewvkkfk difgddlyle 
      181 lqannipeqe vanrnlieia kkydvkliat qdahylnped ryahtvlmal qmkktihels 
      241 sgnfkcsned lhfappeymw kkfegkfegw ekallntlev mektadsfei fenstyllpk 
      301 ydvppdktle eylrelaykg lrqriergqa kdtkeywerl eyelevinkm gfagyflivq 
      361 dfinwakknd ipvgpgrgsa ggslvayaig itdvdpikhg flferflnpe rvsmpdidvd 
      421 fcqdnrekvi eyvrnkyghd nvaqiitynv mkakqtlrdv aramglpyst adklaklipq 
      481 gdvqgtwlsl eemyktpvee llqkygehrt diednvkkfr qiceespeik qlvetalkle 
      541 gltrhtslha agvviapkpl selvplyydk egevatqydm vqleelgllk mdflglktlt 
      601 elklmkelik erhgvdinfl elplddpkvy kllqegkttg vfqlesrgmk ellkklkpds 
      661 fddivavlal yrpgplksgl vdtyikrkhg kepveypfpe lepvlketyg vivyqeqvmk 
      721 msqilsgftp geadtlrkai gkkkadlmaq mkdkfiqgav ergypeekir klwediekfa 
      781 sysfnkshsv aygyisywta yvkahypaef favklttekn dnkflnlikd aklfgfeilp 
      841 pdinksdvgf tiegenrirf glarikgvge etakiivear kkykqfkgla dfinktknrk 
      901 inkkvvealv kagafdftkk krkellakva nsekalmatq nslfgapkee veeldplkle 
      961 kevlgfyisg hpldnyekll knrytpiedl eewdkeseav ltgvitelkv kktkngdyma 
     1021 vfnlvdktgl iecvvfpgvy eeakelieed rvvvvkgfld edletenvkf vvkevfspee 
     1081 fakemrntly iflkreqaln gvaeklkgii ennrtedgyn lvltvdlgdy fvdlalpqdm 
     1141 klkadrkvve eieklgvkvi i 
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